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The NF-κB signaling pathway performs a pivotal role in the acute-phase of 
microbial infection, by activating immune-related gene expression. The NF-κB 
transcription factors are evolutionarily conserved from Drosophila to humans.  
Unexpectedly, the canonical NF-κB signaling pathway is not functional in the immune 
system of C. elegans.  Therefore, the ancient origin of NF-κB signaling pathway is still 
unknown.  This project focused on tracing the ancient origin of the NF-κB signaling 
pathway, characterization of its functions in innate immune response and regulation of its 
activity by thioredoxin.  To this end, the horseshoe crab was examined as this species 
boasts >500 million years of evolutionary success. 
This thesis reports the discovery and characterization of a primitive and functional 
NF-κB/IκB cascade in the immune defense of a “living fossil”, the horseshoe crab, 
Carcinoscorpius rotundicauda.  The ancient NF-κB/IκB homologues, CrNFκB, CrRelish 
and CrIκB, share numerous signature motifs with their vertebrate orthologues.  CrNFκB 
recognizes both horseshoe crab and mammalian κB response elements.  CrIκB interacts 
with CrNFκB and inhibits its nuclear translocation and DNA-binding activity.  We 
further show that Gram-negative bacteria infection causes rapid degradation of CrIκB 
and nuclear translocation of CrNFκB.  Infection also leads to an increase in the κB-
binding activity and up-regulation of immune-related gene expression, like inducible 
nitric oxide synthase and Factor C, an LPS-activated serine protease.  Altogether, our 
study shows that, although absent in C. elegans, the NF-κB/IκB signaling cascade 
 vi
remained well-conserved from horseshoe crab to human playing an archaic but 
fundamental role in regulating the expression of critical immune defense molecules. 
  In connection with the NF-κB mediated immune signaling, we discovered a 
novel 16 kDa thioredoxin (TRX) from the horseshoe crab, designated Cr-TRX1.  TRX is 
a small ubiquitous protein-disulfide reductase, hitherto known to be conserved from 
prokaryotes to human.  This novel 16 kDa TRX is larger than the known classical 12 kDa 
counterpart and contains an atypical WCPPC catalytic motif.  Although Cr-TRX1 
contains three Cys, only the two in its active motif are exposed and redox sensitive.  Cr-
TRX1 possesses the classical thiodisulfide reductase activity, as indicated by the insulin 
reduction assay and thioredoxin reductase assay.  Additionally, Cr-TRX1 protected DNA 
from reactive oxygen species-mediated nicking.  Over-expression of Cr-TRX1 regulated 
the expression of NF-κB-dependent genes by enhancing NF-κB DNA-binding activity, 
suggesting possible roles of the Cr-TRX1 in modulating NF-κB signaling pathway.  In 
vivo, the antioxidant downregulated the expression of NF-κB controlled genes, such as 
IκB and inducible nitric oxide synthase, which further supports our suggestion that 
oxidative stress is a regulator of NF-κB signaling pathway, a phenomenon which has 
been entrenched for several hundred million years.   Furthermore, we demonstrated that 
the 16 kDa TRXs are evolutionarily conserved from C. elegans to human.  Interestingly, 
thioredoxin-like 6, a human homologue of Cr-TRX1, could enhance the NF-κB DNA-
binding activity as well, suggesting that the NF-κB regulatory ability of the 16 kDa TRXs 
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CHAPTER 1:  INTRODUCTION 
 
1.1 The innate immune system 
1.1.1 The innate and adaptive immunity 
The immune response is the body's natural defense mechanism that protects us 
from foreign invaders, such as viruses and bacteria.  The vertebrate immune system uses 
two types of defense mechanisms to combat pathogens –the innate immunity and the 
adaptive immunity (Medzhitov and Janeway, 2000).  Adaptive immunity is mediated by 
T and B cells by generating antigen-specific antibody through DNA rearrangement, and 
responding specifically to pathogens.  The cornerstone of vertebrate adaptive immunity is 
the possibility to “remember” previous infections through generating long living memory 
cells and thereby mount a faster and stronger immune reaction the next time the 
individual encounters the same pathogen.  However, the adaptive immunity is far too 
slow to take care of invading microorganisms by its own.  The sequence of events from 
the adaptation to the antigens, the maturation of B lymphocytes and thence the production 
of such a repertoire of antibodies takes several days to be established after an infection 
(Janeway and Medzhitov, 2002).  On the other hand, innate immunity is the immediate 
front line defense that also shapes the ensuing adaptive immunity.  Without the presence 
of the innate immune system, the adaptive immunity would not even have a chance to 
initiate its defense, before the host organism is dead. 
The innate immune system is phylogenetically the oldest immune system and is 
present in all higher eukaryotic organisms.  Although by the late nineteenth and early 
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twentieth century, important advances had been made in the study of innate immunity in 
invertebrates; such as the finding that insects have macrophage-like cells and produce a 
variety of antimicrobial substances (Kurz and Ewbank, 2003),  it was only comparatively 
recent that the attention of the scientific community turned towards innate immunity.  
This was partially, a result of the realization that even in the vertebrates, the innate 
immune mechanisms are extremely important –they can often successfully block 
infections at an early stage, and if not, they can influence the subsequent adaptive 
immune response (Medzhitov and Janeway, 1998).  In contrast to the adaptive immune 
system, the innate immune system is functional at birth and includes the first line of 
defense against foreign agents.  Innate immunity is mediated by a repertoire of 
recognition molecules and responds non-specifically to a broad-spectrum of invaders 
(Janeway and Medzhitov, 2002).  Upon the recognition of invading pathogens by the 
receptors, the innate immune system rapidly mounts various responses including 
phagocytosis, synthesis of antimicrobial peptides, production of reactive oxygen species, 
and activation of the alternative complement pathway to contain the proliferation of 
infective pathogens until the adaptive immune response is ready to execute effective 
defense actions (Akira and Takeda, 2004). 
 
1.1.2 Recognition of pathogens by pattern recognition receptors 
The first step in innate immune responses is the recognition of microbial 
components by the germ-line encoded receptors, called pattern recognition receptors, 
PRRs (Medzhitov and Janeway, 2000).  In contrast to the amazing diversity of the T- and 
B-cell receptors of adaptive immunity, which are generated by somatic recombination 
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and hypermutation events, the repertoire of PRRs is much more restricted due to the 
limited number of genes encoded in the genome of every organism.  To overcome this 
limitation, rather than detect every possible antigen, the PRRs have evolved to recognize 
invariant molecular motifs common for the large groups of microorganisms.  These 
pathogen-specific molecular motifs are called pathogen-associated molecular patterns 
(PAMPs).  Furthermore, most PRRs have evolved into multiple isoforms, which interact 
in variable combinations during an infection to form formidable pathogen recognition 
assemblies (Ng et al, 2004; Zhu et al, 2005).  This feature not only allows the detection 
of a wide variety of microorganisms by a restricted repertoire of PRRs but also ensures 
that the innate immune system mounts the most appropriate responses at the critical time 
of infection.  Examples of PAMPs are lipopolysaccharide (LPS) of the Gram-negative 
bacteria, lipoteichoic acid of Gram-positive bacteria; zymosan, mannan and β-glucan of 
fungi (Aderem and Ulevitch, 2000).  On recognition, those receptors activate signaling 
cascades that regulate the transcription of target genes encoding regulator and effector 
molecules.  One outcome of the recognition, which is probably common to all animals, is 
the induction of genes encoding antimicrobial peptides that act by damaging the 
microbial cell membranes (Lehrer and Ganz, 1999; Li et al, 2004). 
 
1.1.3 The innate immunity of invertebrates 
As the first line of defense against infectious microorganisms, innate immunity is 
an evolutionarily ancient mechanism in many aspects.  Due to the lack of adaptive 
immunity, the invertebrates have developed a potent innate immune system.  Indeed, the 
findings over the last decade have demonstrated that the study of innate immunity in 
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invertebrates can aid our understanding of how mammals defend themselves against 
infection (Kurz and Ewbank, 2003).  The invertebrate innate immunity is mainly 
composed of three parts: (i) cellular response, namely phagocytosis of invading 
microorganisms by blood cells, (ii) proteolytic cascades leading to localized blood 
clotting, melanin formation, and opsonization, and (iii) transient expression of potent 
antimicrobial peptides (Hoffmann et al, 1999).  Other important components include 
nitric oxide synthase, clotting reaction and serine protease inhibitors (Little et al, 2005).   
Among all the mechanisms, the strong and rapid induction of antimicrobial 
peptides in Drosophila is most well-studied and serves as a model system for the analysis 
of innate immunity (Imler and Bulet, 2005).  At least seven distinct antimicrobial 
peptides have been isolated in Drosophila.  Among them, drosomycin is potently 
antifungal, whereas the others (cecropins, diptericin, drosocin, attacin, defensin, and 
metchniknowin) act primarily on bacteria (Lemaitre et al, 1996).  The production of 
antimicrobial peptides is slightly delayed and usually occurs within a few hours after 
entry of the pathogen.  Obviously, the recognition of the foreign particles has to take 
place in order to transfer the message to the cells that synthesize the appropriate immune 
effectors. Recognition of the invading pathogen in Drosophila is believed to occur 
through the Toll receptor on the membrane and transmitted to the downstream signaling 
pathways.  Several signaling pathways have been reported to control the innate immune 
response in Drosophila such as JAK/STAT, NF-κB and JNK signaling pathways 
(Agaisse and Perrimon, 2004; Boutros et al, 2002).  Within the scope of this thesis, the 
following sections will focus on the significance of NF-κB-mediated signaling pathway 
to the host defense against infections. 
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1.2 The NF-κB signaling pathway 
1.2.1 Introduction to the NF-κB signaling pathway 
The NF-κB signaling pathway is one of the most important pathways in innate 
immunity because it controls the expression of numerous immune-related genes including 
antimicrobial peptides, cytokines and enzymes for the production of reactive oxygen and 
nitrogen species (ROS, RNS) (Dixit and Mak, 2002; Ghosh et al, 1998).  NF-κB 
transcription factors are the central components of the NF-κB signaling pathway as all of 
the signals will be conveyed to various isoforms of the NF-κB transcription factors.  
Different stimuli cause the formation of different hetero- or homo- dimers of NF-κB 
proteins which control the specificity and duration of the immune response (Hayden and 
Ghosh, 2004).  Up to now, five NF-κB transcription factors have been found in mammals: 
RelA (p65), RelB, c-Rel, NF-κB1 (p105/p50) and NF-κB2 (p100/p52) (Figure 1.1).  A 
common feature of the NF-κB proteins is that all of them contain a Rel-homology 
domain (RHD) which is located towards the N-terminus of the protein.  The RHD is 
involved in the dimerization, DNA-binding and interaction with the inhibitory IκB 
(inhibitor of NF-κB) proteins.  The difference is that RelA, RelB and c-Rel have an 
activation domain in their C-terminal which is absent in NF-κB1 and NF-κB2 (Figure 
1.1).  On the contrary, NF-κB1 and NF-κB2 contain a C-terminal inhibitory IκB-like 
domain which are later processed to produce the DNA-binding subunits, p50 and p52, 
respectively (Gilmore, 1999).  
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The NF-κB members dimerize to form homo- or hetero-dimers, which are 
associated with specific responses to different stimuli and they induce differential effects 
on transcription.  The balance between different NF-κB homo- and hetero-dimers will 
determine which dimers are bound to specific κB sites and thereby regulate the level of 
transcriptional activity (May and Ghosh, 1997).  In addition, these proteins are expressed 
in a cell- and tissue-specific manner providing an additional level of regulation.  For 
example, NF-κB1 (p50) and p65 are ubiquitously expressed, and the p65/p50 
heterodimers constitute the most common inducible NF-κB binding activity.  In contrast, 
NF-κB2, RelB, and c-Rel are expressed specifically in lymphoid cells and tissues 
(Caamano and Hunter, 2002).   
In unstimulated cells, NF-κB dimers are retained in the cytoplasm in an inactive 
form, because of their association with members of another family of proteins called IκB.  
The IκB family of proteins includes IκBα, IκBβ, IκBγ, IκBε, Bcl-3, and the carboxyl-
terminal regions of NF-κB1 (p105) and NF-κB2 (p100) (Figure 1.1).  The IκB proteins 
are characterized by the presence of five to seven ankyrin repeats that assemble into 
cylinders that bind the dimerization domain of NF-κB dimers (Hatada et al, 1992).  The 
IκB proteins bind with different affinities and specificities to NF-κB dimers.  Activation 
of the NF-κB proteins requires phosphorylation and subsequent degradation of the IκB 
inhibitors, thus allowing the translocation of NF-κB into the nucleus for the 
transcriptional activation of genes harbouring κB response elements.  Therefore, not only 
are there different NF-κB dimers in a specific cell type, but the large number of 
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combinations between IκB and NF-κB dimers illustrates the sophistication of the system 














Figure 1.1: The family of mammalian NF-κB and IκB proteins.  (A) Schematic representation 
of the seven mammalian NF-κB proteins — RelA/p65, c-Rel, RelB, p105, p50, p100 and p52. 
The N-terminal portion of the RHD is responsible for DNA-binding. The C-terminal portion of 
the RHD mediates dimerization with other NF-κB family members and binds to the IκB proteins. 
The p105 and p100 proteins also contain ankyrin repeats (circles), as well as glycine-rich regions 
(GRRs). The GRRs are important for processing of p100 to p52. Phosphorylation of p65 at S276, 
S311, S529 and/or S536 is required for optimal NF-κB transcriptional activity. Acetylation of p65 
at K122, K123, K218, K221 and K310 regulates distinct functions of NF-κB, including DNA 
binding, IκBα association and p65-mediated transactivation. (B) The family of IκB proteins. The 
IκB family protein includes IκBα, IκBβ, IκBγ, IκBε and BCL3.  A hallmark of these IκB proteins 
is an ankyrin-repeat domain, which mediates the assembly with NF-κB proteins. When bound by 
IκBα, the nuclear localization signal (NLS) of p65 is masked, and p65 cannot localize to the 
nucleus or bind to DNA.  Phosphorylation of two serine residues (SS) at the amino-terminal 
region of IκBα triggers polyubiquitylation and proteasome-mediated degradation of IκBα.  





In mammals, two major signaling pathways (the classical and alternative 
pathways) lead to the translocation and activation of NF-κB dimers (Bonizzi and Karin, 
2004).  In the classical pathway, NF-κB family proteins are sequestered in the cytoplasm 
by their natural inhibitor, IκB proteins.  Bacterial factors such as lipopolysaccharides 
(LPS) and peptidoglycans can be recognized by the Toll-like receptor (TLR) on the cell 
membrane.  TLRs are evolutionarily conserved PRRs that recognize conserved PAMPs 
present on the surface of various microbes.  Up to now, 11 mammalian TLRs have been 
described and different TLRs can recognize different PAMPs including LPS, 
peptidoglycan, DNA, RNA and flagellin.  After recognition, the TLR will convey signals 
stimulated by these factors, through the adapter proteins such as MyD88 and TRAF6 to 
the IκB kinase (IKK) complex (Hayden and Ghosh, 2004).   
The IKK complex comprises IKKα and IKKβ catalytic subunits and IKKγ 
regulatory subunits.  In the classical NF-κB pathway, the IKKβ will phosphorylate the 
IκBs (Ghosh et al, 1998).  The phosphorylated IκB proteins are then degraded by the 
proteasome via the ubiquitin pathway (Figure 1.2).  The degradation of IκB unmasks the 
nuclear localization signal (NLS) of the NF-κB protein, leading to its nuclear 
translocation.  In the nucleus, NF-κB transcription factor binds to the promoter of various 
genes with the consensus κB sequence, 5’–GGGRNNYYCC–3’, and upregulate the 
expression of these target genes (Bonizzi and Karin, 2004).  The activation and nuclear 
translocation of classical NF-κB dimers (mostly p50-p65) activate the expression of 
genes encoding chemokines, cytokines and adhesion molecules.  These molecules are 
important components of the innate immune response to invading pathogens and are 
required for the ability of inflammatory cells to migrate into areas where NF-κB is being 
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activated (Bonizzi and Karin, 2004).  The activated NF-κB pathway can then be 
downregulated through multiple mechanisms, such as the synthesis of IκBα proteins. 
Recently, a new pathway for NF-κB activation that is strictly dependent on IKKα 
but not IKKβ and IKKγ was described (Figure 1.2) (Senftleben et al, 2001).  The 
alternative pathway is activated by LTβ (lymphotoxin), BAFF (B-cell activating factor) 
and CD40L (CD40 ligand) and leads to the phosphorylation and processing of p100, 
generating the p52/RelB heterodimers.  It has been shown that the NF-κB inducing 
kinase (NIK) is responsible for directly phosphorylating and activating IKKα; however 
events that occur upstream of NIK are still unclear.   
Because LTβ, BAFF and CD40L also activate the classical pathway, it would 
appear that intracellular signaling domains of these receptors possess additional sequence 
motifs that allow their coupling to NIK and activation of the alternative pathway (Hayden 
and Ghosh, 2004).  Many findings strongly support that the alternative pathway plays a 
central role in the expression of genes involved in the development and maintenance of 
secondary lymphoid organs (Bonizzi and Karin, 2004).  Based on evolutionary 
considerations, the original function of the NF-κB signaling pathway was the activation 
of innate immune responses.  Indeed, the function of IKK and NF-κB in the fruit fly is in 
the activation of innate immune responses.  Thus, it has been proposed that the function 
of the alternative NF-κB pathway in adaptive immunity and lymphoid organ 








Figure 1.2: Classical and alternative NF-κB signaling pathway. (A) The classical NF−κB 
pathway is activated by a variety of inflammatory signals, resulting in coordinate expression of 
multiple inflammatory and innate immune genes.  The proinflammatory cytokines IL-1β and 
TNF-α activate NF-κB, and their expression is induced in response to NF-κB activation, thus 
forming an amplifying feed forward loop. (B) The alternative pathway for NF-κB results in 
nuclear translocation of p52–RelB dimmers, which is strictly dependent on IKKα homodimers 
and is activated by LTβR, BAFF and CD40L by NIK. Many data strongly suggest that the 
alternative pathway plays a central role in the expression of genes involved in development and 
maintenance of secondary lymphoid organs. Abbreviations: BAFF, B-cell-activating factor 
belonging to the TNF family; BLC, B-lymphocyte chemoattractant; CD40L, CD40 ligand; COX-
2, cyclooxygenase 2; ELC, Epstein–Barr virus-induced molecule 1 ligand CC chemokine; GM-
CSF, granulocyte–macrophage- colony-stimulating factor; ICAM-1, intercellular adhesion 
molecule 1; IKK, IκB kinase; IL-1β, interleukin-1β; iNOS, inducible nitric oxide synthase; LT, 
lymphotoxin; MCP-1, monocyte chemotactic protein-1; MIP-1α, macrophage inflammatory 
protein-1α; NIK, NF−κB-inducing kinase; PLA2, phospholipase 2; SDF-1, stromal cell-derived 
factor-1α; SLC, secondary lymphoid tissue chemokine; TLRs, Toll-like receptors; VCAM-1, 





1.2.2 NF-κB signaling pathway in Drosophila 
The NF-κB signaling pathway is conserved in many different species, 
underscoring its pivotal role in immune response.  Studies on Drosophila NF-κB 
signaling pathway have had a major impact on this field, leading to the key discoveries 
on the fundamental concepts on how organisms effectively fight pathogens (Hoffmann, 
2003).  In Drosophila, three NF-κB homologues have been described -Dorsal, Dif, and 
Relish (Figure 1.3).  Of these three NF-κB proteins, Dif is the predominant transactivator 
in the antifungal and anti-Gram-positive bacterial defense in adults.  Dorsal can substitute 
for Dif in the larvae (Baeuerle and Baltimore, 1996; Rutschmann et al, 2000).  Both 
Dorsal and Dif can be activated by a transmembrane protein called Toll, which is a 
homologue of human TLR.  Two main groups of microorganisms (Gram-positive 
bacteria and fungi) can induce the Toll pathway.  Among Gram-positive bacteria, 
Micrococcus luteus is a very strong inducer of this pathway.  In contrast to what has been 
proposed for the TLRs in mammals, Drosophila Toll is not a bona fide pattern 
recognition receptor for microbial substances, but binds instead to the cleaved form of its 
endogenous ligand, Spätzle (Schneider et al, 1994).  The recognition of Gram-positive 
bacteria requires PGRP-SA, which initiates an extracellular signaling cascade (Royet et 
al, 2005).  Recently, Wang et al (2006a) found that gram-negative binding protein 1 
(GNBP1) is essential for for sensing of pepitoglycan (PG) by PGRP-SA and the 
interaction between these proteins and PG is essential for downstream signaling.  
Downstream of the extracellular signaling events is the cleavage of Spätzle, which then 
binds to and activates the Toll receptor (Belvin and Anderson, 1996). 
 12
Most of the intracellular signaling components of the Toll pathway are related to 
factors of the human IL-1 and Toll-like receptor pathways (Hoffmann and Reichhart, 
2002).  Upon activation, Toll binds to the intracellular adapter protein, MyD88, which is 
a homologue of the adapter protein MyD88 in mammals.  Then the signal is transmitted 
to Pelle (a homologue of mammalian IRAK) which leads to the phosphorylation of 
Cactus (Figure 1.3) (Hoffmann et al, 1999).  Cactus is a homologue of the mammalian 
IκB protein, which keeps transcription factors of Dorsal and Dif at the resting stage, 
preventing them from entering the nucleus (Geisler et al, 1992).  The phosphorylation of 
Cactus is believed to be mediated by an unknown serine protease, which leads to its 
degradation.  Like IκB, the ubiquitin/proteasome pathway is required for signal-
dependent Cactus degradation.  Mutants in slimb, the Drosophila β-TrCP homolog, 
exhibit defects in dorsoventral patterning (Spencer et al, 1999).  Like the mammalian NF-
κB proteins, after the inhibitor Cactus is degraded, Dif and Dorsal are released and 
translocated into the nucleus (Figure 1.3).  Thus, it appears that the mechanisms involved 
in the activation of the Drosophila Dorsal and Dif proteins during antifungal immunity 
are highly similar to those required for the activation of NF-κB in mammals.   
The most specific target gene of the Toll pathway is Drosomycin, which have 
antifungal activity (Silverman and Maniatis, 2001).  The Toll/Dif pathway also partially 
activates the expression of Cecropins and Attacins and seems to be indispensable for 
some Gram-positive bacterial infections.  However many insect antibacterial genes, 
including cecropin, defensin and diptericin are not regulated by Dorsal or Dif.  It suggests 
that an additional NF-κB transcription factor is involved in responding to microbial 
infection in Drosophila. Indeed, the third NF-κB protein known as Relish was described 
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in 1996, which is the homolog of the mammalian p105 and p100 proteins (Dushay et al, 
1996).  
 
Figure 1.3:  The Drosophila NF-κB signaling pathway. (A) Toll/anti-fungal signaling pathway. 
The pattern recognition receptors that recognize fungal pathogens are believed to activate a serine 
protease cascade, culminating in the cleavage of the Toll ligand Spätzle. Ligand binding to Toll 
leads to the recruitment of two proteins, the adaptor Tube and the kinase Pelle. Recruitment of 
Pelle is thought to cause its activation and disassociation from Toll. Activated Pelle may then 
activate, directly or indirectly, a Cactus kinase that is responsible for signaling the proteasome-
mediated degradation of Cactus. Currently, the biochemical steps between Pelle and Cactus 
degradation remain undetermined, and the Cactus kinase has not yet been identified.  (B) The 
antibacterial signaling pathway. In this model, the signaling pathway is activated by LPS through 
unidentified receptor(s) and leads to Relish cleavage. Downstream of the receptors, this signaling 
pathway bifurcates. One part leads to activation of the Drosophila IKK complex, which then 
phosphorylates Relish. The other part functions through the caspase Dredd and leads to the 
cleavage of phosphorylated Relish. At present it is not known whether Dredd acts directly or 
indirectly to cleave Relish. The Imd protein may function in one or both of these pathways. N: 







Compared to Dorsal and Dif, Relish contains both the transcription factor and the 
inhibitor in one protein (see Figure 1.1A).  Like mammalian p105 and p100, the Relish 
contains the N-terminal Rel-homology domain and the C-terminal IκB-like domain 
(Dushay et al, 1996).  This Relish pathway shares similarity with the human TNF 
pathway, however there is no TNF receptor homolog found in Drosophila.  Subsequently, 
it was shown that the putative transmembrane protein PGRP-LC is the receptor of the 
Relish pathway (Choe et al, 2002).  Intracellular activation of the Relish pathway 
commences with recruitment of Imd, a death domain protein sharing similarities with the 
mammalian TNF-α receptor interacting protein, RIP, although the mechanism of how 
PGRP-LC signals to Imd is still unknown.   
In unstimulated cells the Relish C-terminal IκB module sequesters its own N-terminal 
NF-κB module in the cytoplasm.  Upon activation of the antibacterial signaling pathway, 
Relish is proteolytically cleaved and the N-terminal NF-κB module translocates into the 
nucleus (Figure 1.3B), while the stable C-terminus remains in the cytoplasm.  The 
activation of Relish requires the Drosophila IKKγ homolog, Kenny, for which Relish is 
the substrate (Silverman et al, 2000).  Genetic studies with mutant flies for the Relish 
gene revealed that the Relish pathway has influence on all antimicrobial peptides.  The 
Diptericin gene stands solely under the regulation of Relish, while all the other genes are 
also partially influenced by Dif  (Hedengren et al, 1999).  It suggests that different 
members of the NF-κB family are activated to regulate distinct sets of antimicrobial genes 
in response to different pathogens. 
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1.2.3 Evolution and conservation of NF-κB signaling pathway 
An intriguing parallel to the human NF-κB signaling pathway also exists in other 
insects and vertebrates such as mosquito, beetle and zebrafish.  The second NF-κB 
homologue in invertebrates was cloned from Anopheles gambiae, a species of mosquito 
(Barillas-Mury et al, 1996).  Gambif, which is the mosquito orthologue of Dorsal, has 
been characterized and shown to translocate to the nucleus following bacterial infection.  
In 2002, a Relish-like NF-κB protein was described in Aedes aegypti, another species of 
mosquito (Shin et al, 2002).  The A. aegypti Relish gene has three alternatively spliced 
transcripts encoding three different proteins: full length Relish, IκB-type, which lacks the 
Rel homology domain (RHD) and the Rel-type in which the carboxy-terminal ankyrin 
repeats are missing.  The involvement of A. aegypti Relish in the regulation of immune 
response to bacterial challenge has been shown using transgenic mosquitoes (Shin et al, 
2003).  Although no orthologue of Dif has been found in the mosquito genome, the 
identification of the mosquito orthologue of MyD88, Tube and Pelle indicates that the 
Toll pathway in the mosquito is at least partially conserved (Christophides et al, 2002).  
The absence of a Dif orthologue in the mosquito genome suggests that Dorsal may play a 
functional role in the mosquito Toll-mediated innate immune responses.  Indeed, Shin et 
al. (2005) found that AaREL1, the mosquito homologue of Drosophila Dorsal, is a key 
regulator of the Toll antifungal immune pathway in A. aegypti female mosquitoes. 
The evolutionary conservation of NF-κB transcription factors was further 
demonstrated by the cloning and characterization of NF-κB proteins in zebrafish, beetles 
and mollusk in 2004 (Correa et al, 2004; Montagnani et al, 2004; Sagisaka et al, 2004).  
The evolutionary conservation of the NF-κB transcription factors, from Drosophila to 
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humans, probably suggests that the NF-κB signaling pathways of Drosophila and humans 
have evolved from a common ancestral family of building blocks (Hoffmann and 
Reichhart, 2002).  
 
1.2.4 TLR/NF-κB signaling pathway in C. elegans 
Unexpectedly, the NF-κB signaling pathway seems not to be conserved in the C. 
elegans.  Although sequence comparisons show the worm possesses homologues of 
certain components of the NF-κB pathway (Figure 1.4), the genetic studies showed that 
these functional homologues (Toll, Traf, Cactus) in C. elegans  are not involved in 
resistance to  pathogen infection (Pujol et al, 2001).   Most strikingly, there is no obvious 
NF-κB homologue in the genome of the C. elegans (Figure 1.4) (Pujol et al, 2001).  
These observations suggest that the classical NF-κB signaling pathway is not functional 
in the immune system of C. elegans (Kim and Ausubel, 2005).  Those findings indicate 
that the NF-κB signaling pathway should have originated in a species between C. elegans 
and Drosophila in the evolutionary chain.  However, the origin of the NF-κB signaling 
pathway remains unknown.  Furthermore, whether the similarities between Drosophila 
and human NF-κB signaling pathway have resulted from convergent evolution or 
reflected common ancestral pathways is still a conundrum.  As Hoffmann and Reichhart 
(2002) have suggested, more information on the NF-κB-signaling pathway in species 









Figure 1.4: The NF-κB signaling pathways in human, Drosophila and C. elegans.  (A) A 
simplified Toll signaling pathway in Drosophila (a) compared to the mammalian TLR4 pathway 
(b). Homologues of some, but not all, of these proteins can be found in C. elegans (c). (B) A 
simplified Imd signaling pathway in Drosophila (a) compared to the mammalian tumor necrosis 
factor (TNF) pathway (b). Activation of the Drosophila Toll and Imd pathways leads to the 
nuclear import of Relish-type transcription factors. Crosses indicate the degradation of 
Cactus/IκB. CD, cluster of differentiation; Dif, Dorsal-related immunity factor; DREDD, death-
related cell death abnormality-3 (ced-3)/Nedd2-like; FADD, Fas-associated death domain protein; 
Ird, immune response deficient; Imd, immune deficiency; IRAK, interleukin 1 receptor associated 
kinase; IRD, immune response deficient; MEKK, mitogen-activated protein kinase kinase; MOM, 
more of MS; NF, nuclear factor; PIK, Pelle/IRAK homologue; RIP, receptor interacting protein; 
TAK, TGFβ activated kinase; TOL, Toll homologue; TRAF, TNF receptor associated factor; 




1.2.5 Some clues on the possible existence of NF-κB signaling pathway   
in the horseshoe crab 
The horseshoe crab, commonly referred to as Limulus is one of the most ancient 
arthropods, which has survived unchanged for almost ~550 million years (Størmer, 1952). 
It has evolved a formidable host defense system (Iwanaga, 2002).  Therefore, it will be 
interesting to examine if horseshoe crab harbors an NF-κB signaling pathway, as it will 
be helpful in the understanding of the origin and evolution of this crucial innate immune 
signaling pathway.  Recently, Inamori et al (2004) reported the presence of TLR in the 
horseshoe crab.  However the existence of TLR does not necessarily suggest the presence 
of NF-κB proteins as was observed in the C. elegans (Kim and Ausubel, 2005).  Thus, 
the question of whether the horseshoe crab possesses functional NF-κB homologue 
remains uncertain.  Recently, in our laboratory, it has been found that the Factor C (the 
LPS-activated serine protease that triggers the coagulation cascade in immune defense) 
promoter contains several functional κB motifs, suggesting the possible existence of NF-
κB transcription factor in this ancient animal (Wang et al, 2003).  Besides this clue, there 
is no direct evidence to demonstrate the presence of NF-κB transcription factor in the 
horseshoe crab.  Thus, the issue of whether the ancient origin of the NF-κB signaling 
cascade can be traced back to this “living fossil” remains a mystery.  Therefore, we 
decided to investigate if the NF-κB signaling pathway also existed in the horseshoe crab 
and the function of the ancient NF-κB signaling pathway in innate immunity in this 
archaic arthropod species.  The cloning of NF-κB transcription factors from horseshoe 
crab will provide critical insights into the evolution of the NF-κB transcription factor.  
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This will clarify the viewpoint that the NF-κB signaling cascade originated from a 
common ancestral family of building blocks and was already present in the Urbilateria 
(Hoffmann and Reichhart, 2002). 
 
1.3 Thioredoxins and their roles in regulating immune 
response 
 
1.3.1 Reactive oxygen species (ROS) and antioxidant system 
It is well known that ROS plays important roles in immune defense by directly 
killing the pathogen, or as a signaling molecule (Flohe et al, 1997; Nakano et al, 2006; 
Segal, 2005; Swain et al, 2002).  Although the ROS response is designed to restrict any 
damage to the smallest possible region where the pathogen is located, some of the ROS 
inevitably leak into the surrounding areas where they have the capacity to inflict tissue 
damage at sites of inflammation (Swain et al, 2002).  Thus, it is essential that the host 
defense responses of these cells are finely tuned to result in the appropriate level of 
oxidative response to any given situation.  To protect themselves against ROS toxicity, 
the hosts have developed different antioxidant systems.  Amongst these are low 
molecular weight antioxidant molecules, such as ascorbic acid, uric acid and glutathione 
(GSH) as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase, 
glutathione peroxidase (GPX), glutathione reductase (GR) and the thioredoxin (TRX) 
system (Nakano et al, 2006).  Figure 1.5 illustrates the mechanisms for the generation of 
ROS in the mitochondria and their elimination by cellular antioxidants.  Within the scope 
of this thesis, the following sections will focus on the significance of thioredoxin in 
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regulating the redox status to ensure accurate self-nonself recognition, and antimicrobial 




























Figure 1.5: Generation of ROS in the mitochondria and their elimination by cellular 
antioxidants. (A) The mitochondrial respiratory chain consists of four multimeric complexes 
(complexes I–IV), coenzyme Q (CoQ), and cytochorome c (Cyt C). Electrons (e−) are transferred 
from the reducing equivalent (NADH-FADH2) to molecular oxygen through the mitochondrial 
respiratory chain, finally generating water at complex IV. During the electron transfer, reactive 
oxygen species (ROS) are generated at complexes I and III. The mitochondrial permeability 
transition pore (mPTP) is regulated by cyclophilin D. Opening of this pore results in massive loss 
of ions and metabolites from the matrix.  (B) O−2 is converted into H2O2 by superoxide 
dismutases (SODs). H2O2 is then eliminated by catalase, glutathione peroxidases (GPXs), and 
peroxiredoxins (PRXs). During elimination of H2O2, reduced glutathione (GSH) is converted to 
disulfide form (GSSG) by GPXs, and then GSSG is recycled to GSH by glutathione reductase 
(GR). However, PRXs also catalyze H2O2 into H2O by using reduced thioredoxin (TRX). 
Oxidized TRX is then recycled back to reduced TRX by thioredoxin reductase (TR).  NADPH is 







1.3.2 Thioredoxin superfamily 
Thioredoxin (TRX), which functions as a general protein-disulfide reductase, is 
commonly known to be a small ubiquitous protein of 12 kDa.  It is evolutionarily 
conserved from prokaryotes to eukaryotes, plants, and animals (Holmgren, 1985).  The 
redox activity of TRX has been reported to reside in a conserved active site, Cys-Gly-
Pro-Cys (CGPC), in which the two Cys residues undergo reversible oxidation, converting 
its dithiol group to a disulfide bond (Powis and Montfort, 2001).  The three-dimensional 
structure of TRX is conserved throughout evolution and consists of four or five central β-
sheets externally surrounded by three or four α-helices (Figure 1.6).  The active site is 
located in a protrusion of the protein between the β2-strand and the α2-helix.  Both the 
conserved active site sequence and the three-dimensional structure of TRX are the 
hallmarks of this superfamily (Martin, 1995).   
TRX is maintained in its active reduced form by the thioredoxin reductase (TR), a 
selenocysteine-containing protein that uses the reducing power of NADPH (Powis and 
Montfort, 2001).  TRXs have been implicated in a number of mammalian cell functions: 
(a) outside the cell in cell growth stimulation and chemotaxis, (b) in the cytoplasm as an 
antioxidant and a cofactor, and (c) in the nucleus in regulation of transcription factor 
activity.  TRX is also upregulated in response to a wide variety of oxidative stresses, 
including viral infections and ultraviolet irradiation (Nakamura et al, 1997).   
Furthermore, abnormal expression of TRX has been correlated with a number of 
pathophysiological conditions such as cancer, Alzheimer’s and Parkinson’s diseases, 
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suggesting that the activation-regulation of TRX plays an important role in human 
diseases (Hirota et al, 2002). 
Thioredoxin functions in a variety of cellular processes that can be generalized 
into two major roles.  Firstly, the TRX functions as an electron carrier to catalyze the 
biosysthesis of antioxidant enzymes such as ribonucleotide reductases, methonine 
sulfoxide reductase and the peroxiredoxins.  Secondly, they act as antioxidants to protect 
cytosolic proteins from inactivation via oxidant-mediated disulfides (Arner and 




Figure 1.6: The three-dimensional structure of TRX.  Schematic drawing of the T. brucei 
TRX with central pleated five β sheets surrounded by four α helices.  The redox active disulfide 
(Cys30 & Cys33) is located in a small cleft between the main body of the molecule and a 





So far, several kinds of TRX with different catalytic sites have been characterized 
in various organisms (see Figure 3.44).  The first characterized human TRX (TRX1) is a 
12 kDa protein with a catalytic sequence of CGPC.  Although the 12 kDa bacterial TRX 
only contains the two cysteine residues at its catalytic site, the human 12 kDa TRX 
contains three other cysteine residues.  The C-terminal Cys73  is involved in dimerization, 
and may convey unique biological properties to mammalian TRX (Holmgren, 1985).  A 
second slightly larger TRX (TRX2) is a 166-amino acid protein with a molecular weight 
of 18 kDa, containing a conserved TRX catalytic site. It has been identified in the 
mitochondria of pig’s heart (Spyrou et al, 1997).  The 60-amino acid N-terminal 
extension of TRX-2 exhibits characteristics consistent with a mitochondrial translocation 
signal, and mitochondrial localization of TRX-2 was confirmed by Western blotting 
(Miranda-Vizuete et al, 2000).  A 32 kDa thioredoxin-like cytosolic protein was first 
cloned from a human testis cDNA library (Lee et al, 1998).  The 289 amino acid protein 
has an N-terminal TRX domain of 105 amino acids, a conserved TRX active site (CGPC), 
and a high degree of homology to human TRX.  It is ubiquitously expressed in human 
testis.  In 1997, a type of TRX called nucleoredoxin (NRX) with a WCPPC catalytic site 
was cloned from mice. Interestingly, this 435-amino acid protein is localized to the 
nucleus (Kurooka et al, 1997).  Recently, a family of 16 kDa TRX has been identified 
from the Nematodes and protozoa of the family Trypanosomatidae with an active site of 
WCPPC (Kunchithapautham et al, 2003).  Despite notable differences in the molecular 
mass and amino acid sequence of the catalytic site, those forms of TRXs appear to be 
functionally similar to the classical 12 kDa TRXs.  Therefore, it appears that there is 
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considerable flexibility in the two residues between the conserved Cys residues in the 
active site, and that the different catalytic sequences might confer diverse enzymatic 
activity and substrate specificity (Kunchithapautham et al, 2003).  This observation 
supports the versatility of the TRX molecule and reflects its prowess in anti-oxidative 
protection of the host. 
 
1.3.3 The influence of TRX in NF-κB signaling pathway  
In resting cells, TRX does not have a specific localization signal; and is hence 
expressed in the cytoplasm.  However, under pathophysiological stress, TRX shows 
various intracellular localizations.  It was observed that in HeLa cells, TRX translocates 
from the cytoplasm into the nucleus after exposure to phorbol 12-myristate 13-acetate, 
PMA (Hirota et al, 1999).   In human retinal pigment epithelial cells, TRX was detected 
in the mitochondria after H2O2 treatment.  From the varied subcellular localizations of 
TRXs, it may be suggested that TRXs play essential roles in many cellular processes 
(Hirota et al, 2002).  Indeed, several functions have been assigned to TRX, mostly related 
to its redox activity, including the regulation of transcription factor DNA-binding activity, 
antioxidant defense, modulation of apoptosis, and the immune response (Hirota et al, 
2002; Powis and Montfort, 2001).  Furthermore, TRX has been shown to selectively 
activate the DNA-binding activity of a number of transcription factors, including NF-κB, 
AP-1, p53, estrogen receptor and glucocorticoid receptor (Hirota et al, 2002).   This 
thesis will focus on the roles of TRX in the NF-κB signaling pathway. 
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The binding of NF-κB to DNA requires the NF-κB to be fully reduced especially 
the Cys62 of the NF-κB p50 subunit.  If the Cys62 of one subunit is linked in a disulfide 
bridge with the Cys62 of the other subunit, the DNA can no longer gain access to the 
binding surface of the p50 homodimer (Powis and Montfort, 2001).  In the nucleus, the 
human 12 kDa TRX1 enhances the DNA-binding of NF-κB by directly reducing the 
cysteine groups in the DNA-binding motif of NF-κB (Figure 1.7) (Flohe et al, 1997).  It 
has been shown that TRX1 is 500 times more effective in enhancing NF-κB DNA-
binding ability than 2-mercaptoethanol or DTT, conventionally used in EMSA 
(Electrophoretic mobility shift assay) techniques to demonstrate DNA-binding (Hayashi 
et al, 1993).  However, other studies have found that transient transfection of TRX1 also 
inhibits NF-κB activation upon PMA stimulation (Schenk et al, 1994).   From the study 
of  Hirota et al. (1999), it has been suggested that TRX plays dual and opposing roles in 
the regulation of NF-κB in the nucleus and cytoplasm.  In the cytoplasm, TRX interferes 
with the signals to IκB kinases, and blocks the degradation of IκB, thus maintaining the 
inactivity of NF-κB as a complex; but in the nucleus, it was observed that TRX enhances 
NF-κB transcriptional activities by augmenting its DNA-binding ability.  The authors 
proposed that this two-step TRX-dependent opposing regulation of the NF-κB complex 
might be a novel activation mechanism of redox-sensitive transcription factors.  However, 
the dual roles of TRX in the regulation of NF-κB underlying the accompanying redox 









Figure 1.7: Activation of NF-κB signaling pathway involves TRX. Oxidative stress causes 
activation signals to phosphorylate IκB, which results in the dissociation of IκB from NF-κB and 
ubiquitination of IκB. Activated NF-κB translocates into the nucleus, and TRX enhances NF-κB 
DNA binding, resulting in the transcription of NF-κB dependent genes.  Adapted with 
modification from Alberts et al (2002). 
 
 
1.3.4 The thioredoxin family in arthropods 
It has been shown that the defense mechanisms against oxidative damage in 
insects have diverged from both higher and lower organisms.  In insects, which lack a 
genuine glutathione reductase, TRXs fuel the glutathione system with reducing 
equivalents (Kanzok et al, 2001).   The crucial role of the thioredoxin system in vivo is 
supported by the fact that Drosophila TRX reductase (TRXR) null mutations are lethal in 
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the larval stage and that reduced TRXR activity severely affects the life span of the 
insects.  Thus, characterizing TRXs from these organisms contributes to our 
understanding of redox control in glutathione reductase-free systems and provides 
information on novel targets for insect control (Wahl et al, 2005).  So far, two TRX 
proteins from Drosophila melanogaster and one TRX from Anopheles gambiae have 
been biochemically characterized (Bauer et al, 2002).  However, no report is available on 
the TRX system in other arthropod species besides insects.  Furthermore, in invertebrates, 
the functions of TRX in regulating transcription factors are still unknown.  
Previously, we utilized subtractive cDNA hybridization to identify genes that are 
important for immune defense in horseshoe crab (C. rotundicauda) (Ding et al, 2005).  
The subtracted cDNAs were subsequently cloned into plasmids and screened for 
differential expression.  Using this approach, we identified one cDNA clone that was 
differentially expressed in the hepatopancreas (equivalent to liver in mammals) upon P. 
aeruginosa challenge.  Sequence analysis revealed that this gene encodes a protein 
possessing the characteristic organization of TRX proteins, henceforth referred to as C. 
rotundicauda TRX (Cr-TRX1).  In order to understand the functions of TRX in the 
arthropod anti-oxidant system and NF-κB signaling pathway, we decided to examine the 
biochemical characteristics of the Cr-TRX1 and investigate its roles in regulating the NF-







1.4 The horseshoe crab as model for innate immunity study 
1.4.1 Horseshoe crab is a “living fossil” 
The horseshoe crab belongs to the order Xiphosura that has more than 500 million 
years of evolutionary success. Because its basic body design remains virtually unchanged 
for millions of years, the horseshoe crab is often called the “living fossil” (Størmer, 1952). 
Today, there are four species of horseshoe crabs in different habitats around the world: 
Limulus polyphemus in the East coast of USA; Tachypleus tridentatus in China and Japan 
and Tachypleus gigas and Carcinoscorpius rotundicauda in South Asia.  The species of 
interest in this project is Carcinoscropius rotundicauda, which thrive in 30 % seawater 
condition, in brackish mangrove swamps that teem with very high counts of pathogenic 
microbes. 
 
1.4.2 Advantages of using horseshoe crab for innate immunity 
research 
Several obvious reasons have made invertebrates good models for the study of 
innate immunity.  First, the invertebrates lack adaptive immunity and rely solely on the 
innate immune system for protection against pathogen infection.  Therefore, the influence 
from the adaptive immune system to the innate immune responses is totally absent.  
Secondly, due to the evolutionary conservation of innate immune-related molecules, 
knowledge of the innate immunity in the invertebrates is very useful for the 
understanding of molecular mechanisms underlying the innate immune responses in the 
vertebrates (Little et al, 2005).  Particularly, those molecules which have counterpart 
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homologs in humans will be an important translational significance to understanding the 
immune system in humans. 
Over the last two decades, a wide variety of invertebrates have been used as 
experimental models for the studies of the innate immunity, such as the C. elegans, 
freshwater crayfish, ascidians, Pacific oysters, horseshoe crab and insects including 
Drosophila melanogaster (fruit fly), Bombyx mori (silkworm), Manduca sexta (tobacco 
hornworm), Anopheles gambiae (mosquito) (Iwanaga and Lee, 2005).  Amongst these 
species, the Drosophila and C. elegans are the animal models of choice due to the 
availability of genome sequences that allows the high throughput genomic and proteomic 
analysis and ease of genetic manipulation (Royet, 2004).  Indeed, studies in these 
organisms have greatly contributed to the understanding of innate immunity, especially 
the discovery of Toll/NF-κB signaling pathway in Drosophila.  However, there are some 
drawbacks with the model organism, Drosophila.  These include such impracticalities 
such as the low volume of hemolymph obtainable from each individual and the fragile 
nature of the experimental subject.  In contrast, the horseshoe crab is a good model for 
innate immune study since it has much larger volume of blood and bigger tissues 
compared with most of the other invertebrate models, allowing convenient physiological 
and molecular manipulations.  In addition, this organism harbors a very sophisticated 
innate immune system that has enabled it to survive for more that 500 million years.  
Furthermore, it has been shown that the horseshoe crab possesses some critical 
components in innate immune response, for example, the complements which are 




1.4.3 Horseshoe crab possesses a powerful innate immune system 
The burrowing habits of the horseshoe crabs cause them to encounter large 
numbers of challenging microorganisms.  The horseshoe crab has developed a powerful 
innate immune system to combat the pathogenic microorganisms, especially Gram-
negative bacteria.  Indeed, it has been demonstrated that the horseshoe crab, C. 
rotundicauda, survived an infection of 2 × 107 CFU of P. aeruginosa / kg of body weight 
(Ng et al, 2004), a dose that was shown to be lethal to mice (Stieritz and Holder, 1975).  
The immune response was so fast and efficient that the majority of the bacterial inoculum 
was cleared from the plasma after three hours of infection and the rest was completely 
eradicated within 72 hours (Ng et al, 2004).  
The horseshoe crab relies completely on innate immunity, employing a unique 
array of efficient host defense system.  The hemolymph of the horseshoe crab contains 
soluble defense molecules and large members of granular hemocytes (amoebocytes), 
which undergo degranulation upon contact with Gram-negative bacteria. Ninety nine % 
of the circulating hemocytes are granular being filled with two types of granules (Figure 
1.8): large (L)- and small (S)- granules (Iwanaga et al, 1998).  In Tachypleus tridentatus 
(the Japanese species),  the L-granule selectively stores more than 20 defense molecules 
with molecular masses mainly between 8 and 123 kDa, such as clotting factors (Factor C, 
B and G), a clottable protein coagulogen, proteinase inhibitors, lectins and antimicrobial 
peptides (Iwanaga, 2002).  In contrast, the S-granule contain at least 6 proteins with 
molecular masses of less than 30 kDa, and large amounts of hairpin-like tachyplesin 
peptides, tachystatins, tachycitins and big defensins (Table 1.1), all of which show 
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antimicrobial activities against Gram-negative and Gram-positive bacteria, and fungi 
(Iwanaga, 2002).  The hemocytes are extremely sensitive to LPS and respond to its 
presence by degranulation, so releasing large numbers of defense molecules that work in 
concert to defend the host from the invading microbes. 
The presence of such a broad spectrum of immune responsive molecules suggests 
that the molecular mechanisms of innate immune responses in the horseshoe crab are 
very complex.  However, how the sophisticated immune system is regulated is largely 
unknown and the cellular signaling pathways that are critical for controlling innate 
immunity in the horseshoe crab remain to be uncovered and exploited.  Since the 
horseshoe crab contains many innate immune molecules which are well conserved in 
humans, an understanding on the molecular mechanism of actions of these functional 
homologues would be very beneficial towards the understanding of the functions of their 
counterparts in the humans for meaningful translational research on human immune 
















Figure 1.8: Defense systems in horseshoe crab hemocytes. The hemocytes detect LPS on 
Gram-negative bacteria and initiates exocytosis of the large and small granules. The clotting 
factors thus released are activated by LPS or (1, 3)-β-D-glucan on the pathogens, which result in 
hemolymph coagulation. Thus, the pathogens are cell-agglutinated by various lectins and 
subsequently killed by antibacterial substances. The large granules also contain protease 
inhibitors, such as serpins, α2-macroglobulin, and cystatin, and an azurocidin-like pseudoserine 
protease with antibacterial activity, named factor D. The figure was adapted from Iwanaga and 
Kawabata (1998). 
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    Table 1.1: Defense molecules found in the horseshoe crab 
LICI, Limulus intracellular coagulation inhibitor; LTI, Limulus trypsin inhibitor; LEBP-PI, 
Limulus endotoxin-binding protein-protease inhibitor; FN, fungus;  LAF, Limulus 18-kDa 
agglutination-aggregation factor; KDO, 2-keto-3-deoxyoctonic acid; PC, phosphorylcholine; PE, 
phosphorylethanolamine; SA, sialic acid; TTA, Tachypleus tridentatus agglutinin; LCRP, 
Limulus C-reactive protein; HLA, hemolytic activity; LTA, lipoteichoic acid; GBP, galactose-
binding protein; PAP, protein A binding protein; PO, phenoloxidase; ND, not determined. 
Adapted from Iwanaga and Lee (2005). 
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1.4.4 Homology between the two serine protease cascades in horseshoe 
crab and Drosophila 
Serine protease cascades are indispensable in various fundamental biological 
processes in both the invertebrates and vertebrates. They play major roles in signal 
transduction in development, immunity, and hemostasis.  
In Drosophila, a well-established serine protease cascade is thought to be 
upstream of the Toll/NF-κB signaling pathway.  This serine protease cascade includes 
four different members of the serine protease family (Figure 1.9), Nudel, Gastrulation 
defective (Gd), Snake and Easter (Smith and DeLotto, 1992).  The proteolytically 
processed product of this cascade---Spätzle, in its active form, is thought to be recognized 
by the Toll receptor (Figure 1.9).  Toll receptor triggers signal transduction through Tube 
and Pelle, and ultimately leads to the nuclear translocation of the Dorsal transcription 
factor and promotes ventral and lateral development of the embryo (Belvin and Anderson, 
1996).  
In the horseshoe crab, two serine protease pathways that involve either an LPS-
mediated or a (1-3)-β-D-glucan-mediated coagulation reaction have been well-
established.  Three serine protease zymogens: Factor C, Factor B and proclotting enzyme 
are involved in the coagulation cascade triggered by LPS (Ding et al, 1993).  In this 
cascade, Factor C responds to LPS, and is autocatalytically activated to its active form; 
this in turn transforms Factor B to its active form (Figure 1.9).  The activated Factor B 
converts the proclotting enzyme to clotting enzyme, which converts coagulogen to an 





Figure 1.9: Serine protease cascades in the Drosophila and horseshoe crab (Limulus).  On 
the left are the serine protease cascades in dorsoventral determination, immune response against 
Gram-positive bacteria and fungal infection in Drosophila. Dotted arrows with "?" indicate 
unidentified components in the cascades. On the right are the serine protease cascades in limulus 
blood coagulation and innate immunity, which are activated by Gram-negative bacteria and fungi, 
respectively. Factor G is the upstream serine protease in the alternate blood coagulation pathway 
that is triggered by β-1, 3-glucan. Discontinuous arrows annotate the putative signaling pathway.  
Homologues in all the cascades are boxed. Gd, gastrulation defective. Adapted from Wang et al. 
(2003). 
 
A striking similarity between the horseshoe crab blood clotting serine protease 
cascade and the Drosophila dorsoventral-determination serine protease cascade has long 
been noticed (Gay and Keith, 1992).  The horseshoe crab clotting enzyme and the 
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Drosophila serine protease, Snake and Easter, show significant sequence homology. 
Therefore, they have been considered as members of a distinct subfamily of serine 
proteases (Ding et al, 2004; Smith and DeLotto, 1992).  Horseshoe crab Factor B also 
exhibits a similar primary structure and the disulfide linkage to the clotting enzyme and 
Easter.   Furthermore, persephone, a serine protease involved in signal transduction of 
anti-fungal immune responses, is deduced to contain structural domains homologous to 
those in Easter, Snake in Drosophila and proclotting enzymes in horseshoe crab (Ding et 
al, 2005).  Spätzle, the ligand for Toll, also shares homology with the horseshoe crab 
coagulogen (Osaki and Kawabata, 2004).  The proposed similarity amongst these serine 
proteases in each cascade (Factor B, Proclotting enzyme and Coagulogen versus Snake, 
Easter and Spätzle) strongly suggests a common ancestry of the two serine protease 
pathways in the Drosophila and horseshoe crab (Figure 1.9). 
Interestingly, a Toll-like receptor has recently been reported in the Japanese 
horseshoe crabs (Inamori et al, 2004) and a C. rotundicauda TLR cDNA clone has also 
been isolated from a hepatopancreas cDNA library in our laboratory (Loh et al).  
Although the ligand of the horseshoe crab TLRs remains to be determined, the structural 
homology between coagulogen and Spätzle has raised speculations that the processed 
coagulogen might be the candidate ligand for horseshoe crab TLR (Figure 1.9) (Osaki 
and Kawabata, 2004; Wang et al, 2003).  Therefore, it is reasonable to postulate that the 
horseshoe crab blood coagulation cascade probably transduces an extracellular signal into 
the hemocytes during the innate immune response initiated by LPS.  The bacterial 
infection signaled by the serine protease cascades ultimately results in the activation of 
the NF-κB transcription factors as illustrated in Figure 1.9 (Ding et al, 2004; Wang et al, 
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2003).  Similar to its counterparts in Drosophila, the putative horseshoe crab NF-κB 
transcription factors also transactivate other antimicrobial effector genes to defend against 
microbial infection.  
 
 
1.5 Objectives and experimental approaches 
1.5.1 Objectives of this project 
The main objective of this research was twofold: (1) to trace the ancient origin of 
the NF-κB signaling pathway in the horseshoe crab and investigate the function of the 
ancient NF-κB/IκB signaling cascade in innate immunity; (2) to define the biochemical 
characteristics of the novel 16 kDa TRX and examine its roles in regulating the NF-κB 
signaling pathway. 
 
1.5.2 Experimental strategies 
First, degenerate PCR, using primers that were designed based on the sequence 
analysis of RHDs and ankyrin repeats was used to isolate the horseshoe crab (C. 
rotundicauda) NF-κB and IκB homologues.  Then, the following main experiments were 
carried out to study the functions of NF-κB signaling pathway in the immune defense of 
horseshoe crab.  (1) Electrophoretic mobility shift assay (EMSA) was used to examine 
the DNA-binding activity of recombinant horseshoe crab NF-κB.  (2) The interaction 
between the horseshoe crab NF-κB and IκB proteins was examined by in vitro pull-down 
and immunoprecipitation assays.  (3) Transient co-transfection studies in Drosophila S2 
cells with the κB-reporter were utilized to investigate if the horseshoe crab NF-κB can 
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regulate gene transcription.  Then the inhibitory effects of horseshoe crab IκB on NF-κB 
transactivation activity were determined by co-transfection. (4) The subcellular 
localization of horseshoe crab NF-κB and IκB in transfected cells and horseshoe crab 
hemocytes was investigated by method of immunocytochemistry.  (5) The functions of 
the horseshoe crab NF-κB signaling pathway on the expression of immune-related gene 
were examined by RT-PCR, with or without NF-κB specific inhibitors. 
 
To investigate the functions of horseshoe crab TRX, first the recombinant protein 
was expressed.   After that, a series of mass spectrometric methods was used to determine 
the active motif of the horseshoe crab TRX.  To understand the biochemical 
characteristics of the 16 kDa Cr-TRX1, an array of enzymatic assays were carried out, 
such as insulin reduction assay, thioredoxin reductase assay and DNA-nicking assay.  
The relationship between Cr-TRX1 and NF-κB signaling pathway was then examined in 
a mammalian cell line, HeLa, by overexpression using the gel shift assay and κB-reporter 
assay.  Finally, using bioinformatics methods, we identified the human homologue of Cr-
TRX1 and examined its NF-κB regulatory ability by EMSA. 
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CHAPTER 2:  MATERIALS AND METHODS 
 
2.1 Organisms and Materials 
2.1.1 Organisms 
The horseshoe crab, C. rotundicauda, was collected from mangrove swamps at 
the northeastern part of Singapore and cleaned off mud and barnacles.  The specimens 
were acclimated overnight in 30% (v/v) sea water/fresh water before being used for 
experiments. 
Drosophila Schneider S2 cells were maintained at 25 °C in Drosophila SFMTM, 
Serum-Free Medium, (Invitrogen, Carlsbad, CA) supplemented with 20 mM L-
Glutamine and 5% fetal bovine serum (FBS).  HeLa cells are routinely grown in 
complete medium consisting of Dulbecco’s modified Eagle’s medium, DMEM 
(Invitrogen) supplemented with 10 % FBS and 1 % penicillin/streptomycin at 37 ºC in a 
humidified atmosphere of 5 % CO2 and 95 % air.  Bacteria strains used for infection 
experiments was Pseudomonas aeruginosa ATCC 27853.   Escherichia coli BL21 (DE3) 
was used for recombinant protein expression. 
 
2.1.2 Biochemicals, enzymes and antibodies  
Glutathione Sepharose 4B, protein A Sepharose, redivue [γ-p32] ATP, thrombin 
and hybond-N+ nylon membrane were products of GH Healthcare.  Advantage 2 DNA 
polymerase and X-α-gal was from BD Biosciences, Clontech.  Complete cocktail 
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protease inhibitors were from Roche.  SuperSignal® West Pico Chemiluminescent 
Substrate was from Pierce. Phenylmethylsufonylfluoride (PMSF), bovine serum albumin 
(BSA) fraction V, the recombinant TRX (thioredoxin), rat liver TRXR (TRX reductase) 
and NADPH were from Sigma.  Super RX X-ray film was from Fuji.  Common 
chemicals of molecular biology grade were from Sigma and Merck.  The NF-κB 
inhibitors MG-132 and helenalin were from Calbiochem.  All restriction enzymes were 
from New England Biolabs, Roche or Fermentas. 
                 Mouse monoclonal anti-V5, anti-c-Myc, anti-c-Myc-HRP and anti-pEGFP 
antibody were from Invitrogen.  Mouse monoclonal antibody to FLAG (M2) and rabbit 
antibody to actin were obtained from Sigma.  Polyclonal antibodies to NF-κB p50 and 
IκB were from eBiosciences.  Anti-CrNFκB and anti-CrIκB antibodies were raised in 
rabbits against Keyhole Limpet Hemocyanin (KLH)-conjugated peptides (CrNFκB: 
LPVNRDPEGLSRKR; CrIκB: VSSHSHHSPQKEYK), by BioGenes (Germany).  The 
antibodies were affinity-purified using specific peptide as ligand.  All antibodies were 
tested for specificity by Western blot using recombinant CrNFκB and CrIκB as controls. 
 
2.2 cDNA cloning of targeted molecules 
In order to clone the NF-κB gene from the horseshoe crab, we first prepared the 
mRNA from naïve and Gram-negative bacteria challenged horseshoe crab tissues.  Those 
mRNA were then used for RT-PCR to clone the targeted molecules and gene expression 
analysis.   
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2.2.1 Infection of horseshoe crab and RNA extraction 
2.2.1.1 Preparation of P. aeruginosa for infection 
A single clone of P. aeruginosa was inoculated into 5 ml of Tryptone soy broth 
(Oxoid) and cultured overnight at 37 °C with shaking at 230 rpm.  Bacteria was collected 
by centrifugation at 5,000 × g for 10 min at 4 °C, washed with 10 ml of saline (0.9 % 
NaCl) and resuspended to the original culture volume in saline.  An aliquot of 100 μl of 
this Pseudomonas suspension was serially diluted for bacterial enumeration and the rest 
was stored at 4 oC as stock culture for infection of the horseshoe crabs.  
 
2.2.1.2 Challenging horseshoe crabs with bacteria and collection of tissues 
              Prior to infection, the dorsal hinge of the horseshoe crab leading to the cardiac 
chamber was swabbed with 70 % ethanol.  A sub-lethal dose of 1.2 × 107 colony-forming 
unit (CFU) of P. aeruginosa/ kg body weight was injected intracardially to challenge the 
horseshoe crab (Ng et al, 2004).  Sample collection was performed at indicated hours 
post infection (hpi). Uninfected (naïve) or infected horseshoe crabs were bled for the 
collection of the hemocytes.  The animals were bled by cardiac puncture using an 18 G 
needle (Becton-Dickinson). The hemolymph was collected in pre-chilled pyrogen free 
tubes (Falcon). The hemolymph was diluted with the same volume of 3 % pyrogen-free 
NaCl.  The mixture was immediately pelleted by centrifugation at 150 × g for 5 min at 4 
oC.  The supernatant was discarded and the hemocytes were snap-frozen in liquid 
nitrogen before storage at -80 oC.  Hepatopancreas was excised under RNase-free 




2.2.1.3 RNA purification 
RNA is extremely sensitive to RNase contamination.  In order to maintain the 
RNase free condition, water and solutions were treated overnight with 0.1 % of 
diethylpyrocarbonate (DEPC, Sigma) at 37 °C and autoclaved for 2 h to remove residual 
DEPC.  Plastic-wares were soaked overnight in 3 % hydrogen peroxide, rinsed 
thoroughly with DEPC treated water and autoclaved for 2 h.  Metal and glass apparatus 
were baked at 200 oC for 4 h. 
Tissues were homogenized in Trizol reagent (Invitrogen) on ice with an Ultra-
Turrax T25 homogenizer (IKA-labotechnik).  The total RNA was extracted according to 
the manufacturer’s instructions with slight modifications.  Briefly, homogenized samples 
were left at room temperature for 5 min.  Chloroform (1/5 volume of the homogenate) 
was then added and the mixture was shaken vigorously for 15 s, and incubated at room 
temperature for 2 min.  Next, the mixture was centrifuged 1,000 × g for 15 min at 4 oC 
and the top colorless aqueous phase, which contained RNA, was transferred to a fresh 
tube.  RNA was precipitated by incubation with isopropanol for 10 min and the RNA 
precipitate was collected by centrifugation.  The RNA pellet was washed twice with 75 % 
ethanol and the air-dried RNA pellet was stored at – 70 oC.  
The RNA pellet was dissolved in DEPC treated water by incubation at 60 oC for 
10 min. The concentration of the isolated RNA was determined by OD reading at 260 nm.  




2.2.2 Cloning of CrNFκB, CrIκB and CrRelish 
To obtain a cDNA fragment of targets, cDNA was first synthesized with 
SuperScriptTM RT-PCR System (Invitrogen) using oligo-dT primers according to the 
manufacturer’ instructions.  Briefly, a mixture of 1 μl of 0.5 μg/μl oligo-(dT), 1 μl of 10 
mM dNTP and 3 μg of total RNA was made to a final volume of 10 μl with DEPC-
treated water.  The RNA was incubated at 65 °C for 5 min and then placed on ice.  A 
reaction mixture containing 2 μl of 10 × RT buffer, 2 μl of 0.1 M dithiothreitol (DTT) 
stock, 4 μl of 25 mM MgCl2, 1 μl of RNaseOUT and 1 μl of Reverse Transcriptase 
enzyme was prepared in a final volume of 10 μl and added to the denatured RNA sample.  
The 20 μl sample was then incubated for 50 min at 42 °C for cDNA synthesis.  The 
reaction was terminated at 70 °C for 15 min and 1 μl of RNase H was added and 
incubated for 20 min at 37 °C to remove the RNA.  The synthesized cDNA was then 
frozen at -20 °C for later use. 
Homologues of NF-κB (CrNFκB) and IκB (CrIκB) from C. rotundicauda were 
obtained by RT-PCR using degenerate primers designed from the conserved region of 
insect and mammalian NF-κB and IκB proteins.  The primers used were: CrNFκB 
forward primer, 5′-TTTCGCTAYRARTGCGARGG-3′; CrNFκB reverse primer, 5′-
TCCTTIGTWACRCAWGAIACMAC-3′; CrIκB forward primer, 5′-
GAYGGIGACWCRIYIITSCACYTRGC-3′; CrIκB reverse primer, 5′-
CAGGMMAIRTGIARIGSIGTRTIDCC-3′.  The PCR products were electrophoresed on 
1-1.2 % agarose gels.  The correctly sized bands were excised and isolated from the gel 
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using QIAquick gel extraction kit (Qiagen) and cloned into pGEM-T Easy vector 
(Promega) for sequencing.  
 
2.2.3 Cloning of PCR products and sequencing 
For ligation into pGEMT-Easy vector (Promega), purified cDNA was incubated 
overnight at 4 °C with pGEM®-T Easy vector and T4 DNA ligase in the Rapid Ligation 
Buffer.  The next day, the ligation product was transformed into competent cells, E. coli 
Top 10.  For transformation, 5 μl of the ligated product was added to 80 μl of competent 
bacteria, and the mixture was incubated in ice for 30 min.  This was followed by a 90 s 
‘heat shock’ treatment at 42°C and rapid cooling in ice for 2 min.  The cells were then 
incubated in 900 μl of LB broth for 1 h at 37°C with shaking at 150 rpm.  The 
transformed bacteria cells was resuspended with fresh LB and plated on selective LB-
ampicillin plates.  The plates were incubated overnight at 37°C.   
Transformed bacteria were isolated and cultured for purification of recombinant 
DNA for sequence verification.  The Wizard® Plus SV Minipreps DNA Purification 
System (Promega) was used to purify plasmid DNA for sequencing.  The sequencing 
reaction was performed in a 20 μl volume, using 2 μl of BigDye Terminator V3.1 
(Applied Biosystems), 100-250 ng of DNA template, 3 μl of 5 × buffer and 100 nM  
primer.  The sequencing reaction was then subjected to 1 min of incubation at 95 °C, 
followed by 40 cycles of 95 °C for 10 s, 50 °C for 10 s and 60 °C for 4 min.  At the end 
of the reaction, the extension products were precipitated with 70 % ethanol with sodium 
acetate (pH 4.6) to remove excess dye terminators.  The DNA was pelleted by 
centrifugation at 14,000 × g for 30 min.  The pellet was rinsed twice with 70 % ethanol 
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and air-dried.  The precipitated DNA was redissolved in HiDye formamide (Applied 
Biosystems) before loading in the capillary sequencer for sequencing (ABI 3100, Applied 
Biosystems). 
 
2.2.4 Isolation of full length cDNA by RACE PCR 
The 3′ and 5′ ends of CrNFκB, CrIκB and CrRelish were obtained using BD 
SMART™ RACE cDNA amplification kit (Clontech).  The first strand cDNA for 5′ and 
3′-RACE PCR were generated with 3.0 μg of total RNA from naïve hemocytes according 
to the instructions in the manual.  The reaction mixture was then diluted in 50 μl of water 
and stored at – 20 oC until use.  
RACE PCR was performed with the gene-specific primers and the universal 
primer mix (UPM), which was the mixture of the long (5’-
CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT-3’) and the 
short (5’-CTAATACGACTCACTATAGGGC-3’) oligonucleotides.  Typically, the 
RACE PCR reactions were set up with 2.5 μl of first strand cDNA, 1 μl of 10 mM gene 
specific primer, 5 μl of 10 × UPM (0.4 mM of long and 2.0 mM of short oligonucleotide), 
0.2 mM dNTP mix, and 1 μl of 50 × BD Advantage 2 Polymerase Mix in 1 × Advantage 
2 PCR Buffer.  Standard PCR program was performed with one cycle at 95 °C for 3 min, 
followed by 28 - 35 cycles of denaturing at 95 °C for 30 s, annealing at 68 °C for 30 s, 
extension at 72 °C for 3 min, and termination with one cycle at 72 °C for 8 min.  In some 
cases, touchdown PCR that is performed by cycles of decreasing annealing temperature 
and nested PCR were used for the amplification of the 3′ or 5′ end.  After agarose gel 
analysis, the correctly sized bands were excised and isolated from the gel using QIAquick 
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gel extraction kit (Qiagen).  The purified band was cloned into pGEMT-Easy vectors and 
then sequenced using primers that bind to the vectors at the regions flanking the insert. 
 
2.2.5 Phylogenetic analysis of target molecules 
To investigate the evolutionary relationship of CrNFκB, CrIκB, CrRelish, Cr-
TRX-1 and their homologues, multiple sequence alignments were performed to compare 
the degree of sequence homology between them.  The amino acid sequences of their 
homologues were obtained from the NCBI database.  Sequence alignment was performed 
using Clustal X (version 1.83) or DNAMAN with the default parameters.  Based on the 
alignments, unrooted phylogenetic trees were constructed using neighbor-joining method.  
Bootstrap tests at 1000 replicates were carried out to examine the validity of the 
branching topologies.  
 
2.2.6 Transcriptional analysis during Pseudomonas infection 
First strand cDNAs of various tissues were synthesized using SuperScript™ First-
Strand Synthesis System (Invitrogen).  For each sample, 20 μl reaction mixture was set 
up with 3 μg of total RNA, 0.5 mM dNTP mix, 500 ng of oligo-(dT)12-18 primers, 5 mM 
of MgCl2, 10 mM DTT, 40 Units of RNaseOUT™ recombinant RNase inhibitor and 50 
units of SuperScript™ II reverse transcriptase in 1 × RT buffer.  Reverse transcription 
reaction was carried out for 50 min at 42 oC and terminated by incubation at 70 oC for 15 
min.  Next, RNA was removed by incubation of the reaction mixture with 2 Units of 
RNase H at 37 oC for 20 min.  First strand cDNA was stored at - 20 oC until use.  
Changes in the transcription level of CrNFκB, CrIκB and Cr-TRX1 were studied by 
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semi-quantitative RT-PCR.  Horseshoe crab Actin-11 was used as an internal 
normalization standard to eliminate sample-to-sample variations in the initial cDNA 
concentrations.  PCR was performed under the following conditions: initial denaturation 
at 95 oC for 3 min, followed by 25 - 35 cycles of denaturation at 95 oC for 30 s, annealing 
at 56 oC for 30 s, and extension at 72 oC for 1 min.  PCR products were resolved on 1.2 % 
agarose gel, stained with ethidium bromide and the gel image was acquired and analyzed 
by Image Master VDS version 2.0 software (Pharmacia Biotech). 
 
2.3 Functional characterization of CrNFκB and CrIκB 
2.3.1 Construction of expression vectors 
For bacterial recombinant protein expression, a cDNA fragment encoding the N-
terminal half of the CrNFκB including RHD (amino acids: 1-353), was subcloned into 
the NdeI and BamHI sites of the pET15b expression vector (Novagen).  The full length 
CrIκB was subcloned into the BamHI and XhoI sites of expression vector pGEX-4T-1 
(GE Healthcare).  
For insect expression plasmids, Drosophila expression vector, pAc5.1/V5-HisA 
(Invitrogen), was used for expression of full-length and truncated CrNFκB proteins 
(CrNFκB-RHD and CrNFκB-ΔNLS).  All fusion proteins are tagged with His and V5.  
Except for CrNFκB-ΔNLS, the other 2 constructs contained the nuclear localization 
signal (NLS) (see Figure 2.1 & Figure 3.12).  All the primers were designed according to 
the CrNFκB sequence with the additional digestion site sequences.  Figure 2.1 illustrated 
the cloning strategies of full-length and truncated CrNFκB.  The full-length CrIκB with a 
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c-Myc epitope was similarly cloned into the KpnI and AgeI sites of pAc5.1/V5-HisA.  
The primers used for cloning CrIκB with a c-Myc tag at the C-terminus are listed below.  
The underlined nucleotides encode the c-Myc tag.  Forward primer: 5’-
GGTACCATGGGAAAATCAAAAGAATT-3’; Reverse primer: 5’ ACCGGTCAGATC 
TTCCTCTGAGATGAGCTTCTGCTCCACTGCTCTAACTTCATCTCC-3’. 
 
Figure 2.1: The cloning strategy of the full-length and truncated CrNFκB into the pAc5.1 
expression vector.  After PCR reaction, the fragment was doubled digested by KpnI and ApaI 
and gel purified.  The purified fragment was subsequently cloned into the KpnI and ApaI sites of 
the pAc5.1 expression vector.  The full length CrIκB with the c-Myc tag was similarly cloned 
into the pAc5.1 vector.   
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2.3.2 SDS-PAGE & Western Blot  
SDS-PAGE was carried out in vertical gel composed of 10 % - 15 % running gel 
and 5 % stacking gel using the Mini-Protean II system (Biorad).  Prior to electrophoresis, 
samples were reduced with SDS-PAGE gel loading buffer (125 mM Tris-HCl, pH 6.8, 10 
% glycerol, 2 % β-mercaptoethanol, 0.1 % bromophenol blue and 2 % SDS) and boiled 
for 5 min to denature the proteins.  Electrophoresis was performed in Tris-glycine buffer 
(25 mM Tris, pH 8.3, 250 mM glycine, and 0.1 % SDS).  Precision Plus Protein 
Standards (prestained protein ladder, GibcoBRL, USA) was electrophoresed alongside 
the sample for molecular weight determination. 
 In Western blot, the electrophoretic transfer was performed in the Mini Trans-
Blot Electrophoretic Transfer Cell (Biorad).  The transfer of proteins was carried out at a 
constant current of 220 mA for 2 h at 4 °C.  After transfer, the membrane was incubated 
for 2 h at room temperature with 20 ml of blocking buffer containing 5 % (w/v) skim 
milk in PBST (PBS containing 0.1 % of Tween-20, v/v).  After incubation, the membrane 
was rinsed 3 times with 20 ml of PBST.  The blot was then incubated overnight at 4 ºC 
with primary antibody at indicated dilution in PBST containing 3 % BSA.  Subsequently, 
the membrane was washed four times with 20 ml of PBST to remove unbound antibody.  
Secondary antibody in PBST containing 3 % BSA was then added to the membrane and 
incubated for 2 h with gentle shaking.  The antigen-antibody complexes were then 
immunoblotted by incubating the blot with Supersignal® West Pico (Pierce) 




2.3.3 Pull-down assay for protein-protein interaction analysis 
The GST-CrIκB recombinant protein was expressed in E. coli strain BL21.  After 
4-6 h induction with 0.1 mM IPTG at 30 °C, the bacterial culture was pelleted at 6,000 × 
g for 5 min and resuspended in PBS.  The cell lysate was prepared by sonicating on ice at 
28 amplitude microns, for 6 × 10 s each with intervals of 30 s chilling in ice and 
centrifuged at 12,000 × g.  The bacterial lysate containing the recombinant GST-CrIκB 
was immobilized onto Glutathione-Sepharose 4B beads (GE Healthcare).  The 
preparation of His-tagged CrNFκB will be described under Section 2.3.5.1.  For protein-
protein interaction assays, one μg of GST-CrIκB fusion protein was bound to 25 μl of 
Glutathione Sepharose 4B beads in phosphate-buffered saline (PBS).  The beads were 
washed 5 times with 0.5 ml of ice-cold PBS after incubating with bacterial lysate 
expressing recombinant CrNFκB-RHD.  Bound proteins were eluted with 30 μl of SDS-
PAGE sample buffer, resolved by SDS-PAGE, and detected with anti-GST and anti-His 
antibodies. 
  
2.3.4 Immunoprecipitation assay 
For immunoprecipitation assays, Drosophila S2 cells were transfected with 
several combinations of 500 ng CrNFκB-V5 and 500 ng IκB-c-Myc using CellFectin kit 
(Invitrogen).  After 48 h of transfection, the cells were disrupted by lysis buffer (50 mM 
Tris, pH 8.0, 150 mM NaCl, 0.2 % Nonidet P40, protease inhibitor cocktail (Roche) and 
10 μM MG-132.  The cell lysate was centrifuged at 12,000 × g for 10 min at 4 ºC to 
remove particulate matter.  The supernatant was transferred to a fresh tube and pretreated 
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with Protein A Sepharose (GE Healthcare) at 4 oC for 1 h.  After centrifugation at 12,000 
× g for 20 s, the supernatant was precipitated with 2 μg of anti-V5 antibody and 2 μg 
rabbit anti-mouse bridge antibody at 4 oC overnight.  Then the immunocomplex was 
precipitated by adding the Protein A Sepharose beads and incubated at 4 oC for 1 h.  The 
immunoprecipitates were then washed three times with lysis buffer and analyzed by 
Western blot. 
 
2.3.5 Electrophoretic gel mobility-shift assay (EMSA) 
The electrophoretic mobility shift assay (EMSA) was used to study DNA-protein 
interactions.  This technique is based on the fact that DNA-protein complexes migrate 
slower than non-bound DNA in a native polyacrylamide gel, resulting in a “shift” in 
migration of the DNA.   
 
2.3.5.1 Preparation of recombinant CrNFκB from bacteria and whole hemocyte      
lysate for EMSA 
To obtain the His-tagged CrNFκB recombinant protein extract, the recombinant 
plasmid was transformed into E. coli BL21 and cultured at room temperature with 
shaking at 230 rpm until the OD600 reaches 0.8.  The culture was then induced with 0.02 
mM IPTG and for another 8 h.  The bacteria was harvested by centrifugation at 5,000 × g 
for 5 min, washed with PBS and then pelleted again.  The cells were resuspended in 
binding buffer (50 mM NaCl, 2 mM MgCl2, 2 mM DTT, 1 mM EDTA, 10 % glycerol 
and 10 mM HEPES, pH 7.8) and sonicated for 6 times on ice at 28 amplitudes for 10 s 
each time.  After centrifugation at 9,000 × g for 1 h at 4 °C, the supernatant was collected 
 52
into a fresh tube.  The freshly prepared supernatant of the lysate was immediately used in 
EMSA.   
Horseshoe crab hemocytes were collected according to Section 2.2.1.2.  
Hemocytes were washed with PBS and homogenized in binding buffer (50 mM NaCl, 2 
mM MgCl2, 2 mM DTT, 1 mM EDTA, 10 % glycerol and 10 mM HEPES, pH 7.8).  
Whole hemocyte extracts were centrifuged at 4 °C for 10 min at 13,000 × g, and the 
resulting supernatants were used for subsequent EMSA.   
 
2.3.5.2 Extraction of nuclear proteins from hemocytes 
 
Nuclear extracts were prepared according to the procedures described previously 
(Lin et al, 2004; Wang et al, 2003) with modifications.  Briefly, the horseshoe crab 
hemocytes were collected by centrifugation for 10 min at 150 × g.  Cell pellets were 
resuspended in ice cold PBS to remove the plasma and collected again by centrifugation.  
All the remaining steps were carried out at 4 oC. Washed cells were resuspended in two 
packed cell volumes of lysis buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 
0.5 mM DTT and 0.2 mM PMSF).  After 10 min, cells were homogenized with 20 
strokes of a loose fitting Dounce homogenizer (Wheaton, USA).  Nuclei were collected 
by centrifugation for 10 min at 3,000 × g, and resuspended in 5 volumes of lysis buffer.  
Proteins were extracted from washed nuclei by high salt buffer (20 mM HEPES pH 7.9, 
25 % (v/v) glycerol, 420 mM KCl. 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT and 1.5 
mM MgCl2).  After centrifugation, the extracts was dialysised against buffer (20 mM 
HEPES, pH 7.8, 25 mM NaCl, 25 mM KCl, 0.1 mM EDTA, 0.5 mM DTT, 0.5 mM 
PMSF, 20 % glycerol and 0.05 % Nonidet-P40).  The supernants and nuclear extracts 
were quickly frozen and stored at – 70 oC for subsequent use by EMSA.  
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2.3.5.3  [γ−32P] ATP labeling of the oligonucleotides 
The sequences of the commercially synthesized oligonucleotides for EMSA are 
listed in Table 3.2 (page 85).  Before labeling, the single-stranded oligonucleotides were 
annealed in the annealing buffer (10 mM Tris-HCl pH 7.9, 2 mM MgCl2, 50 mM NaCl 
and 1 mM EDTA) with corresponding DNA strands at 85 oC for 15 min.  After 
incubation, the reaction was cooled down slowly to 25 oC and incubated for another 30 
min.  Subsequently, the annealed double-stranded oligonucleotides were end-labeled with 
fresh [γ−32P] ATP with T4 polynucleotide kinase (NEB).  The 32P labeled probes were 
subsequently purified using the Qiagen Nucletide Removal Kit (Qiagen).  The 
radioactivity and labeling efficiency of the labelled probes were measured by dry 
Cerenkov count. 
 
2.3.5.4 Electrophoretic gel mobility-shift assay (EMSA) 
EMSA was performed using the recombinant CrNFκB protein, whole hemocyte 
lysate or nuclear extract of hemocytes.  The reactions were set up in the presence of 
1×105 cpm/pmol 32P-labeled oligonucleotide and 2 μg of poly (dI-dC) at 25 °C for 30 min 
in binding buffer (50 mM NaCl, 2 mM MgCl2, 2 mM DTT, 1 mM EDTA, 10 % glycerol 
and 10 mM HEPES, pH 7.8) before electrophoresis on a 4 % native PAGE gel 
(acrylamide:bisacrylamide ratio of 79:1).  In competition assays, 10×, 100× cold probes 
(see Table 3.2) or indicated amounts of recombinant CrIκB were used in each reaction 
and incubated for 30 min before adding the 32P-probe.  For supershift assays, hemocyte 
extracts were incubated with the respective antibody for 30 min on ice before adding the 
 54
probe.  After 2-3 h of electrophoresis at 120 V-130 V at 25 oC, the gel was fixed in 7 % 
acetic acid for 5 min.  Next, the gel was transferred to a Whatman paper with a 
comparable size to the gel and covered with a saran wrap to be dried in the gel drier 
(Biorad, model 583) for 1.5-2 h.  The dried gel was subsequently exposed to an X-ray 
film (Biomax, Kodak).  After autoradiography, the film was developed in an automated 
X-ray developer (Kodak). 
 
2.3.6 Cell culture and transfection 
Because of the lack of direct cell lines derived from the horseshoe crab, and the 
relative evolutionary closeness of horseshoe crabs to insects, Drosophila S2 cell line was 
used in our transfection studies (Wang et al, 2003).  The Drosophila Schneider S2 cells 
were maintained at 25 °C in Drosophila SFMTM supplemented with 20 mM L-glutamine 
and 5 % FBS.  Twelve hours prior to transfection, cells were seeded in a 6-well plate at 
1.2 × 106 cells/well.  When the cells had attached to the well surface and had reached 60-
80 % confluency, transfections were conducted with 2 μg of DNA using CellFectin 
(Invitrogen) according to the manufacturer's recommendation.  After 6 h incubation of the 
cells with the transfection medium, the cells were renewed with 2 ml fresh medium.  At 
36 - 48 h post-transfection, the cell were harvested and lysed.  In this study, the κB 
reporter was horseshoe crab Factor C promoter (p186) CAT reporter (CrFC-CAT) whose 
activity correlates with the activity of NF-κB (Wang et al, 2003).  pACH110 containing 
the β-galactosidase gene fused with the Drosophila actin promoter, was used as internal 
control (Wang et al, 2003).  Plasmids used for transfection were isolated using 
CsCl/ethidium bromide gradient ultracentrifugation described by Sambrook et al (1988). 
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2.3.7 CAT and β-Gal ELISA assay  
CAT and β-Gal activities were measured in the cell extracts using the CAT and β-
Gal ELISA kits (Roche).  Following lysis of the transfected cells, 200 μl of the cell 
extracts, which contain the CAT enzyme and the β-Gal enzyme, were added to the wells 
of the microtiter plate modules (MTP modules), and incubated at 37 °C for 2 h.  After 
rinsing with the wash buffer, a digoxigenin-labeled antibody to CAT (anti-CAT-DIG) or 
to β-Gal (anti-β-Gal-DIG) was added and incubated at 37 °C for 1 h.  The excess 
antibody was removed by rinsing with the wash buffer.  Next, an antibody to digoxigenin 
conjugated to peroxidase was added.  This was incubated at 37°C for 1 h, followed by 
rinsing to remove excess antibody.  Finally, the peroxidase substrate ABTS® was added.  
The peroxidase enzyme catalyzes the cleavage of the substrate yielding a colored product.  
The absorbance of the sample was determined at 405 nm using an ELISA reader 
(Molecular Divices, Spectra MAX 340) and is directly correlated to the level of CAT 
present in the cell extract.  
 
2.3.8 Immunofluorescence 
To determine the subcellular localization of CrNFκB and CrIκB, 
immunofluorescence experiments were performed.  In these experiments, the S2 cells 
were transfected with plasmids expressing either CrNFκB-V5 or CrIκB-c-Myc fusion 
proteins.  After 24 h, cells were transferred to an 8-well chamber slide (NUNC) and 
allowed to attach for 2 h.  The cells were fixed for 15 min in 4 % paraformaldehyde and 
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permeabilized by 0.1 % Triton X−100/PBS for 2 min at room temperature.  The 
permeabilization reagent was removed and the cover slip was rinsed thrice with PBS for 
5 min each time.  They were then incubated with mouse monoclonal antibody against V5 
or c-Myc (1:500 dilutions, Invitrogen) overnight at room temperature.  After washing 
with PBS, the cells were incubated with Alex594 rabbit anti-mouse IgG antibody (1:500 
dilutions, Molecular Probes) for 2 h at room temperature.  These cells were 
counterstained with DAPI (1 μg/ml) for 1 min and rinsed thrice with PBS prior to 
fluorescence microscopy analysis (Olympus, BX60). 
To examine the subcellular localization of CrNFκB and CrIκB in horseshoe crab 
hemocytes, the hemocytes from naïve horseshoe crab or 30 min-challenged with P. 
aeruginosa (1.2 × 107 colony forming units/kg) were collected into 3 % saline at 42 °C.  
The diluted hemocytes were spread on pyrogen free cover slip for cell attachment.  After 
5 min, the cells were fixed in 2 % paraformaldehyde, blocked with 5 % goat pre-immune 
serum (Sigma) in PBS for 1 h and incubated for 2 h with anti-CrNFκB or anti-CrIκB 
antibody (1:500 dilutions).  After washing with PBS, cells were incubated with Alex594 
goat anti-rabbit IgG antibody (1:500 dilutions, Molecular Probes) which has been pre-
absorbed to paraformaldehyde-fixed hemocytes in 5 % goat pre-immune serum for 1 h.   
The secondary antibody was then completely removed and the cover slip was rinsed 
thrice with PBS for 5 min each time. The cover slips were carefully blotted dry using 
Kimwipes, and a drop of Prolong® Gold antifade reagent with DAPI (Molecular Probes) 
was added onto the center of the cover slip.  The cover slip was carefully placed onto a 
glass slide.  Cells were then observed under the confocol microscope (Zeiss). The 




Figure 2.2: A schematic diagram of immunocytochemistry.  Indirect cell stainining method is 
used.  Cell was fixed onto a glass slide, permeabilized 0.1 % Triton X-100 and tagged with rabbit 
or mouse antibody against the target protein of interest. A secondary fluorophore-coupled 
antibody is directed against the rabbit or mouse antibodies, and cells were observed directly under 




2.3.9 Inhibitor treatments and reverse-transcription PCR 
NF-κB inhibitors were obtained from Calbiochem. Helenalin and MG-132 were 
dissolved in dimethylsulfoxide (DMSO) at stock concentrations of 10 mM and 25 mM 
respectively.  Five hundred microliters/kg (body weight) of DMSO or inhibitor drug 
solution were given intracardially.  One hour later, the horseshoe crabs were injected with 
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P. aeruginosa at 1.2 × 107 colony forming units/kg of horseshoe crab body weight (Ng et 
al, 2004).  The hemocytes were collected at indicated time points.  Total RNA was 
prepared by the Trizol technique according to previous description.  RT-PCR was 
performed by using the Invitrogen RT-PCR kit with 3 μg of total RNA and oligo dT.  
Semi-quantitative RT-PCR was performed with a rapid heating to 95 °C for 3 min 
followed by 19−25 cycles of 56 °C for 30 s, 72 °C for 1 min, and 95 °C for 30 s.  PCR 
products were resolved on 1.2 % agarose gel, stained with ethidium bromide and the gel 
image was acquired and analyzed by Image Master VDS version 2.0 software (Pharmacia 
Biotech).  The mRNA expression was normalized according to the expression level of 
horseshoe crab actin-11 gene.  The primers used for RT-PCR experiments are listed as 
follows: Actin, primer 1 (5′-CGAGGGTACAGTTTCACCAC-3′) and primer 2 (5′-
TCCTTTTGCATTCTATCAGC-3′); CrNFκB, primer 1 (5′-
AAATGGTGCCAACAAATCCTAC-3′) and primer 2 
(5′ACAACAACTACTGCTGAGCCTTT-3′); CrIκB, primer 1 (5′-
CAACAGTGGACATGAGGGATCGCCAT-3′) and primer 2 (5′-
GTCAACATCACTTTCTGGAGGTCTTC-3′); CrFC, primer 1 (5′-
AATAGGTCAGTGGCCGTGG-3′) and primer 2 (5′-TGCTGGCTGCAACAACAG-3′); 
CriNOS, primer 1 (5′-CCATCAGTTAAAATCAACGCTGCAT-3′) and primer 2 (5′-
CTTGAACATACTTCTTTGGGTTTAGG-3′); Transglutaminase, primer 1 (5′-




2.4 Functional characterization of Cr-TRX1 
2.4.1 Construction of plasmids 
In order to study the enzymatic function of horseshoe crab TRX homologue 
(henceforth referred to as C. rotundicauda TRX, Cr-TRX1), we expressed the full length 
Cr-TRX1 in bacteria.  For bacterial expression, the full length Cr-TRX1 was cloned into 
the BamHI-XhoI sites of the pGEX-4T-1 expression vector (GE Healthcare).  Figure 2.3 
illustrated the cloning strategies of the full-length Cr-TRX1. TRX6, the human 
homologue of Cr-TRX1, was similarly cloned into the pGEX-4T-1 plasmid for bacterial 
expression. 
 
Figure 2.3: The cloning strategy of GST-Cr-TRX1 expression vector.  The Cr-TRX1 
fragment was PCR-amplified from the pGEM-T easy Cr-TRX1 construct. With the BamHI and 
XhoI sites introduced into the primers, the fragment was subcloned into the BamHI and XhoI sites 
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For mammalian expression, full-length Cr-TRX1 was cloned into the expression 
vector pcDNA3.1 (Invitorgen) as follows.  We used PCR to amplify the Cr-TRX1 with 
the following two primers: Primer1:  5’-GGTACCATGGAATTTATCCAAGG-3’; 
Primer 2: 5’-ACCGGTTTTGTCGTCATCGTCCTTATAGTCTCTTGCCCAGTTCTGG 
AA-3’. The primer 2 introduced a FLAG tag at the C-terminus of the Cr-TRX1.  The 
amplified Cr-TRX1-FLAG sequence was inserted into pGEM-T vector (Promega).  Then, 
the insert was released by digestion with KpnI and AgeI and ligated into pcDNA3.1 
vector using T4 DNA ligase.  For the mutant Cr-TRX1, both of the cysteine residues at 
the active site were replaced with alanine residues using QuikChange® XL Mutagenesis 
Kit (Stratagene). 
 
2.4.2 Site-directed mutagenesis of Cr-TRX1 
The two cysteine residues in the catalytic site (CXXC) are responsible for the 
oxido-reductase function of the thioredoxin superfamily. Hence, to investigate the 
importance of these two residues in catalyzing the redox function of Cr-TRX1, they were 
converted to alanine residues.  Alanine was selected due to its small functional group and 
non-polarity; hence the effect on protein structure would be minimized without change in 
polarity of protein.   The primers used for the mutagenesis are listed at below:  
Cr-TRX1-DM-For: 5’-CAGTGCCCACTGGGCTCCCCCAGCTCGAGGGTTCACC-3’ 
Cr-TRX1-DM-Rev: 5’-GGTGAACCCTCGAGCTGGGGGAGCCCAGTGGGCACTG-




Site-directed mutagenesis of both the cysteine residues at the active site of Cr-
TRX1 was performed using QuikChange® XL Site-Directed Mutagenesis Kit (Stratagene) 
according to the kit manual.  Briefly, 10 ng of pcDNA3.1-Cr-TRX1, 5 µl of 10 × reaction 
buffer, 125 ng each of the primers for mutation, dNTP mixture, QuikSolution and 2.5 U 
of Pfu Turbo DNA polymerase were sequentially added and mixed in a PCR tube.  PCR 
was carried out with initial denaturation at 95 ºC for 1 min, denaturation at 95 ºC for 50 s, 
annealing at 60 °C for 50 s, and extension at 68 °C for 6 min for 18 cycles, and kept at 68 
°C for 7 min.  Following the temperature cycling, the product was treated with 10 U Dpn 
I endonuclease, which was used to digest the parental DNA template.  The nicked vector 
DNA incorporating the desired mutations was then transformed into XL10-Gold®
 
ultracompetent cells (Stratagene). 
 
2.4.3 Expression and purification of Cr-TRX1 
The pGEX-4T-1 Cr-TRX1 plasmids were transformed into E. coli BL21 (DE3) 
for bacterial expression.  The induction and purification of the GST-Cr-TRX1 fusion 
protein was performed as previously described (Sadek et al, 2003).  Briefly, after 4-6 h 
induction with 0.1 mM IPTG at 30°C, the bacterial culture was pelleted at 6,000 × g for 
10 min and resuspended in 20 ml PBS.  Overexpressing cells were disrupted by 
sonication on ice at 28 amplitude microns, for 6 × 10 s each with intervals of 30 s and 
centrifuged at 12,000 × g, and the supernatant was loaded onto a Gutathione-Sepharose 
4B column (GE Healthcare).  Binding to the matrix was allowed to occur overnight at 4 
°C.  Thrombin (5 Units/mg of fusion protein) was used to cleave off the Glutathione S-
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transferase.  The protein concentration was determined by Bradford method (Bradford, 
1976) using bovine serum albumin, BSA, fraction V (Sigma) at calibration standard. 
 
2.4.4 Mass spectrometric analysis 
In addition to the two conserved Cys residues, the horseshoe crab TRX contains 1 
extra Cys residues (Cys15) at the N-terminus (Figure 3.27).  Therefore, it was important to 
identify which Cys residue is redox sensitive in Cr-TRX1.  To achieve this, we 
determined the number and the position of the active Cys residues in horseshoe crab TRX 
molecule using mass spectrum. 
First, the number of active Cys residues in Cr-TRX1 molecule was determined 
using MALDI-TOF. In this experiment, the reduced Cr-TRX1 was prepared by 
incubation with 1 mM dithiothreitol (DTT) for 30 min at room temperature.  The 
unreduced controls were treated under identical conditions but in the absence of DTT.  
The reduced and non-reduced Cr-TRX1 were incubated with 3 mM iodoacetamide (IAM) 
for 30 min at room temperature for derivatisation (Gommel et al, 1997).  The samples 
were diluted 10 times with 0.1 % (v/v) trifluoroacetic acid and mixed with an equal 
volume of a saturated solution of sinapinic acid in 33 % (v/v) acetonitrile and 0.1 % (v/v) 
trifluoroacetic acid.  An aliquot of 0.5 μl of this mixture was crystallized on a 
microcrystalline layer and analyzed using ABI Voyager-DE™ STR Biospectrometry™ in 
the linear model.   
To identify the position of active Cys residues, aliquots of the Cr-TRX1 samples 
were subjected to SDS-PAGE.  The Cr-TRX1 bands were recovered and subjected to in-
gel digestion analysis according to the methods described by Shevchenko et al (1997). 
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However, the alkylation step was omitted.  After overnight in-gel digestion with trypsin, 
the protein fragments were extracted from the gel with 20 mM ammonium bicarbonate, 
followed by 5 % formic acid in 50 % aqueous acetonitrile and with 100 % acetonitrile. 
The extracts were pooled and the solvent was allowed to vaporize in a speed-vacuum 
before mass spectrometric analysis.  The peptide samples were analyzed by the Applied 
Biosystems 4700 Proteomics Analyzer. 
 
2.4.5 Biochemical characterization of Cr-TRX1 
In order to investigate the enzymatic function of Cr-TRX1, we expressed and 
purified the recombinant full-length Cr-TRX1 in E. coli.   With this recombinant Cr-
TRX1, the following biochemical experiments were performed. 
 
2.4.5.1 Fluorescence spectroscopy analysis 
Reduction of oxidized E. coli TRX was previously shown to increase tryptophan 
fluorescence due to the quenching effect of the active site disulfide on the fluorescence of 
the adjacent tryptophan (Windle et al, 2000).  The horseshoe crab TRX also contains a 
Trp residue in the active site motif, WCPPC.  Therefore, we examined the fluorescence 
emission spectra of horseshoe crab TRX before and after reduction.  The change of 
fluorescence emission spectra indicates the status of the disulfide band in the active motif.  
The fluorescence emission spectra of Cr-TRX1 were determined with a Perkin Elmer 
LS50B spectrofluorimeter by excitation at 280 nm and emission was recorded from 300 
to 400 nm using a light path of 1 cm.  The bandwidth of the excitation and emission were 
5 nm.  All measurements were made in 50 mM Tris-HCl, pH 7.4 containing 1 mM EDTA 
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and 20 μg/ml TRX at room temperature.  Complete reduction of TRX was achieved by 
the addition of 1 mM DTT (Windle et al, 2000).  The solvent blanks were run as control 
spectra.  
 
2.4.5.2 Insulin reduction assay & thioredoxin reductase assay 
Enzymatic activity of TRX is usually assayed by their capacity to reduce the 
disulfide bonds of insulin using DTT as artificial reductant (Kunchithapautham et al, 
2003).  Insulin reduction can be measured spectrophotometrically as an increase in 
turbidity due to precipitation of the free insulin B chain.  To examine the enzymatic 
antivity of horseshoe crab TRX, the insulin reduction assay was performed using DTT, 
insulin and recombinant TRX as previously described (Sadek et al, 2001).  The reduction 
of insulin was recorded by monitoring the OD600.   
Except for DTT, the NADPH and TRX reductase (TRXR) can function as a 
physiological system to reduce TRX.  Therefore, we also examined whether oxidized 
horseshoe crab TRX is reduced by TRXR in the presence of NADPH by monitoring 
NADPH oxidation at 340 nm.  Thioredoxin reductase assays were conducted at room 
temperature in phosphate buffered saline (PBS), pH 7.4, containing 2 mM EDTA, 55 μM 
insulin, 100 μM NADPH and 1 μm Cr-TRX1.  The assay was initiated by the addition of 
50 nM rat liver TRXR (Reckenfelderbaumer et al, 2000). 
 
2.4.5.3 Peroxidase activity assay of Cr-TRX1 
Like peroxidase, the human TRX1 has been suggested to act as an antioxidant that 
directly scavenges H2O2 (Hirota et al, 2002).  The reactive CXXC motif of TRX readily 
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undergoes oxidation-reduction in the presence of H2O2, NADPH and TRXR.  In order to 
examine if the horseshoe crab TRX also possesses the peroxidase activity, we performed 
the peroxidase activity assay.  The peroxidase reactions were performed at room 
temperature and the absorbance at 340 nm (A340) was monitored.  Sample mixtures 
lacking Cr-TRX1 served as controls.  The reaction mixtures contained phosphate 
buffered saline, pH 7.4, 2 mM EDTA, 100 μM NADPH, 50 nM rat  liver TRXR, 2.5 mM 
H2O2, and Cr-TRX1 (Jeong et al, 2004b). 
 
2.4.5.4 DNA nicking assay 
Thioredoxin is detectable in human plasma up to a concentration of 6 nM and it 
has been suggested that TRX plays a direct role as an antioxidant (Kunchithapautham et 
al, 2003).  A DNA nicking assay was performed to determine whether recombinant 
horseshoe crab TRX was capable of functioning as an antioxidant protein.  pGEM-T easy 
plasmid DNA (Promega) was used as a substrate for detecting DNA damage mediated by 
the mixed function oxidase (MFO) system which generates hydroxyl (OH-) and thiol 
(RS*) radicals capable of damaging a DNA template (Kunchithapautham et al, 2003).  
The extent of MFO-mediated nicking can be evaluated by assessing the shift in gel 
mobility of the plasmid as it was converted from the supercoiled to the nicked form.  The 
MFO system consists of 66 μM FeCl3, 3.3 mM DTT and 2 mM EDTA in 25 mM HEPES 
buffer, pH 7.0.  Plasmid DNA (500 ng) was incubated in the MFO system at 37 °C with 
or without recombinant Cr-TRX1.  The recombinant GST and commercial BSA were 
used as controls.  The extent of DNA damage was evaluated on ethidium bromide-stained 
agarose gels.   
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2.4.6 Gene reporter assay 
To determine if Cr-TRX1 could regulate the NF-κB transactivation activity, we 
performed the co-transient transfection assay in HeLa cells with the wild type and mutant 
Cr-TRX1 and κB-reporter.  In this project, the κB reporter was p5 × NF-κB-luciferase 
(Stratagene, La Jolla, CA), whose activity correlates with the expression of NF-κB.  pRL-
CMV (Promega) was used as an internal control.  pcDNA3.1 vector (Invitrogen) was 
used for the expression of wild type and mutant Cr-TRX1 proteins.   
For transient transfection, HeLa cells were maintained at 37 °C in DMEM 
supplemented with 10 % FBS.  Twelve hours prior to transfection, cells at a density of 
0.8×106 cells/well were seeded in a 6-well plate.  Transfection was conducted using 
Lipofectamine 2000 (Invitrogen), according to the manufacturer's recommendation.  
Briefly, cells were transfected by incubation with 2 μg of DNA and 5 μl of Lipofectamine 
2000 dissolved in 1.5 ml of Dulbecco’s modified Eagle’s medium (DMEM) alone for 6 h 
at 37 ºC.  The transfection medium was completely removed, replaced with complete 
growth medium and incubated for another 36-48 h.   
Collection of cell lysate was performed using the passive lysis buffer (PLB) from 
the Dual Luciferase Reporter Assay System (Promega).  In brief, the growth medium was 
removed and the cells in the six-well plate were rinsed twice with 2 ml of ice-cold 
phosphate buffered saline (PBS).  Five hundred μl of 1 × PLB was added to each well 
and the plate was placed on an orbital shaker with gentle shaking for 15 min at room 
temperature.  The lysate was then transferred into a 1.5 ml tube and centrifuged for 30 s 
at 14,000 × g at 4 ºC in a refrigerated centrifuge.  The cleared lysate was then transferred 
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to a new 1.5 ml tube.  The protein concentration in the soluble cell lysate was quantified 
by Bradford analysis. To perform gene reporter assays, dual luciferase activities were 
measured using the Dual-Luciferase Reporter (DLR) Assay System (Promega) at 36 h 
after transfection according to the manufacturer’s manuals.  The luminescent signal was 
measured using TD-20/20 Luminometer (Turner Designs). 
 
2.4.7 Non-radioactive electrophoretic mobility shift assay (EMSA) 
In order to examine if Cr-TRX1 could affect the NF-κB DNA-binding activity, 
we performed the EMSA.  In this experiment, the LightShift® Chemiluminescent EMSA 
Kit (Pierce), based on a non-isotopic method, was used to detect DNA-protein 
interactions.  To perform the EMSA, we first extracted the nuclear extraction and 
prepared the biotin-labeled DNA probe according to the procedures described below. 
 
2.4.7.1 Preparation of nuclear and cytoplasmic extraction 
Nuclear extract was prepared using NE-PER® Nuclear and Cytoplasmic 
Extraction Reagents (Pierce).  In brief, the growth medium was removed and the cells in 
the six-well plate were rinsed with 2 ml of PBS.  An aliquot of 0.5 ml of TryLETM 
Express (Invitrogen) was added to each well and incubated for 5 min at 37 °C until all 
cells have detached.  The cell suspension was transferred to a 2 ml centrifuge tube. The 
nuclear and cytoplasm extracts were prepared according to the manufacturer's 
recommendation.  The nuclear and cytoplamic extracts were immediately stored at - 80 
°C.    The extracts were thawed just before use in EMSA. 
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2.4.7.2 3’ End biotin labeling 
Biotin-labeled double stranded DNA was prepared using the Biotin 3’ End DNA 
Labeling kit (Pierce).  The mammalian κB DNA sequence was synthesized in both the 
forward and reverse orientations. The complementary oligos were first end-labeled 
separately as follows: 1 × TdT Reaction Buffer, 5 pmol ends of DNA, 0.5 μM biotin-11-
UTP and 0.2 U/μl diluted TdT were incubated at 37 ºC for 30 min; and the reaction was 
stopped by adding 2.5 μl of 0.2 M EDTA.  Fifty μl of chloroform/isoamyl alcohol (24:1) 
was added to extract the TdT.  The mixture was then vortexed and centrifuged at 16,000 
× g for 2 min to separate the phases.  The aqueous phase, containing the biotin-labeled 
DNA, was removed and saved.  The labeled complementary oligos were annealed by 
adding equal amounts of each and incubating at room temperature for 1 h.  The 
mammalian κB DNA sequence is 5’-AGTTGAGGGGACTTTCCCAGGC-3’.  The 
annealed oligos were stored at -20 ºC. 
 
2.4.7.3 Electrophoretic mobility shift assay (EMSA) 
            The EMSA was used to study DNA-protein interactions. The LightShift
®
 
Chemiluminescent EMSA Kit (Pierce), based on a non-isotopic method, was used to 
detect DNA-protein interactions.  A 4 % native polyacrylamide gel in 0.5 × TBE was 
prepared.  The gel was pre-electrophoresed for 60 min at 100 V.  Twenty fmol of biotin 
end-labeled DNA was incubated with 2 µl of nuclear extract, 1 × Binding Buffer and 50 
ng/µl Poly (dI•dC) for 30 min at room temperature, and finally mixed with Loading 
Buffer via gentle pipetting.  Twenty µl samples were loaded and electrophoresed at 100 
V until the bromophenol blue dye had migrated approximately 3/4 down the length of the 
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gel.  The Hybond-N+ (GE Healthcare) membrane was soaked in 0.5 × TBE for 15 min, 
before transfer.  Electrotransfer was carried out at 380 mA for 30 min in 0.5 × TBE 
cooled to 10 ºC.  The membrane was placed on a dry paper towel and cross-linked at 120 
mJ/cm2 using the SpectrolinkTM XL-1000 UV Crosslinker (Spectronics Corporation). The 
membrane was then processed according to the manual of LightShift® Chemiluminescent 
EMSA Kit (Pierce). 
 
2.4.8 Antioxidant inhibits NF-κB signaling pathway 
To determine if oxidative stress could also play a crucial role in mediating 
immune response in the horseshoe crab, we checked the effect of an antioxidant -
pyrrolidine dithiocarbamate, PDTC (Calbiochem) on the expression of immune-related 
genes.  At 50 mM, the antioxidant PDTC was administered intracardially at 500 μl/kg 
body weight of horseshoe crab.  After 1 h, the horseshoe crabs were injected with 1.2 × 
107-colony forming unit of P. aeruginosa / kg body weight.  The hemocytes were 
collected at indicated time points after infection with P. aeruginosa.   The semi-








CHAPTER 3:  RESULTS 
 
3.1 Isolation of C. rotundicauda NF-κB and IκB homologues 
To address the issue of whether the ancient origin of the NF-κB signaling cascade 
can be traced back to this “living fossil”, we decided to clone the horseshoe crab 
homologues of NF-κB and IκB.  Because the genome of the horseshoe crab is still 
unknown and the homology of Rel homology domains (RHD) amongst different NF-κB 
proteins is relatively well-conserved from the vertebrate and insect, we used the 
degenerate primers that were designed based on the RHDs from various species to isolate 
the horseshoe crab NF-κB homologue.  Similarly, in order to clone the IκB gene from the 
horseshoe crab, we designed the degenerate primers based on the sequence homology of 
the ankyrin repeats. 
 
3.1.1 Cloning and characterization of NF-κB p65 homologue, CrNFκB 
Using degenerate primers that were designed based on sequence homology of 
RHDs and C. rotundicauda hemocyte cDNA as template, we performed the RT-PCR to 
isolate the horseshoe crab NF-κB.  The RT-PCR amplified a 160 bp product.  Sequence 
analysis of this PCR fragment confirmed that it is a homologue of NF-κB transcription 
factor.  Based on this 160 bp sequence, we designed two gene specific primers and 
performed the 3′ and 5′ RACE to obtain the full-length horseshoe crab NF-κB.  By 3′ and 
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5′ RACE, the full-length C. rotundicauda NF-κB cDNA of 2527 bp was isolated 
(GenBank accession number: DQ090482).  With an open reading frame of 1686 bp, the 
horseshoe crab NF-κB encodes a protein of 562 amino acids with a predicted molecular 
weight of 62 kDa (Figure 3.1).  Amino acid analysis revealed that C. rotundicauda NF-
κB possesses the characteristic organization of Rel/NF-κB proteins, thus, it is henceforth 
referred to as CrNFκB.   
The overall sequence identity of CrNFκB with other NF-κB proteins ranged from 
16 % to 32 %.  In particular, CrNFκB shares homology with insect Dorsal-like proteins 
with highest sequence similarity to that of the honey bee, Apis mellifera dorsal protein 
(GeneBank accession number: AAP23055).  Specifically, the CrNFκB contains an N-
terminal Rel homology domain (RHD) of 282 amino acids (residues: 19-301) and a C-
terminal transactivation domain, TD (residues: 315-562) (Figure. 3.1).  The CrNFκB 
contains two conserved motifs in the RHD: the DNA binding motif (R-XX-R-X-R-XX-C) 
and the nuclear localization signal, NLS, which characterizes all NF-κB family of 
proteins (Figure 3.1).  Sequences flanking the RHD show no homology to known 
proteins and do not contain any recognizable protein motifs.  Interestingly, like the 
molluscan NF-κB homologue Cg-Rel (Montagnani et al, 2004), the C-terminal TD of 
CrNFκB also lacks the polyglutamine, polyalanine or polyasparagine stretches which 
characterizes the TD of Drosophila Dorsal and several insect Dorsal-like proteins (Shin 






Figure 3.1: Comparison of amino acid sequence of CrNFκB with homologous proteins. 
Drosophila Dorsal (DmDorsal, AAA28479), Honey bee Dorsal (AmDorsal, AAP23055) and 
human RelA (HsRelA, AAH33522) were used for the comparison.  Alignments were done by 
Clustal X. The RHD (Rel homology domain) is indicated by black lines. The NLS (Nuclear 
localization signal) is indicated by *. The potential DNA binding motif is indicated by a dotted 
line. Black and grey shades indicate identity and similarity of the residues, respectively. 
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The availability of the vertebrate and invertebrate (mostly insect) NF-κB protein 
sequences in databases allowed us to perform a phylogenetic analysis of the NF-κB 
family to confirm the relationship between CrNFκB and the other NF-κB transcription 
factors.  The accession numbers of all the NF-κB and IκB proteins used in this study are 
listed in Table 3.1 (page 78).  Based on the multisequence alignment of full-length 
proteins built with ClustalX, we constructed an unrooted phylogenetic tree.  
The NF-κB protein family can be divided into two subfamilies.  The class I 
subfamily includes vertebrate p100, p105 and invertebrate Relish proteins.  The class II 
subfamily includes vertebrate RelA/p65, RelB, c-Rel and invertebrate Dorsal-like 
proteins (Gilmore, 1999).  The difference is that RelA, RelB and c-Rel have an activation 
domain in their C-terminal which is absent in NF-κB1 and NF-κB2.  On the contrary, 
NF-κB1 and NF-κB2 contains a C-terminal inhibitory IκB-like domain (see Figure 1.1).  
The phylogenetic analysis demonstrated that CrNFκB clustered amongst Dorsal-like 
proteins that belong to the invertebrate class ΙΙ NF-κB (Figure 3.2).  This cluster differs 
from the vertebrate class ΙΙ NF-κB, which includes RelA, RelB and c-Rel proteins.  This 
result is consistent with the previous sequence analysis where CrNFκB shared most 
similarities with insect Dorsal-like sequences.  The class II NF-κB proteins from the 
invertebrates and vertebrates are more distant from the class Ι NF-κB proteins (Figure 
3.2), which includes vertebrate p100, p105 and invertebrate Relish-like proteins (Gilmore, 





Figure 3.2: Phylogeny of CrNFκB and related NF-κB proteins. Multiple sequence alignments 
were produced with Clustal X using Gonnet series protein weight matrix. Unrooted phylogenetic 
tree was constructed using neighbor-joining method based on the alignments. The confidence 
scores (in %) of a bootstrap test of 1000 replicates are indicated for major branching nodes. The 
accession numbers of all the proteins used in this study are listed in Table 3.1 (page 78).  
 
3.1.2 Cloning of Cactus and IκB homologue, CrIκB 
The C. rotundicauda IκB (CrIκB) cDNA was similarly cloned using primers 
designed from the conserved ankyrin repeat regions of Drosophila and mammalian IκB 
proteins using horseshoe crab hemocyte cDNA as template.  Subsequently, the full-length 
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CrIκB cDNA was obtained by 3′ and 5′ RACE.  The full-length CrIκB cDNA (GenBank 
Accession number: DQ090483) contains 1566 bp encoding a 439 amino acid protein with 
a predicted molecular weight of 49 kDa.  The CrIκB protein (Figure 3.3) contains several 
features exemplified by IκB members: 5 ankyrin repeats with homology to the 
mammalian and Drosophila IκB counterparts; two serine residues at the N-terminal 
serine rich region that are critical for its degradation; and the C-terminal PEST (proline-, 
glutamic acid-, serine- and threonine-rich) domain necessary for phosphorylation and 
intrinsic stability of the IκB protein (Ernst et al, 1995).  Furthermore, at the C-terminal 
PEST domain, several putative casein kinase II phosphorylation sites can be identified 
which have been shown to be required for PEST-mediated Cactus degradation (Liu et al, 
1997).  
A comparison of full-length amino acid sequences between CrIκB and insect IκB 
proteins showed that CrIκB has the highest homology to Drosophila IκB homologue, 
Cactus.  Using the vertebrate and invertebrate (mostly insect) IκB protein sequences in 
databases, we performed a phylogenetic analysis of the IκB family.  The accession 
numbers of all the IκB proteins used in this study are listed in Table 3.1.  Based on the 
multisequence alignment, we constructed an unrooted phylogenetic tree.  The 
phylogenetic analysis revealed three main clusters: the invertebrate IκB, vertebrate IκBα, 
and vertebrate IκBβ and IκBε (Figure 3.4).  The horseshoe crab IκB, together with 
Drosophila IκBs, formed a separate cluster that is different from the group of vertebrate 
IκB proteins.  Interestingly, compared with that of the invertebrate IκB proteins, the 
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genetic distances between the vertebrate IκB clades are rather short.  This is in contrast to 





Figure 3.3: Amino acid sequence alignment of CrIκB and homologous proteins.  Drosophila 
Cactus (AAA85908) and human IκBα (AAP35754) were aligned with CrIκB using Clustal X.  
The five ankyrin repeats of CrIκB are underlined in black lines. The N-terminal serine rich region 
is underlined by a black line. The potential N-terminal phosphorylation sites which have been 
shown to be critical for IκB degradation in response to extracellular signals are indicated by 
arrows. The C-terminal PEST domain implicated in regulating the stability of IκB is underlined 
in dashed line. The serine residues which are potentially phosphorylated by casein kinase II are 













Figure 3.4: Unrooted phylogenetic tree of IκB proteins. The tree was built by the neighbor-
joining method based on the alignment of the sequences using Clustal X. The confidence scores 
(in %) of a bootstrap test of 1000 replicates are indicated for major branching nodes. The 








Table 3.1: The sequences used for phylogenetic analysis of the NF-κB and IκB proteins 
 
NF-κB proteins 
Code Name Name Accession Number Organism 
DmDif Drosophila Dif A49435 Drosophila melanogaster 
DmDorsal Drosophila Dorsal AAA28479 Drosophila melanogaster 
AmDorsal Honey bee Dorsal AAP23055 Apis mellifera 
AdRelA Beetle RelA BAD20728 Allomyrina dichotoma 
AgGambif1 Mosquito Gambif1 S71889 Anopheles gambiae 
CrNFκB Horseshoe crab NF-κB DQ090482 Carcinoscorpius rotundicauda
HsRelA Human RelA AAH33522 Homo sapiens 
MmRelA Mouse RelA AAH94053 Mus musculus 
GgRelA Chicken RelA NP_990460 Gallus gallus 
Hsc-Rel Human c-Rel X75042 Homo sapiens 
Drc-Rel Zebra fish c-Rel AAO26402 Danio rerio 
HsRelB Human RelB Q01201 Homo sapiens 
GgRelB Chicken RelB NP_990181 Gallus gallus 
XlRelB Frog RelB S60161 Xenopus laevis 
AsRel1 Ascidian  Rel1 BAB47172 Halocynthia roretzi 
CrRelish Horseshoe crab Relish DQ345784 Carcinoscorpius rotundicauda
Ggp105 Chicken p105 Q04861 Gallus gallus 
Mmp105 Mouse p105 NM_008689 Mus musculus 
Drp100 Zebra fish p100 NP_001001840 Danio rerio 
Hsp100 Human p100 AAW56071 Homo sapiens 
SpRel Sea urchin NF-κB NP_999819 Strongylocentrotus purpuratus
AaRelish Mosquito Relish AAM97895 Aedes aegypti 
DmRelish Drosophila Relish AAF20137 Drosophila melanogaster 
IκB proteins 
Code Name Name Accession Number Organism 
CrIκB Horseshoe crab IκB DQ090483 Carcinoscorpius rotundicauda
AgCactus Mosquito Cactus EAA12805 Anopheles gambiae 
DmCactus Drosophila Cactus AAA85908 Drosophila melanogaster 
AmIκB Honey bee IκB XP_394485 Apis mellifera 
HsIκBα Human IκBα AAP35754 Homo sapiens 
MmIκBα Mouse IκBα NP_035037 Mus musculus 
GgIκBα Chicken IκBα NP_001001472 Gallus gallus 
DrIκBα Zebra fish IκBα AAH62524 Danio rerio 
HsIκBβ Human IκBβ AAP36616 Homo sapiens 
MmIκBβ Mouse IκBβ Q60778 Mus musculus 
HsIκBε Human IκBε AAC51216 Homo sapiens 
MmIκBε Mouse IκBε AAB97517 Mus musculus 
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3.1.3 Cloning of horseshoe crab NF-κB p100 and Relish homologue, 
CrRelish  
              During the process of cloning CrIκB with the degenerate primers designed based 
on the ankyrin repeats, a 120 bp DNA fragment was serendipitously isolated, which 
shows moderate homology with mammalian p100.  Because the ankyrin repeat region is 
conserved between the IκB proteins and class I NF-κB, which include vertebrate p100, 
p105 and invertebrate Relish proteins, we speculated that this 120 bp fragment probably 
represents the horseshoe crab class I NF-κB homologue.  To confirm this possibility, the 
full-length sequence was cloned by 5′ and 3′ RACE.   
Indeed, this clone shows high homology with Drosophila Relish and mammalian 
p100 (Figure 3.5), therefore, it was designated as CrRelish.  The full-length CrRelish 
contains 3405 bp encoding an 1135 amino acids protein.  Like the p100, p105 and Relish 
proteins, it contains an N-terminal RHD with conserved DNA-binding motif and NLS, 
and a C-terminal IκB-like domain (Figure 3.5).  Like Drosophila Relish, the CrRelish 
also contains 6 ankyrin repeats in its C-terminal IκB-like domain.  In Drosophila Relish, 
two serine-rich stretches are located at the N-terminal region (S22-S45) and just 
downstream of the nuclear localization signal (S460-S475).   Similarly, in CrRelish, two 
long serine-rich stretches were found in the N-terminal region and downstream of the 
nuclear localization signal.  Interestingly, similar to mosquito Relish and mammalian 
p100 and p105 but not Drosophila Relish (Shin et al, 2002), a death domain is located at 
the C-terminus of the CrRelish.  Another apparent difference between the CrRelish and 
Drosophila Relish is that the length of the linker sequence between the RHD and C-
terminal IκB domain in CrRelish is longer than that of the Drosophila homologue. 
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Figure 3.5: Amino acid sequence comparison of CrRelish with homologous proteins. 
Drosophila Relish (NM_206467) and human p100 (NM_002502) were used for the comparison.  
Alignments were done by Clustal X. The potential DNA binding motif is indicated by a yellow 
line. The Rel homology domain 1 (RHD) is underlined by blues lines and the Rel homology 
domain 2 (IPT) is marked by purple lines. The NLS (nuclear localization signal) is indicated by a 
black line. The six ankyrin repeats of CrIκB are underlined in red.  The C-terminal death domain 
is indicated by a green line. 
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A phylogenetic study demonstrated that both the horseshoe crab and insect Relish 
proteins were clustered to the same subgroup, distinctive from the invertebrate class II 
NF-κB family proteins (Figure 3.6).  This Relish subgroup could be clustered with p105 
and p100, indicating that these Rel/IκB compound proteins might have branched off at an 
early evolutionary stage from other NF-κB family proteins including the insect NF-κB 
proteins. 
 
Figure 3.6: Phylogeny of CrRelish and related NF-κB proteins. Multiple sequence alignments 
were produced with Clustal X using Gonnet series protein weight matrix. Unrooted phylogenetic 
tree was constructed using neighbor-joining method based on the alignments. The confidence 
scores (in %) of a bootstrap test of 1000 replicates are indicated for major branching nodes. The 




3.2   CrNFκB binding to κB motif is inhibited by CrIκB 
3.2.1 CrNFκB binding to the κB motif 
To examine the ability of CrNFκB to recognize the κB motif, recombinant His-
tagged RHD of CrNFκB (amino acids: 1-353) was produced.  EMSA was performed 
using the recombinant protein with the C. rotundicauda Factor C (CrFC) promoter NF-
κB binding site.  This CrFC NF-κB response element (-143 to -133) was previously 
reported to be recognized by the human NF-κB and Drosophila Dorsal protein (Wang et 
al, 2003).    
The results of EMSA revealed that the RHD of the CrNFκB could interact with 
the κB response element on CrFC promoter (Figure 3.7).  As a negative control, the GST 
(Glutathione S-transferase) and CrIκB could not bind to the CrFC κB probe.  The 
presence of κB motif is critical to the binding; since mutation of the κB motif (-143 to -
141), from GGG to ATT, abolished the binding (Figure 3.7; lane 8).  The interaction is 
specific as the binding was markedly reduced by excess cold competitor oligonucleotides 
(Figure 3.7; lane 2-3), whereas the addition of mutant competitor did not affect the 
binding (Figure 3.7; lane 6-7).  The identity of the two small bands below the NF-κB-
DNA complexes is still unknown at present.  However, when the mutant probe was used 
for EMSA (lane 8), the intensity of the two lower bands decreased significantly. This 
suggests that they are probably the CrNFκB-DNA complexes as well.  Furthermore, 
because only the N-terminal CrNFκB was used for the EMSA experiments, this result 
indicates that the C-terminal TD of CrNFκB is not necessary for DNA binding activity, 
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which was similarly observed for Drosophila Dorsal and mosquito NF-κB homologues 











Figure 3.7: Binding of CrNFκB protein to horseshoe crab Factor C (CrFC) κB probe.  
Sequences of all probes used in this assay are listed in Table 3.2. Complex formations (lane 1) 
were significantly abolished by cold CrFC probes (lanes 2 & 3), but not by an excess of unlabeled 
mutant CrFC (Mut CrFC) probes (lanes 6 & 7). As a negative control, GST alone or recombinant 
CrIκB showed no binding to the CrFC probe (lanes 4 & 5).  Almost no complex was formed 
when mutant CrFC probe was used (lane 8).  The NF-κB-DNA complexes are indicated by an 
arrow.  
Further analysis of the CrFC promoter revealed other potential Dorsal-like 
binding sites:  Prox3Dor (-219 to -209; -200 to -190; -193 to -183), Dor348 (-359 to -
348), Dor586 (-596 to -586) and Dor788 (-798 to -788) (Wang et al, 2003).  Previous 
studies have shown that the Prox3Dor and the Dor788 site can be recognized by the 
Drosophila Dorsal protein.  Therefore, we examined the binding ability of CrNFκB on 
those potential κB sites.  As shown in Figure 3.8A, the EMSA results indicated that 
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except for Prox3Dor site, the recombinant CrNFκB protein showed no obvious binding to 
the other individual dorsal sites.  This is different with the Drosophila Dorsal protein. 
The probe sequences and the binding characteristics of all the probes with CrNFκB are 
listed in Table 3.2.  Interestingly, CrNFκB also recognizes the consensus mammalian 
NF-κB binding motif, 5′-AGTTGAGGGGACTTTCCCAGGC-3′ (Figure 3.8B), and thus 
CrNFκB may serve as a functional substitute for the vertebrate NF-κB or vice versa.  
Furthermore, our results also suggest that the specific sequence recognition of NF-κB 
transcription factor was acquired early and maintained during evolution. 
 
Figure 3.8: Binding ability of CrNFκB on potential κB sites on Factor C promoter 
and mammalian consensus κB sites.   (A) The CrNFκB can form stable complexs with 
Prox3Dor probe.  The possible NF-κB-DNA complexes are indicated by arrows. Almost no 
complex was formed when Dor348, Dor586, Dor788 probe was used. (B) The CrNFκB binds 
with mammalian consensus κB probe.  The bacteria expressing CrNFκB were sonicated in the 
binding buffer. The bacterial lysate was used for EMSA (lane 1 & lane 2).  The NF-κB-DNA 
complexes are indicated by an arrow.  Almost no complex was formed when bacterial lyste 
without expressing CrNFκB was used (lane 3).  Sequences of all probes used in this assay are 




Table 3.2: Probes used in EMSA and binding characteristics of CrNFκB and Dorsal  
                   to various probes 
Binding 
characteristics 
Probes DNA Sequence Potential NF-κB or Dorsal-like binding sites 
CrNFκB Dorsal#
CrFC κB 5’-AAAAGCCGGGAAATCCATTAGA-3’ (-143) 5’-GGGAAATCCA-3’ (-133) + + 
(-200) 5’-TTGGAAAACGT-3’ (-190) 




(-209) 5’-AAGGAAAAATT-3’ (-219)* 
+ + 
Dor348 5’-GTTGTTGTTTTCTTGTAACAG-3’ (-348) 5’-CAAGAAAACAA-3’ (-359)* − − 
Dor586 5’-GTGTGTGTTTTCTTATAGCA-3’ (-586) 5’-TAAGAAAACAC-3’ (-596)* − − 
Dor788 5’-CAAACGAAGAAAAAACTTCC-3 (-798) 5’-GAAGAAAAAAC-3’ (-788) − + 
*Sequences shown are in the antisense strand.  # Adapted from Wang et al (2003). 
 
 
3.2.2 CrNFκB interacts with CrIκB 
By binding to the RHD and masking the NLS of NF-κB, the IκB is the natural 
endogenous inhibitor of the NF-κB activity (Karin and Ben-Neriah, 2000).  To 
investigate whether CrIκB can interact with CrNFκB, pull-down assay and 
immunoprecipitation were performed.  In vitro GST pull-down was performed using 
recombinant His-tagged RHD of CrNFκB (amino acids: 1-353) and full length GST-
tagged CrIκB.  First, we purified the recombinant GST-CrIκB fusion protein and the 
purified GST-CrIκB fusion protein was resolved on SDS-PAGE (Figure 3.9, lane 1).  The 
molecular weight of the purified protein (75 kDa) is consistent with the predicted size of 
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the recombinant GST-CrIκB fusion protein.  The His-fusion CrNFκB protein was 
expressed in bacteria as well.  The expression of CrNFκB was confirmed by probing 
bacteria lysates with anti-His antibody (Figure 3.9, lane 2).  Next, the GST-CrIκB fusion 
protein was immobilized on glutathione beads and assessed for its ability to retain 
recombinant His-fusion CrNFκB.  As shown in Figure 3.9, the pull-down assay showed a 
stable complex between these two recombinant proteins (lane 5).  This interaction 
between CrNFκB-RHD and CrIκB was specific as no interaction was observed between 
either control Sepharose beads or GST protein with CrNFκB-RHD (Figure 3.9, lane 3-4).   
 
 
Figure 3.9: In vitro interaction of CrNFκB and CrIκB. GST pull-down assay. The purified 
GST-CrIκB fusion protein was resolved on SDS-PAGE (lane 1). His-fusion CrNFκB protein was 
recombinantly expressed in bacteria. The expression of CrNFκB was confirmed by probing 
bacteria lysates with anti-His antibody (lane 2). His-fusion CrNFκB expression bacteria lysates 
were incubated with glutathione-Sepharose beads loaded with GST-IκB. After washing the beads, 
the eluted proteins were analyzed by SDS-PAGE and detected by anti-His antibody (lane 5). One-
tenth volume of the His-CrNFκB was also electrophoresed as positive control (lane 6). Negative 
control included Sepharose beads alone (lane 3) and Sepharose beads with GST (lane 4). His-





To determine whether CrNFκB interacts with CrIκB in vivo, we performed the 
immunoprecipitation assay.  First, we transiently co-expressed full length V5-tagged 
CrNFκB and c-Myc-tagged CrIκB in Drosophila S2 cells.  As shown in Figure 3.10, the 
expression of CrNFκB and CrIκB was confirmed by Western blot using anti-V5 and anti-
c-Myc antibodies. Then the extracts of transfected cells were subjected to 
immunoprecipitation using anti-V5 antibody.  The immunecomplexes were resolved in 
SDS-PAGE and subjected to Western blotting analysis with anti-c-Myc antibody to 
detect interaction.  The CrIκB was confirmed to interact with CrNFκB to form an 
immunoprecipitated complex (Figure 3.10).  This interaction between CrNFκB and 
CrIκB was specific as no interaction was observed without the expression of CrNFκB.   
 
 
Figure 3.10: Immunoprecipitation (IP) of CrNFκB and CrIκB in Drosophila S2 cell. S2 cells 
were transiently transfected with the indicated combination of CrNFκB-V5 and CrIκB-c-Myc 
expression plasmids. The cell lysates were subjected to IP using anti-V5 antibody 48 h after 
transfection. The beads were washed 3 times with lysis buffer and subjected to Western analysis 
with antibodies against V5 and c-Myc. 5 % volume of the cell lysates used for IP was 




3.2.3 CrIκB inhibits CrNFκB DNA-binding activity 
It has been shown that the human IκBα but not IκBβ can efficiently remove NF-
κB from the DNA (Tran et al, 1997).  To verify whether CrIκB could also inhibit the 
DNA-binding activity of CrNFκB, we performed EMSA with or without purified CrIκB 
proteins.  The EMSA results showed that the presence of CrIκB inhibited the DNA-
binding activity of CrNFκB in a dose-dependent manner (Figure 3.11).  However, the 
adding of excess amount of GST did not affect CrNFκB DNA-binding ability.  This 
suggests that CrIκB can specifically inhibit the DNA-binding activity of CrNFκB, which 
was similarly observed in IκBα (Karin and Ben-Neriah, 2000).  We noticed that the 
adding of CrIκB increased the intensity of the nonspecific binding complexes (Figure 
3.11, arrowhead).  This is probably caused by the contaminant in the purified CrIκB or 
the increased amount of free κB probe because CrIκB significantly inhibited the binding 
of CrNFκB to the κB probe.  Altogether, the results demonstrate that CrIκB interacts 
with and specifically inhibits the DNA binding activity of CrNFκB.  In addition, in spite 
of their ancient origin, this familiar relationship between the two homologues forming the 
NF-κB/IκB cascade suggests that they probably underwent co-evolution.   
 
3.3 Functional activation of the CrNFκB/CrIκB cascade 
Sequence analysis of the CrNFκB showed strong similarities between NFκB 
proteins in the horseshoe crab and insects.  The effect of CrNFκB on the gene 
transcription was analyzed in Drosophila S2 cell line.  First, we examined whether 
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Figure 3.11: CrIκB protein inhibits the CrNFκB DNA-binding activity. A known amount of 
CrNFκB was titrated with increasing amounts of CrIκB (lanes 2-6). As a negative control, GST 
(3 μg) alone does not inhibit the CrNFκB binding to the CrFC κB probe (lane 7). The NF-κB-
DNA complexes are indicated by an arrow.  The unspecific bindings are marked by an arrowhead. 
 
3.3.1 Overexpression of CrNFκB activates κB reporter expression 
Previously, it has been shown that the horseshoe crab Factor C promoter contains 
several potential NF-κB binding motifs which can be recognized by Drosophila Dorsal 
protein (Wang et al, 2003).  Therefore, we examined the ability of CrNFκB to regulate 
gene transcription of CrFC promoter (-186 to +1)-CAT reporter using transient co-
transfection studies with the horseshoe crab wild-type or truncated V5-tagged CrNFκB 
expression constructs.  The schematic representation of the expression vectors and 





Figure 3.12: Schematic representation of the expression vectors and reporters used in 
transfection experiments. (A) Schematic representation of the expression vectors used in 
transfection experiments: CrNFκB (full-length); CrNFκB-RHD (lacks the C-terminal 
transactivation domain, TD); CrNFκB-∆NLS (lacks the C-terminal TD and nuclear localization 
signal, NLS); (B) Schematic representation of the wild type (κB) and mutant CrFC-CAT (Mut κB) 
reporter vectors. 
 
As shown in Figure 3.13, the overexpression of full-length CrNFκB resulted in 
10-fold increase in CAT reporter expression compared to the control vector suggesting 
that the CrNFκB has the gene transactivation ability.  However the CrNFκB-RHD 
(amino acids: 1-321) and CrNFκB-ΔNLS (amino acids: 1-266) led to significantly 
reduced CAT expression.  This suggests that the C-terminal TD of CrNFκB, which is not 
necessary for DNA-binding (Figure 3.7), is essential for reporter gene activation.  The 
transactivation activity of CrNFκB-ΔNLS was even lower compared with that of 
CrNFκB-RHD suggesting that the NLS of CrNFκB is also important in regulating NF-κB 
activity.  To show that the κB motif (-143 to -133) of CrFC promoter is responsible for 
the transcriptional activation, transfection studies were carried out using a CrFC promoter 
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(-186 to +1)-CAT reporter where the 5′ end of the potential NF-κB binding motif, 
GGGAAA (-143 to -138), was deleted.  The mutant κB reporter showed significantly 
reduced CAT expression suggesting that the putative κB motif of Factor C promoter is 
functional and necessary for transactivation.  The slight induction by the mutant promoter 
construct (Figure 3.13) is likely due to the presence of putative non-canonical κB 
response element (-156 to -146) in the reporter (Wang et al, 2003).  These results 
demonstrated that CrNFκB is able to trigger the expression of κB reporter.  This 
transactivation capacity relied primarily on the integrity of the C-terminal domain and 




Figure 3.13: The transactivation ability of CrNFκB. S2 cells were transiently co-transfected 
with wild type and mutant CrFC-CAT reporters (1 μg), a β-galactosidase expression plasmid (50 
ng), together with full length or truncated CrNFκB constructs (500 ng). CAT expression level 










3.3.2 CrIκB inhibits CrNFκB transactivation ability 
To examine the effect of CrIκB on CrNFκB transactivation ability, similar 
transfection studies were also performed in the presence of increasing amounts of CrIκB.  
Consistent with the role of IκB, which is the natural inhibitor of NF-κB, the 
overexpression of CrIκB caused a dose-dependent reduction in CAT reporter expression 
(Figure 3.14).  Therefore, functional analysis of the CrNFκB and CrIκB revealed that the 
CrNFκB was an efficient NF-κB like activating transcription factor and the CrIκB can 
interact with CrNFκB and inhibited its transactivation activity.  Taken together, these 
results strengthen the idea that horseshoe crab IκB proteins are functionally identical to 
mammalian IκBα. 
 
Figure 3.14: The transactivation ability of CrNFκB is inhibited by CrIκB. Co-transfection of 
CrNFκB (500 ng) and increasing amounts of CrIκB in S2 cells. Results are expressed as relative 
fold-induction in CAT expression as compared to control cells transfected with vector backbone. 




3.3.3 Subcellular localization of CrNFκB and CrIκB 
To verify whether the decreased gene activation ability of truncated CrNFκB 
(CrNFκB-RHD and CrNFκB-ΔNLS) was attributable to the lack of transactivation 
activity or to impaired nuclear translocation, the subcellular localization of full-length 
and truncated CrNFκB was examined.  Expression vectors for wild type and truncated 
V5-tagged CrNFκB were transiently transfected into S2 cells. The subcellular 
localization of the CrNFκB proteins in Drosophila S2 cells was examined by 
immunofluorescence using anti-V5 antibody. 
As shown in Figure 3.15, the immunofluorescence images demonstrated that both 
the full-length CrNFκB and CrNFκB-RHD (amino acids: 1–321) were evenly distributed 
in the cytoplasm as well as in the nucleus indicating that the TD did not affect the nuclear 
localization of CrNFκB.  This suggests that the decrease in transactivation ability of 
CrNFκB-RHD (Figure 3.13) was not due to the subcellular localization.  Taken together, 
it indicates that despite CrNFκB harboring an atypical carboxy-terminal TD, as compared 
to that of vertebrate or insect homologues (Shin et al, 2005), it is still essential and 
functional for transcriptional activation.  On the other hand, the truncated CrNFκB-ΔNLS 
(amino acids: 1-266) lacking the NLS remained localized to the cytoplasm (Figure 3.15).  
This result indicates that the NLS (RKRQK) of CrNFκB is functional and necessary for 
the nuclear localization.  It is also consistent with the negligible transactivation ability 





Figure 3.15: Localization of full length and truncated CrNFκB and CrIκB in S2 cells.  S2 
cells were transfected with plasmids (1 μg) expressing various CrNFκB-V5 or CrIκB-c-Myc 
proteins. Full length CrNFκB and CrNFκB-RHD are evenly distributed in the cytoplasm as well 
as in the nucleus when expressed alone. CrNFκB-∆NLS and CrIκB localized to the cytoplasm. 






Next, we examined the subcellular localization of CrIκB using anti-c-Myc 
antibodies.  The immunofluorescence revealed that the overexpressed CrIκB was 
exclusively located in the cytoplasm, which is consistent with the role of IκB proteins.  
To determine the effect CrIκB on the localization of CrNFκB, we co-expressed these two 
proteins. As shown in Figure 3.15, the overexpression of CrIκB resulted in the 
sequestration of CrNFκB exclusively to the cytoplasmic compartment which is similar to 
mammalian IκBα (Huang et al, 2000). 
Taken together, the results show that the interaction between CrIκB and CrNFκB 
interferes with the latter’s ability to translocate into the nucleus and consequential DNA-
binding and gene transactivation.  Interestingly, the activation of CrNFκB is analogous to 
the canonical activation cascade observed in the vertebrate (Chen and Greene, 2004), thus 
lending support to our proposal that the NF-κB/IκB signaling co-evolved early during 
evolution. 
 
3.4 Biological significance of a primitive CrNFκB/CrIκB 
cascade 
Thus far, our studies have utilized purified recombinant proteins and over-
expression of CrNFκB and CrIκB.  However, the relevance of this cascade in vivo is still 
unclear.  To this end, we examined CrNFκB DNA-binding and gene regulation activity in 
the hemocytes, the major immune cell in this invertebrate.  First, to examine the 
relevance of the NF-κB cascade in vivo, we investigated the κB-binding activity in the 
hemocytes – the major immune cells in this invertebrate.  Horseshoe crab hemocyte 
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extracts were tested to see whether they contained proteins that could bind specifically to 
the κB site of the CrFC promoter.  EMSA using whole hemocyte lysates and CrFC κB 
motif showed a stable complex; however mutation of the 5’-end of the CrFC κB motif 
from GGG to ATT abolished the binding.  It suggests the presence of proteins in 
hemocytes which bind specifically to the κB site of CrFC promoter (Figure 3.16).   
To investigate the identity of the proteins that were bound to the CrFC κB motif, 
we incubated CrNFκB with helenalin, which specifically inhibits human NF-κB p65 
DNA-binding activity (Lyss et al, 1998), during the EMSA.  As shown in Figure 3.16, 
the EMSA results indicated that the gel shift complexes were partially reduced by 
increasing doses of helenalin, further suggesting that the complexes were formed by NF-
κB related proteins.  To examine whether CrIκB, the natural inhibitor of CrNFκB, could 
inhibit the formation of DNA-binding complex, we performed similar EMSA in the 
presence of increasing doses of CrIκB.  The EMSA results clearly demonstrate that 
increasing amounts of recombinant CrIκB protein disrupted the formation of CrNFκB-
DNA complex in the horseshoe crab hemocytes (lane 3-6) providing further support to 
the conclusion that the complexes were formed by NF-κB related proteins.  The 
inhibitory effects of CrIκB were specific as no inhibition was observed when 
recombinant GST protein was added (Figure 3.16; lane 7).  This suggests that CrIκB can 
specifically inhibit the DNA-binding activity of NF-κB, which was similarly observed in 
IκBα (Karin and Ben-Neriah, 2000).  Similar to previous observation (Figure 3.11), the 
addition of CrIκB also increased the intensity of the unspecific binding as indicated in 
Figure 3.16 by an arrowhead (lanes 4-6).  This unspecificity is probably caused by the 



























Figure 3.16: EMSA of hemocyte extracts incubated with the CrFC κB probe. Hemocyte 
extracts from adult horseshoe crab were used for EMSA. Approximately 20 mg of extract was 
incubated with CrFC κB probe (lanes 1 & 3-9) or mutant (Mut) CrFC κB probe (lane 2). Binding 
complexes were progressively abolished by addition of increasing amounts of recombinant CrIκB 
(lanes 3-6) compared to GST (lane 7), which remained unaffected.  Helenalin, a specific inhibitor 
of NF-κB, partially decreases the intensity of the binding which remained unaffected by DMSO 
(vehicle) (lanes 8, 9). The NF-κB-DNA complexes are indicated by an arrow. The unspecific 
binding caused by the adding of CrIκB is marked by an arrowhead.  
  
Next, we carried out super-shift assay using anti-CrNFκB antibodies which were 
produced from synthetic peptides (Biogenes, Germany), and purified using affinity 
column coupled with the peptide.  As shown in Figure 3.17A, anti-CrNFκB antibodies 
caused a partial supershift of the κB-binding-complex confirming that the CrNFκB binds 
κB probe.  We noticed that the majority of the κB-binding complex cannot be 
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supershifted by anti-CrNFκB antibody suggesting that there might be other κB motif-
binding proteins in the horseshoe crab hemocytes.  Indeed, we have cloned another NF-
κB homologue, CrRelish, which shows high homology to the Drosophila Relish and 
mammalian NF-κB p100 and p105.  Previous study has shown that amongst the three 
Drosophila NF-κB homologues  (Dorsal, Dif and Relish), Relish has relatively higher 
and broader binding activity to κB motifs (Han and Ip, 1999).  The similar mechanism 
probably also exists in horseshoe crab indicating that CrRelish may play a major role in 
forming the κB complex.  Nevertheless, the partial supershift with anti-CrNFκB antibody 
suggests that the DNA–protein complex formed with κB motif at least involves the 
presence of CrNFκB.  Furthermore, although the exact identity of the unshifted 
complexes is unknown at this juncture, the data in Figure 3.16 provide evidence to show 
that the complexes are formed by κB motif binding proteins. 
 
 
Figure 3.17: Bacterial infection activates CrNFκB DNA-binding activity. (A) Supershift of 
κB-binding complex by anti-CrNFκB antibody.  The supershift was indicated by an arrow and 
the κB complex was marked by an arrow.  (B) The naïve, 1 and 3 hpi Pseudomonas-challenged 
horseshoe crab hemocyte nuclear extracts were incubated with CrFC κB probe. The intensity of 
the DNA-binding complexes increased significantly after bacterial challenge. 
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To examine the in vivo activation of CrNFκB by infection, horseshoe crabs were 
injected with 1.2 × 107 cfu of P. aeruginosa per kg of body weight.  After infection, the 
hemocytes were isolated at indicated time points and the nuclear extracts were prepared 
to perform EMSA.  As shown in Figure 3.17B, upon infection, the EMSA signal 
increased markedly in the hemocyte nuclear extract suggesting that bacterial infection 
activates the NF-κB pathway.   
We also examined if bacterial infection could cause the degradation of CrIκB 
proteins using anti-CrIκB antibodies.   After infection, the hemocytes were isolated at 
indicated time points and the protein extracts were prepared to perform Western blot.  As 
shown in Figure 3.18, the CrIκB protein was rapidly degraded upon P. aeruginosa 
infection providing further support to our suggestion that bacterial infection can activate 









Figure 3.18: Degradation of CrIκB after bacterial infection. Hemocyte extracts were 
prepared from naïve and infected animals according to Materials and Methods.  Western 
blots show proteins extracted from hemocytes over time (min) of infection. Equal protein 




We next examined the subcellular localization of CrNFκB and CrIκB in the 
hemocytes upon bacterial challenge.  The cytoplasmic CrNFκB in the naïve hemocytes 
was enriched in the nucleus 30 min after bacterial infection (Figure 3.19) indicating the 
activation of CrNFκB.  Although, the CrIκB remained in the cytoplasm with or without 
bacterial challenge, its intensity decreased significantly upon infection (Figure 3.19).  
This is in agreement with the Western blot (Figure 3.18); which further lends support that 
bacteria infection activates the CrNFκB signaling pathway.   
We also noticed that, in the overexpressed S2 cells, the CrNFκB was evenly 
distributed in the cytoplasm and nucleus (Figure 3.15); however the endogenous CrNFκB 
was exclusively located at the cytoplasm (Figure 3.19).  The overexpression may be 
responsible for the discrepancy, in which the endogenous IκB protein is insufficient to 
capture all of the CrNFκB in the cytoplasm.  Accordingly, coexpression of CrNFκB with 






Figure 3.19: Localization of CrNFκB and CrIκB in horseshoe crab hemocytes.  Hemocytes 
from naïve horseshoe crab or 30 min challenged with P. aeruginosa were collected into 3 % 
saline at 42 °C. The diluted hemocytes were spread on pyrogen free cover slip for cell attachment 
and stained with anti-CrNFκB and CrIκB antibodies. Confocol microscopy showed that the 
CrNFκB and CrIκB exclusively distributed in the cytoplasm in the naïve hemocytes. The 
CrNFκB was enriched in the nucleus after bacterial infection. The CrIκB protein significantly 




In order to determine the expression pattern of CrNFκB and CrIκB upon P. 
aeruginosa infection, RT-PCR was performed with total RNA from hemocytes collected 
at indicated time points post challenge (hpi).  CrNFκB and CrIκB mRNA expression 
were normalized against actin-11 gene for each time point.  As shown in Figure 3.20, the 
RT-PCR results indicated that CrNFκB mRNA was constitutively expressed in the 
hemocytes and remained unchanged throughout the course of infection.  In contrast to 
CrNFκB, the expression of CrIκB was significantly induced after bacterial challenge 
(Figure 3.20). This is consistent with studies on Drosophila and humans in which 
activation of the NF-κB pathway increases the expression of IκB and negatively 
autoregulates the NF-κB activity (Ghosh et al, 1998).  In comparison, CrFC exhibited a 
slight up-regulation over the same time frame as CrIκB, suggesting that both CrIκB and 








Figure 3.20: Expression of CrNFκB, CrIκB and CrFC. The hemocytes were collected from 
adult horseshoe crab 1-72 h post-infection (hpi) with P. aeruginosa.  The mRNA was reverse 
transcribed as described in "Materials and Methods".  The cDNA was used as template for PCR 
analysis with specific primers.  The horseshoe crab actin-11 gene was analyzed under the same 
conditions as the internal control. 
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To examine whether the expression of CrIκB is indeed affected by NF-κB 
pathway, we studied the effect of NF-κB specific inhibitors on the up-regulation of 
CrIκB.  Two different types of NF-κB inhibitors, MG-132 and helenalin were used in this 
experiment.  MG-132 is a proteasome inhibitor which will block the degradation of IκB 
proteins (Gao et al, 2000).  Helenalin is a more specific inhibitor for NF-κB.  It acts by 
alkylating the p65 subunit of NF-κB and prevents its DNA-binding (Lyss et al, 1998).  
As shown in Figure 3.21A, the injection of DMSO (vehicle) did not affect the activation 
of CrIκB during infection, whereas treatment with two unrelated NF-κB specific 
inhibitors, helenalin or MG-132, prior to infection consistently suppressed the up-
regulation of CrIκB.  This indicates a possible role of NF-κB pathway in the regulation of 
CrIκB expression in vivo.  
 
Figure 3.21: Involvement of NF-κB signaling pathway in the transcription of CrIκB and 
CriNOS.  The expression of these genes were examined in horseshoe crab hemocytes that were 
administered with a vehicle, DMSO (•), helenalin (■) or MG-132 (▲) before challenge with P. 
aeruginosa. One hour after treatment with DMSO, helenalin or MG-132, the horseshoe crabs 
were either left unstimulated (0 h) or challenged with P. aeruginosa and the hemocytes were 
collected at the indicated time points (in h). The RT-PCR products were analyzed on gels and 
quantified relative to the levels of Limulus actin-11 mRNA. Results are expressed as relative fold 
increase as compared to naïve control (0 h) which was set to 1 (A). Without infection of P. 
aeruginosa, the expression of CriNOS was undetectable. Therefore, the expression level of 
CriNOS at 3 h post infection was set to 1 (B). 
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To investigate whether NF-κB signaling also plays a role in regulating other 
immune–related gene transcription, we analyzed the expression of C. rotundicauda 
inducible nitric oxide synthase, CriNOS.  iNOS is a classical NF-κB target gene required 
for a robust innate immune response both in the Drosophila and vertebrates (Bogdan, 
2001; Foley and O'Farrell, 2003).  The iNOS activity has been detected in horseshoe crab 
hemocytes and it has been shown to regulate the aggregation of hemocytes (Radomski et 
al, 1991).     As shown in Figure 3.21B, the expression of CriNOS was significantly 
induced after infection by P. aeruginosa.  When cells were treated with the NF-κB 
specific inhibitors, there was negligible increase of CriNOS mRNA clearly showing that 
NF-κB inhibitors blocked the increase of CriNOS gene transcription (Figure 3.21B).  It 
suggests that, like the iNOS in the vertebrates (Lin et al, 1996), the expression of 
horseshoe crab iNOS mRNA is probably under the control of NF-κB signaling pathway. 
Next, we analyzed the expression of horseshoe crab coagulogen and CrC3, a 
functional homologue of vertebrate complement 3 (Zhu et al, 2005), with or without NF-
κB inhibitors.  The observation that the expression levels of coagulogen and CrC3 
remained unchanged during the bacterial challenge with or without NF-κB inhibitors 
(Figure 3.22A & B) suggests that they are probably not target genes of CrNFκB and that 
these NF-κB inhibitors do not exert a non-specific global effect on gene transcription.   
To further demonstrate that the NF-κB inhibitors only affect NF-κB pathway, we 
analyzed the expression of transglutaminase, which has been shown to be under the 
control of Sp1 and CREB/AP-1 in the vertebrate (Medvedev et al, 1999).  Indeed, 
injection of NF-κB inhibitors did not affect the activation of transglutaminase 





Figure 3.22: The effects of NF-κB inhibitors on the transcription of horseshoe crab 
coagulogen, CrC3 and transglutaminase.  The expression of these genes were examined in 
horseshoe crab hemocytes that were administered with a vehicle, DMSO (•), helenalin (■) or 
MG-132 (▲) before challenge with P. aeruginosa.  The RT-PCR products were analyzed on gels 
and quantified relative to the levels of Limulus actin-11 mRNA. Results are expressed as relative 
fold increase as compared to naïve control (0 h) which was set to 1. 
  
Taken together, in this part of the thesis, we have revealed the presence of a 
primitive but functional CrNFκB/CrIκB signaling cascade and demonstrated its relevance 
to the immune defense of the horseshoe crab, C. rotundicauda.  We showed that the 
CrNFκB and CrIκB displayed similar signature motifs found in the vertebrate 
orthologues, despite the huge evolutionary distance between horseshoe crab and 
vertebrates.  The functional studies indicate that the NF-κB activation pathway of 
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horseshoe crab is functionally comparable to that of the Drosophila and mammals, 
suggesting that the roles of NF-κB and its natural inhibitor IκB have co-evolved and 
remained conserved through evolution.  Its ubiquitous regulatory role over many 
downstream immune response genes studied strongly suggests the global function of 
horseshoe crab NF-κB signaling pathway in infection and immunity.  In conclusion, 
although incomplete and non-functional in the C. elegans, the NF-κB/IκB signaling 
pathway has co-evolved and remained well-conserved from horseshoe crab to human, 
playing an archaic but crucial and fundamentally role in innate immune response to 

















3.5 Isolation and sequence analysis of the horseshoe crab 
TRX 
 
The development of high-throughput methods of gene identification by EST 
analysis has become a commonly used approach to identify genes involved in specific 
biological functions.  This is especially so in organisms where genome data is unavailable 
or limited (Aaronson et al, 1996)  and has accelerated the pace at which new immune 
functions can be discovered.  Recently, our lab has used the subtractive cDNA 
hybridization approach, to isolate and identify differentially expressed genes from the 
horseshoe crab, C. rotundicauda, in response to P. aeruginosa infection (Ding et al, 
2005).  Using this approach, we identified one cDNA clone that was differentially 
expressed in the hepatopancreas (equivalent to liver in mammals) when stimulated with P. 
aeruginosa.  Sequence analysis revealed that this gene encodes a protein possessing the 
characteristic organization of TRX proteins, henceforth referred to as C. rotundicauda 
TRX, Cr-TRX1 (Wang et al, 2007). 
Thioredoxin (TRX), which functions as a general protein-disulfide reductase, is 
commonly known to be a small ubiquitous protein of 12 kDa.  Up to now, no TRX 
protein has been identified in the horseshoe crab and the function of TRX proteins in this 
ancient species is still unknown.  Previously, it has been shown that the human 12 kDa 
TRX1 enhances the DNA-binding of NF-κB by directly reducing the cysteine groups in 
the DNA-binding motif of NF-κB (Figure 1.7).  Therefore, it is interesting to examine if 
the horseshoe crab TRX functions as an NF-κB regulator in this “living fossil”.  In order 
to understand the ancient functions of TRX in the horseshoe crab anti-oxidant system and 
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NF-κB signaling pathway, we decided to first examine the biochemical characteristics of 
the Cr-TRX1 followed by investigating its roles in regulating the NF-κB signaling 
pathway. 
 
3.5.1 Sequence analysis of Cr-TRX1 
Sequence analysis showed that the complete sequence of the Cr-TRX1 cDNA 
encompasses an ORF of 429 bp, a 5’-UTR of 40 bp and a 3’-UTR of 353 bp upstream of 
the poly A tail.  The deduced sequence of Cr-TRX1 encodes a protein of 143 residues 
with a predicted molecular mass of 16 kDa and predicted pI of 5.2.  The overall similarity 
to other 12 kDa TRXs from mammalian, insect and bacterial species were approximately 
18 % suggesting that the 16 kDa and 12 kDa TRX molecules have diverged early during 
evolution (Figure 3.23).  A majority of this homology is clustered in the region 
surrounding the respective active sites which are involved in the interaction with 
substrates (Figure 3.23).  Compared with the 12 kDa TRXs, the Cr-TRX1 is about 35 
residues longer.  The sequence alignment shows that most of the additional residues 
appear as an insertion downstream of the active site (Figure 3.23, black line).  The 
classical 12 kDa TRXs are characterized by a conserved WCGPC motif in the active site, 
which is clearly different from the WCPPC motif in the 16 kDa Cr-TRX1 (Figure 3.23).   
Hitherto, two clusters of 16 kDa TRXs have been identified from the nematodes 
and the trypanosomes (Kunchithapautham et al, 2003; Ludemann et al, 1998), which also 
contain the putative WCPPC active site, and these sequences are 42 % and 25 % identical 
respectively, to Cr-TRX1 (Figure 3.24).  Interestingly, except for the 16 kDa TRXs found 
in the nematodes and trypanosomes, several other 16 kDa TRXs containing WCPPC 
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active site can be identified from the zebrafish, pufferfish and frog (Figure 3.25).  
However, a search of the fully sequenced genomes of the Drosophila and mosquito 
showed that such a 16 kDa TRX is absent in these arthropods.  This provides further 
support to the notion that antioxidant defense in insects differs fundamentally from that in 
other organisms (Kanzok et al, 2001).  Furthermore, the Cr-TRX1 also shows high 
homology (18 % to 29 %) to protein disulfide isomerases (PDI) from several plants, 




Figure 3.23: Amino acid sequence comparison between Cr-TRX1 and the 16 kDa TRX, 
Tryparedoxin and 12 kDa TRX.  Alignments were done by Clustal X.  The active sites are 
demarcated by a dashed line.  The extra sequence of 16 kDa TRX is indicated by a black line.  
The additional C-terminal Cys residue of Cr-TRX1 is marked by a big arrow.  Residues 
highlighted in black box are invariant for all of the sequences tested.  The GenBank accession 
numbers of the sequences used in this study are listed in Table 3.3.  
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A phylogenetic analysis demonstrates that Cr-TRX1 clustered amongst the 16 
kDa TRX proteins (Figure 3.25).  This cluster differs from the common 12 kDa TRX and 
the 16 kDa Tryparedoxin from parasitic trypanosomes.  The phylogenetic analysis clearly 
shows that the 16 kDa Cr-TRX1 shares a common ancestor with the nematode 16 kDa 
TRX which is consistent with their high sequence similarity.  This observation suggests 
that the 16 kDa TRXs has evolutionarily diverged from the 12 kDa TRXs at an early 
stage.   
 
Figure 3.24: The homology analysis of Cr-TRX1 and related TRX proteins.  The homology 
tree was produced with DNAMAN.  The sequence homology (in %) of TRX proteins are 




Table 3.3: The sequences used for phylogenetic analysis of the Cr-TRX1 and TRX6 




16 kDa TRX 
Name Accession Number Organism 
Cr-TRX1 DQ489712 Carcinoscorpius rotundicauda 
B. malayi AY117545 Brugia malayi 
C. elegans AAB37590 Caenorhabditis elegans 
Roundworm AAS78778 Ascaris suum 
Frog AAH71162 Xenopus laevis 
Zebrafish AAH86727 Danio rerio 
Pufferfish CAF97179 Tetraodon nigroviridis 
Mouse NP_083449 Mus musculus 
Human CAH71401 Homo sapiens 
Tryparedoxin (16 kDa) 
T. brucei AJ006403 Trypanosoma brucei 
C. fascicul AAD20445 Crithidia fasciculata 
L. infantum AAS48351 Leishmania infantum 
24 kDa TRX (TRX6) 
Zebrafish XP_696316 Danio rerio 
Frog AAH80091 Xenopus laevis 
Dog XM_541952 Canis familiaris 
Mouse  NP_663573 Mus musculus 
Human BC014127 Homo sapiens 
12 kDa TRX 
E. coli P00274 Escherichia coli 
Yeast TXBY1 Saccharomyces cerevisiae 
Drosophila AF220362 Drosophila melanogaster 
Mosquito AAK70900 Aedes aegypti 
Zebrafish AAH49031 Danio rerio 
Frog AAH72884 Xenopus laevis 
Mouse X77585 Mus musculus 
Human JH0568 Homo sapiens 
Plant protein disulfide isomerase (PDI)-like proteins 
Z. mays AAD04231 Zea mays 
Muskmelon AAU04766 Cucumis melo 
Oak CAC87937 Quercus suber 




Figure 3.25: Phylogeny of Cr-TRX1 and related TRX proteins.  Multiple sequence 
alignments were produced with Clustal X using Gonnet series protein weight matrix.  An 
unrooted phylogenetic tree was constructed using neighbor-joining method based on the 
alignments.  The confidence scores (in %) of a bootstrap test of 1000 replicates are indicated for 
major branching nodes.  GenBank accession numbers of the sequences are listed in Table 3.3. 
 
3.5.2 Bacterial expression and purification of recombinant Cr-TRX1 
To obtain large quantities of pure Cr-TRX1 protein for functional studies, the full-
length Cr-TRX1 was cloned into the pGEX-4T-1 plasmid for bacterial expression of GST 
fusion protein.  The cell extract from E. coli transformed with pGEX-TRX and induced 
with IPTG showed a major protein band of 42 kDa in the SDS-PAGE analysis.  The 
molecular weight of this protein agreed well with that predicted for the fusion protein 
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indicating that the GST-Cr-TRX1 fusion protein was successfully expressed.  The cell-
free extract containing the fusion proteins was loaded onto a glutathione-Sepharose 4B 
column and the bound fusion protein was eluted from the matrix with glutathione buffer.  
The purified fusion protein was analyzed with SDS-PAGE.  As shown in Figure 3.26 
(lane 1), the GST-Cr-TRX1 fusion protein was purified satisfactorily.  To obtain the Cr-
TRX1 protein without the GST tag, we digested the fusion protein on the column with 
thrombin.  The eluted Cr-TRX1 was then extensively dialyzed against PBS and analyzed 
by SDS-PAGE (Figure 3.26, lanes 2-4).  The results suggest that the recombinant Cr-



















Figure 3.26: SDS-PAGE analysis of purified GST-Cr-TRX1 and Cr-TRX1 protein.  Lane 1: 
purifed GST-Cr-TRX1 protein.  Lanes 2-4: Different amounts of purified Cr-TRX1 after 





















3.5.3 The CPPC motif of Cr-TRX1 is the redox-active site 
In addition to the two conserved cysteines in the active site, mammalian TRXs 
have three conserved cysteines at their C-terminus.  Those Cys residues may impart 
unique biological properties to the mammalian 12 kDa TRXs (Holmgren, 1985).  The 
crystal structure also revealed that human TRX1 can form a dimer via the Cys73 at the C-
terminus (Weichsel et al, 1996).  However all of these conserved Cys residues are absent 
from the bacterial TRXs and the 16 kDa TRX proteins in C. elegans and the parasite 
trypanosomes (Figure 3.27).  Similar to these 16 kDa TRXs, the Cr-TRX1 also does not 
contain the extra C-terminal cysteines. 
 
 
Figure 3.27 Comparison of CXXC motif, numbers and positions of cysteine residues in 
various TRXs.  The Cys residues are indicated by dashed lines.  The sequences of catalytic motif 
are indicated as well.  TRP14: human 14 kDa TRX-related protein. The GenBank accession 




Interestingly, in addition to the conserved Cys38 and Cys41, the Cr-TRX1 contains 
1 extra Cys residues (Cys15) at the N-terminus (Figure 3.23, big arrow & Figure 3.27).  
To our knowledge, Cr-TRX1 is the first 16 kDa TRX reported to contain an extra Cys at 
the N-terminus of the active site (Figure 3.27).  Therefore, it is important to identify 
which Cys residue is redox sensitive in Cr-TRX1.  To achieve this, we firstly determined 
the number of active Cys residues in Cr-TRX1 molecule using mass spectrometry.  It has 
been demonstrated that the free SH groups in TRX can be modified with iodoacetamide, 
IAM, however the IAM dose not react with the cysteines that are engaged in the disulfide 
bond.  Therefore, the number of free Cys can be deduced from the molecular weight 
change before and after treatment with IAM (Gommel et al, 1997).  
To determine the number of active Cys residues, we treated oxidized and reduced 
Cr-TRX1 with IAM and compared their molecular masses by MALDI-TOF mass 
spectrum.  As shown in Figure 3.28, the molecular mass of the oxidized Cr-TRX1 was 
not changed on exposure to IAM suggesting none of the three Cys residue is active in the 
oxidized Cr-TRX1.  However the molecular mass of the reduced form of Cr-TRX1 was 
increased from 16,209 Da to 16,323 Da after adding IAM.  The molecular mass 
difference (114 Da) precisely corresponds to the addition of two carboxyamidomethyl 
residues (57 Da) indicating that only two Cys can be reduced by DTT and modified by 
IAM and the remaining one Cys residues remained unmodified.  These results indicate 
that the DTT can reduce the disulfide bond of the oxidized Cr-TRX1 which is 
comparable to the observations in human and bacterial homologues (Holmgren, 1985; 
Powis and Montfort, 2001).  
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Figure 3.28: Identification of the number of active Cys in Cr-TRX1 by MALDI-TOF.  The 
mass increment (114 Da) shown in oxidized Cr-TRX1 (left) and reduced Cr-TRX1 (right), which 
are derivatized with iodoacetamide (IAM) correspond to the addition of two caboxyamidomethyl 
groups (57 Da). The molecular mass difference (114 Da) precisely corresponds to the addition of 
two carboxyamidomethyl residues (57 Da) indicating that two Cys residues can be reduced by 
DTT and modified by IAM. 
 
To investigate which of the Cys residues are redox sensitive, the unmodified and 
modified Cr-TRX1(s) were digested by trypsin and the digested peptides were analyzed 
using mass spectrum.  From the mass differences of the peptides, we can determine 
which peptide is modified by IAM and deduce the position of active cysteines.  As shown 
in Figure 3.29, both the unmodified and modified samples showed characteristic peaks of 
Cr-TRX1.  However, the IAM-modified sample contained 2 additional peaks with 
molecular masses of 2,027 and 2,270 Da, respectively, which are absent from the list of 
trypsin-digested peaks (Table 3.4).  Further examination revealed that these two peaks 
corresponded to the peptides 25-42 and 27-42, in which the two Cys residues have been 
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modified by IAM (Table 3.4) suggesting that the two Cys residues in the active motif 
WCPPCR are redox active and can be modified by IAM.  The formation of the peptide 




Figure 3.29: MALDI-TOF analysis of peptides generated by trypsin from IAM-labeled Cr-
TRX1.  Oxidized (top panel) and reduced (lower panel) forms of Cr-TRX1 were labeled with 
IAM and digested before mass spectrometry. The two additional peaks in lower panel 
corresponded to the peptides 25-42 and 27-42, with the two Cys residues modified by IAM.  
Compared to peak 2027.2, peak 2270.3 contains two additional amino acids (DK) because of one 
missed cleavage. 
 
 Further confirmation was obtained from the MS/MS sequencing spectrum.  The 
results clearly showed that both peptide sequences of 25-42 and 27-42 fit unambiguously 
with the active site containing peptide (DKDIIGFYFSAHWCPPCR) and the two Cys 
residues were modified by IAM (Figure 3.30).  Taken together, these results confirmed 
that the conserved Cys residues in the active site of Cr-TRX1 are redox active. 
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Figure 3.30: Identification the position of active Cys residues by MS/MS sequencing.  The 
amino acid sequence of the peptide could be deduced from two complementary series of N-
terminal and C-terminal fragment ions, respectively.  The mass difference between the ions y4 
and y5 is 160 Da which is almost exactly the molecular weight of Cys with the modification of 
IAM. Cys_CAM: carbamidomethyl-cysteine.  Although the y2 ion cannot be identified, the mass 
difference between y1 and y3 ions (257 Da) is just the molecular weight of IAM-modified Cys 
plus Pro (Cys_CAM+Pro) indicating that the Cys38 was modified by IAM as well. 
 
 
Figure 3.31: SDS-PAGE electrophoretic analysis of Cr-TRX1 
in non-reducing (-DTT) and reducing (+DTT) conditions.  The 
dimer formed in non-reducing condition is indicated by an arrow. 







Table 3.4: The list of trypsin digestion peaks of Cr-TRX1 
 
 
The list of trypsin digestion peaks of Cr-TRX1 was predicted with PeptideMass of ExPASy at   
http://kr.expasy.org/tools/peptide-mass.html using average masses of the occurring amino acid 
residues and giving peptide masses as [M+H]+. The two cysteines containing peptides which can 
be modified by iodoacetamide (IAM) were underlined. *Cys_CAM: cysteines have been treated 
with iodoacetamide to form carbamidomethyl-cysteine. #MC: number of missed cleavages. 
 
It has been reported that the 12 kDa human TRX1 forms covalently linked 
homodimers in solution through intermolecular disulfide bonding via Cys73 (Powis and 
Montfort, 2001).  Interestingly, although it lacks the C-terminal extra Cys residue, the 16 
kDa Cr-TRX1 molecule could also form a stable dimer, yielding a molecular mass of 32 
kDa (Figure 3.31).  To confirm the identity of the 32 kDa band, we performed the mass 
spectrum analysis.  As shown in Figure 3.32, the identity of the 32 kDa Cr-TRX1 dimer 
mass position #MC modification(s) peptide sequence 
966.1829 1-8 0   MEFIQGIK 
1091.2238 15-24 0 Cys_CAM*: 15 1148.2750 
CEVNANEALK 
1913.2210 27-42 0 Cys_CAM:  38, 41 2027.3250 
DIIGFYFSAHWCPPCR 
2156.4837 25-42 1 Cys_CAM:  38, 41 2270.5877 
DKDIIGFYFSAHWCPPCR 
3236.6170 43-71 0   
GFTPILADMYSELVDDSAPF 
EIIFVSSDR 
2723.0210 72-93 0   SEDDMFQYMMESHGDWLAIPYR
932.0209 94-103 0   SGPASNVTAK 
1344.6800 104-116 0   YGITGIPALVIVK 
1064.2011 118-127 0   DGTLISMNGR 
943.0471 128-136 0   GEVQSLGPR 
892.9921 137-143 0   AFQNWAR 
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was confirmed by mass spectrometry.  It is still unclear if such dimer also exists under 
physiological conditions, and therefore, the role of the extra Cys in the dimer formation 
needs further examination.  Further mutation and structure studies would be useful to 
















Figure 3.32: MALDI-TOF Mass Spectrum of 16 kDa and 32 kDa bands of Cr-TRX1. The 
purified Cr-TRX1 was run in SDS-PAGE in non-reducing (-DTT) condition. As shown in Figure 
3.26, the 16 kDa (upper panel) and 32 kDa bands (lower panel) were cut out and digested with 
trypsin prior to MALDI-TOF analysis. The fingerprints of the two bands suggest that both of 
them are Cr-TRX1. 
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3.6 Biochemical characterization of Cr-TRX1 
3.6.1 The spectral properties of Cr-TRX1 
It has been demonstrated previously that the classic 12 kDa TRX from the E. coli 
shows a 3.5-fold increase in fluorescence intensity upon reduction of the active site Cys 
residue(s) due to the quenching effect of the active site disulfide bond on the fluorescence 
of two adjacent Trp (W) residues, Trp26 and Trp28 (Windle et al, 2000).  Here, we found 
that the 16 kDa Cr-TRX1 also contains a Trp residue in the active site motif, WCPPC, 
although it lacks the Trp26 residue that is found in the E. coli TRX (Figure 3.23).  To 
confirm whether the 16 kDa Cr-TRX1 displays a similar intrinsic fluorescence 
characteristic, the recombinant Cr-TRX1 was reduced by 1 mM DTT.  The reduction of 
Cr-TRX1 resulted in a 2-fold increase in the Trp fluorescence intensity at 340 nm (Figure 
3.33), suggesting changes in the microenvironment around the Trp residue juxtaposing 
the CXXC active site.  The slightly lower increase in fluorescence intensity (2-fold) 
compared with that of E. coli TRX (3.5-fold) may be attributable to the absence of Trp26 
in Cr-TRX1.   
 
3.6.2 Insulin reduction activity of Cr-TRX1 
The interchain disulfide bonds of insulin are substrates of thioredoxin.  Reduction 
of the disulfide linkage releases the A and B chains of insulin, the latter of which 
precipitates. Therefore, the insulin reduction can be measured turbidometrically due to 
the precipitation of the free insulin B chain (Kunchithapautham et al, 2003).  To 
investigate the activity of Cr-TRX1 in catalyzing the reduction of insulin, we compared 
the rates of insulin reduction by DTT in the presence and absence of Cr-TRX1 and E. coli 
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TRX.  In the reactions containing only DTT or DTT plus 5 μM recombinant GST, 
measurable precipitation was observed through 30 min.  With the addition of Cr-TRX1 or 
E. coli TRX, precipitates were detected within 5 min indicating that both TRXs have the 
disulfide reductase activities targetting insulin as a substrate (Figure 3.34).  Interestingly, 
the kinetics of disulfide reduction observed for Cr-TRX1 was approximately 2-fold more 
efficient at reducing insulin than the equivalent amounts of E. coli TRX (Figure 3.34).  In 
addition, the initial rate of insulin reduction was greater with Cr-TRX1.  These observed 
redox activities of Cr-TRX1 (Figure 3.34) and the differential spectral properties of 
reduced and oxidized Cr-TRX1 (Figure 3.33) indicate that the Cr-TRX1 is not only 
functional, but it appears more efficacious than the E. coli counterpart.   
 
 
Figure 3.33: Fluorescence emission spectra of reduced and oxidized Cr-TRX1.  Reduction of 
oxidized Cr-TRX1 was achieved by addition of DTT to a final concentration 1 mM.  The Tris 







Figure 3.34: Reduction of insulin by recombinant Cr-TRX1.  The increase in turbidity 
measured at OD600 nm was plotted against reaction time.  E. coli TRX was used as a positive 
control (× and ▲).  Recombinant GST was included as a negative control (•). 
 
3.6.3  Reduction of Cr-TRX1 by mammalian thioredoxin reductase 
The TRX function requires a reversible change in the redox status of the CXXC 
motif, and the reduction of oxidized TRX molecules is catalyzed by the NADPH-
dependent enzyme, TRX reductase (TRXR).  To test the cross-species (cross-phylum in 
this case) functionality of Cr-TRX1, we examined whether oxidized Cr-TRX1 can be 
reduced by rat TRXR in the presence of NADPH, by monitoring NADPH oxidation at 
340 nm.  As shown in Figure 3.35, the oxidized Cr-TRX1 was reduced by the rat TRXR 
and the reduction rate was slightly faster than that of the oxidized E. coli TRX, 
suggesting the 16 kDa Cr-TRX1 is functionally conserved with the classical 12 kDa TRX.  
As negative controls, the recombinant GST and commercial BSA cannot be reduce by the 





Figure 3.35: Reduction of Cr-TRX1 by rat TRX reductase (TRXR).  Reduction of Cr-TRX1 
by TRXR was assayed at room temperature by monitoring A340 nm in the presence of GST 5 mM 
(×), BSA 5 mM (∗), Cr-TRX1 1 mM (•) and E. coli TRX 1 mM (▲).  
 
3.6.4 The horseshoe crab thioredoxin functions as an antioxidant  
Normal cellular processes that involve oxygen result in the production of reactive 
oxygen species (ROS) such as singlet oxygen, hydroxyl radical and hydrogen peroxide, 
(H2O2).  Each of these species has the ability to oxidize macromolecules and thereby to 
induce mutation of DNA, impairment of protein function, and lipid peroxidation.  
Intracellular ROS is removed mostly by superoxide dismutase (SOD), catalase, 
glutathione peroxidase and peroxiredoxin (Chang et al, 2004).  It has been suggested that 
TRX also plays a direct role as an antioxidant or scavenger of ROS.  TRX by itself can 
scavenge singlet oxygen, hydroxyl radical and hydrogen peroxide, H2O2 (Hirota et al, 
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2002), thereby buffering the effect of the avalanche of ROS.  To test whether the novel 
Cr-TRX1 is capable of functioning as an antioxidant to scavenge H2O2, the peroxidase 
activity assay (Jeong et al, 2004b) was performed using the recombinant Cr-TRX1.  
Indeed, Cr-TRX1 was capable of reducing H2O2 with an activity comparable to that of 
TRX from E. coli (Figure 3.36).  Like the E. coli TRX, the peroxidase activity of Cr-
TRX1 was also dependent on the enzyme concentration. 
 
 
Figure 3.36: Peroxidase activities of Cr-TRX1.  Peroxidase reactions were performed at 30 ℃ 
and monitored on the basis of A340.  Assay mixtures containing GST (•) served as negative 
controls. 
 
To further confirm that Cr-TRX1 can function by itself as an antioxidant and 
protect DNA, we performed the DNA nicking assay (Kunchithapautham et al, 2003).  
The assay employed the mixed function oxidation (MFO) system that generates hydroxyl 
(OH-) and thiol (RS*) radicals capable of damaging a DNA template.  The extent of 
DNA damage was evaluated by assessing the shift in gel mobility of a plasmid as it was 
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converted from the supercoiled to the nicked form (Kunchithapautham et al, 2003).  In 
the DNA nicking assay, when the plasmid DNA was exposed to the MFO system, all of 
the plasmid DNA was converted to the nicked form within 60 min.  The recombinant Cr-
TRX1 proteins rescued the nicking reaction in a dose-dependent manner (Figure 3.37, 
lanes 2 to 5).  As a control, GST or BSA showed no marked effect on rescuing the 
plasmid DNA nicking activity (Figure 3.37, lanes 6 & 7) suggesting that the protection 





Figure 3.37: Cr-TRX1 functions as an antioxidant to protect DNA from being nicked by 
MFO.  DNA nicking assays were performed in the MFO system with or without Cr-TRX1.  The 
extent of protection against MFO-mediated nicking was evaluated with increasing concentrations 
of Cr-TRX1.  Recombinant glutathione S-transferase (GST) and bovine serum albumin (BSA) 





3.7 Involvement of Cr-TRX1 in the NF-κB signaling pathway 
It has been shown that the binding of NF-κB to DNA requires the NF-κB to be 
fully reduced especially the Cys62 of the NF-κB p50 subunit (Powis and Montfort, 2001).  
In the nucleus, the human 12 kDa TRX1 enhances the DNA-binding of NF-κB by 
directly reducing the cysteine groups in the DNA-binding motif of NF-κB (Figure 1.7) 
(Flohe et al, 1997; Matthews et al, 1992).  Tumor necrosis factor α (TNFα) was one of 
the first receptor ligands shown to generate ROS in nonphagocytic cells and is among the 
ligands whose signaling pathways have been studied most extensively in relation to ROS 
production (Jeong et al, 2004a; Schreck et al, 1991).  We therefore examined the effect of 
overexpression of Cr-TRX1 on TNFα-induced NF-κB activation in HeLa cells.   
 
3.7.1 Cr-TRX1 activates NF-κB in HeLa cells 
As shown in Figure 3.38, transient overexpression of wild type Cr-TRX1 caused a 
dose-dependent activation of TNFα-induced κB-reporter expression.  However, the 
overexpression of mutant Cr-TRX1 caused a slight decrease of κB-reporter expression 
suggesting that the oxidoreductive activity of Cr-TRX1 is essential to enhance the NF-κB 
activity.  Furthermore, the Western blot with anti-p50 antibody revealed equal expression 
of NF-κB p50 protein suggesting that the overexpression of Cr-TRX1 did not affect the 
protein synthesis of p50 (Figure 3.39A).  The overexpression of the 12 kDa TRX has 
been shown to affect TNFα-induced degradation of IκBα in HeLa cells (Zhu et al, 2005).  
Therefore, we also examined the effects of Cr-TRX1 on the IκBα degradation.  Unlike 
the 12 kDa TRX, the Cr-TRX1-transfected cells showed no obvious effect on the 
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TNFα−induced degradation of IκBα (Figure 3.39A).  Then, we investigated whether the 
enhanced NF-κB activity is attributable to its nuclear translocation.  However, the nuclear 
localization of NF-κB p50 was not affected by overexpression of Cr-TRX1 (Figure 
3.39B). 
Subsequently, to examine whether Cr-TRX1 affects the NF-κB DNA-binding 
activity, electrophoretic mobility-shift assay (EMSA) was applied.  As demonstrated in 
Figure 3.40, the wild type Cr-TRX1 slightly enhanced NF-κB DNA-binding activity.  In 
contrast, the mutant form of Cr-TRX1 inhibited the NF-κB DNA-binding activity (Figure 
3.40).  This result is consistent with the κB-reporter assay in which the mutant Cr-TRX1 
also slightly inhibited the TNFα-induced NF-κB activity (Figure 3.38), further 
suggesting that the oxidoreductive activity of Cr-TRX1 is essential in regulating the NF-
κB activity. 
 
Figure 3.38: Effect of overexpression of Cr-TRX1 on the NF-κB activity.  HeLa cells were 
transfected with indicated amounts of wild type and mutant (Mut) Cr-TRX1 together with 0.5 μg 
of pκB-Luc & pRL-CMV (internal controls).  The luciferase activities were measured with dual-
luciferase assay kit and were expressed as fold-increase relative to the internal control.  Data are 
means ± S.D. of values from 3 independent experiments. 
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Figure 3.39: Effect of Cr-TRX1 on the expression and subcellular localization of NF-κB. (A) 
Effects of Cr-TRX1 expression on NF-κB p50 and IκBα expression. HeLa cells were transfected 
with Cr-TRX1 as mentioned in Figure. 3.38. Cell lysates were subjected to Western blot analysis.  
The FLAG-tagged Cr-TRX1 was detected with anti-FLAG antibody. (B) Cr-TRX1 
overexpression did not affect the subcellular localization of NF-κB p50.  After transfection with 
wild-type or mutant Cr-TRX1, cells were treated by TNFα (20ng/ml). The cytoplasmic and 
nuclear extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents 
(Pierce).  The nuclear and cytoplasmic extracts were subjected to Western blot analysis using 





Figure 3.40: Cr-TRX1 increases TNFα-induced NF-κB DNA-binding activity.  HeLa cells 
were transfected with indicated amounts of wild type and mutant (Mut) Cr-TRX1.  Cells were 
harvested at 48 h after transfection.  Nuclear extracts were prepared and EMSA was performed as 




3.7.2 Biological significance of oxidative stress in the regulation of NF-
κB signaling pathway 
 
Thus far, our studies have demonstrated that Cr-TRX1 acts as an antioxidant to 
regulate NF-κB activity in mammalian cells and the regulatory roles of Cr-TRX1 are 
attributable to its oxidoreductive activity.  Therefore, we reasoned that oxidative stress 
could also play a crucial role in mediating immune response in the horseshoe crab, an 
ancient protostome species (Zhu et al, 2005).  In our recent study, we have shown that 
Gram-negative bacteria infection activates the expression of immune-related genes, such 
as CriNOS (C. rotundicauda inducible nitric oxide synthase) and CrIκB (C. rotundicauda 
inhibitor of NF-κB) via NF-κB signaling pathway in horseshoe crab (Wang et al, 2006b).   
To examine the potential effect of the antioxidant on the NF-κB-regulated 
immune gene expression in response to Gram-negative bacterial infection, we treated 
horseshoe crabs with an antioxidant, pyrrolidine dithiocarbamate (PDTC), before 
challenging with P. aeruginosa.  As shown in Figure 3.41A & B, the administration of 
PDTC consistently suppressed the anticipated up-regulation of immune-responsive genes, 
CriNOS and CrIκB, indicating a possible role of reactive oxygen species in the activation 
of NF-κB mediated gene expression in vivo.  As a positive control, we showed that the 
expression of CriNOS and CrIκB genes were also suppressed by an inhibitor of NF-κB 
pathway, MG-132 (Simeonidis et al, 2003).  Furthermore, we analyzed the expression of 
horseshoe crab transglutaminase, whose expression in the vertebrate has been shown to 
be under the control of Sp1 and CREB/AP-1 (Lu et al, 1995; Medvedev et al, 1999).  
Injection of the NF-κB inhibitor, MG-132, did not affect the activation of the 
transglutaminase transcription upon Gram-negative bacterial infection (Figure 3.41C).  
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However, injection of PDTC inhibited the expression of transglutaminase by 50 % 
suggesting that the antioxidant also regulates the AP-1 signaling pathway as has been 
observed in humans (Witte et al, 2000).  As a negative control, the expression of CALF 
(C. rotundicauda anti-LPS factor) was shown to be unaffected with or without NF-κB 
inhibitors, suggesting that the action of the antioxidant, PDTC, was specific and did not 
randomly affect the overall mRNA synthesis (Figure 3.41D). 
 
Figure 3.41: Antioxidant regulates NF-κB signaling pathway in horseshoe crab.  The 
expression of horseshoe crab iNOS (CriNOS), IκB (CrIκB), transgultaminase 
(CrTransgultaminase) and CALF (C. rotundicauda anti-LPS factor) genes in hemocytes was 
examined after challenge with P. aeruginosa with or without inhibitors (■).  One hour after 
treatment with PDTC (♦) or MG-132 (▲), the horseshoe crabs were either infected with P. 
aeruginosa or left unchallenged (0 h) and the hemocytes were collected at the indicated time 
points (in h).  The RT-PCR products were analyzed on gels and quantified relative to the levels of 
horseshoe crab actin-11 mRNA.  Results are expressed as relative fold-increase compared to 
naïve control (0 h) which was set to 1. 
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To examine whether P. aeruginosa infection affects Cr-TRX1 expression, the 
transcript profile of Cr-TRX1 was monitored using RT-PCR with total RNA extracted 
from hemocytes collected at indicated time points post P. aeruginosa challenge.  As 
shown in Figure 3.42, the expression level of Cr-TRX1 decreased slightly after infection.  
This is in agreement with our earlier finding that the Cr-TRX1 gene was obtained from 
the hepatopancreas reverse subtractive library (Ding et al, 2005).  
 
 
Figure 3.42: RT-PCR analysis of the expression level of Cr-TRX1 during bacterial infection.  
The mRNA expression of Cr-TRX1 was analyzed 1-72 h post-infection (hpi) with P. aeruginosa. 
The horseshoe crab actin-11 gene was analyzed under the same conditions as the internal control. 
 
 
3.8 The 16 kDa TRX is conserved from C. elegans to human 
3.8.1 Evolutionary conservation of 16 kDa TRX 
A homology search of the GenBankTM database was conducted using the Cr-
TRX1 cDNA as template.  Interestingly, a number of putative 16 kDa TRX sequences 
were revealed from a variety of organisms.  As shown in Figure 3.43, the 16 kDa TRXs 
are present in several nematode species and in the vertebrates, from zebrafish to human 
suggesting that the 16 kDa TRXs are evolutionary conserved.  Sequence alignment of 
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these homologous proteins revealed that the WCPPC motif was fully conserved amongst 
the invertebrates (Figure 3.44), indicating the potential importance of this motif in the 




Figure 3.43: Phylogenetic study of the 16 kDa Cr-TRX1 and related TRX proteins.  Multiple 
sequence alignments were produced with Clustal X using Gonnet series protein weight matrix.  







Figure 3.44: Sequence analysis of the 16 kDa Cr-TRX1 and related TRX proteins.  Amino 
acid sequences comparison between Cr-TRX1 and the 16 kDa, 24 kDa and 12 kDa TRXs.  
Alignments were done by Clustal X.  The Cys residues in the active sites are demarcated by *.  
Black and grey shades indicate identity and similarity of the residues, respectively.  GenBank 










 Surprisingly, in the vertebrates, another family of TRX-like proteins, with a 
molecular weight of 24 kDa, also shows high homology to the 16 kDa Cr-TRX1 
suggesting that the 16 kDa TRX probably underwent gene duplication and divergence in 
the vertebrates and gave rise to the 24 kDa TRX (Zhang, 2003).  An alignment of the 16 
kDa and 24 kDa TRXs revealed that the active sites of these TRXs have undergone 
marked changes (Figure 3.44).  Alternative active-site sequences include ACPQCQ and 
WCSPCR.  For several members of the 16 kDa TRXs and 24 kDa TRXs, even the most 
conserved Cys has been replaced with Ser (Figure 3.44).  However, besides the active 
motif, several other regions remained conserved amongst the 16 kDa TRXs compared 
with 12 kDa TRXs (Figure 3.44).  This observation suggests that the 16 kDa TRX has 
evolutionary diverged from the 12 kDa TRX at an early stage.   
 
3.8.2 Human TRX6, a homologue of Cr-TRX1, regulates NF-κB DNA 
binding activity 
 
In order to assess whether the function of this family of TRX are also 
evolutionarily conserved, we decided to examine the function of a human homologue of 
Cr-TRX1.  There are two highly homologous proteins of the Cr-TRX1 in the human 
genome, one is 16 kDa and another one is 24 kDa.  Because the 16 kDa human TRX 
harbors a change in one of the two conserved cysteines in the active motif (Cys to Ser) 
(Figure 3.44), we chose the human 24 kDa TRX protein (GeneBank accession number, 
BC014127) for further functional studies.  The human 24 kDa TRX is henceforth referred 
to as TRX6 (“thioredoxin-like 6”, NCBI).  The DNA sequence of TRX6 consists of an 
ORF of 636 bp, a 5’-untranslated region of 47 bp including an in-frame stop codon.  
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Compared with the 16 kDa Cr-TRX1, the TRX6 is 8 kDa longer.  The predicted protein 
does not contain a known signal peptide for a specific subcellular localization.  A search 
of the human genome sequence revealed that the gene for TRX6 is located at 
chromosome 19p13.12 and comprises 2 exons as well as 1 intron.  BLAST search using 
Cr-TRX1 as template indicated the the TRX6 protein shares 27% identities and 54% 
homology with Cr-TRX1 respectively.  The sequence alignment shows that most of the 
additional residues appear at the extreme C-terminus (Figure 3.44).  Next, we predicted 
the structures of TRX6 and Cr-TRX1 using the Swiss-model program at the Expasy 
website.  The structure of TRX6 is highly superimposable on that of Cr-TRX1 and 
Trypanosoma 16 kDa TRX, despite limited sequence identity.  Like other 16 kDa TRXs, 
the Cr-TRX1 and TRX6 contain a characteristic thioredoxin fold, (Alphey et al, 1999;  
Martin, 1995) consisting of 5 central β-sheets and 4 flanking α-helices (Figure 3.45).  
  
Figure 3.45:  The predicted structures of Cr-TRX1 and the human TRX6.  The structure of 
Trypanosoma 16 kDa TRX was obtained from the Protein Data Bank (PDB).  The structures of 
Cr-TRX1 and human TRX6 were predicted using the Swiss-model program at the Expasy 
website: http://swissmodel.expasy.org/SWISS-MODEL.html.  The white arrows indicate the 
active sites of the Trypanosoma 16 kDa TRX and Cr-TRX1.  The additional sequence after the 
conserved active site in TRX6 (dashed arrow) is hypothesized to affect the activity of the TRX6.  
 
Trypanosoma 16 kDaTRX Cr-TRX1 Human TRX6 
Active site Additional sequence 
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In order to determine the enzymatic functions of TRX6, we expressed the 
recombinant TRX6 in E. coli.  However, when expressed in vitro, the TRX6 lacked 
detectable oxido-reductase activity.  This loss of function is probably due to an additional 
sequence (FYVLRAAQ) after the active site (Figure 3.44), resulting in a different 
structure around the catalytic site of the TRX6 (Figure 3.45).  Furthermore, a highly 
conserved tryptophan (W) residue, located before the active site motif of TRX6 was 
replaced by alanine (A) residue (Figure 3.44), which might also have affected the 
enzymatic activity or substrate specificity of the recombinant TRX6. 
To examine if TRX6 has conserved the NF-κB regulatory activity of Cr-TRX1, 
we expressed the recombinant TRX6 in E. coli and examined its ability to regulate 
horseshoe crab NF-κB, CrNFκB (a homologue of human NF-κB p65), DNA-binding 
activity by EMSA (Wang et al, 2006b).  As shown in Figure 3.46, the TRX6 alone did 
not bind to the κB motif (lane 2).  However, it can significantly enhance the DNA-
binding activity of CrNFκB (lane 4) suggesting that like Cr-TRX1, the human TRX6 
probably also possesses the NF-κB regulatory ability although the recombinant TRX6 
has no detectable oxidoreductase activity.  The augmentation is specific, as the control 
recombinant GST showed no effect on the binding activity of CrNFκB (lane 5). 
The TRXs that have been characterized to date are nearly uniformly 12 kDa 
proteins with an active motif of WCGPC.  In this thesis, we report the identification of a 
16 kDa TRX, with an active motif of WCPPC, in horseshoe crab (an arthropod) and 
demonstrate that the 16 kDa TRX are evolutionarily conserved from C. elegans to human 
(Wang et al, 2007).  Despite notable differences in the molecular mass and amino acid 
sequence of the catalytic site, the 16 kDa Cr-TRX1 appears to be functionally similar to 
 138
the classical 12 kDa TRXs.  Our studies also showed that the 16 kDa Cr-TRX1 could 
positively regulate the TNFα-induced NF-κB activation and the enhancement of NF-κB-
dependent gene expression was associated with increased NF-κB DNA-binding activity.  
Although the exact mechanism underlying the regulation of the NF-κB activity by Cr-
TRX1 and TRX6 is still unknown; our studies strongly suggest that the NF-κB regulatory 













Figure 3.46: TRX6 enhances horseshoe crab NF-κB (CrNFκB) DNA-binding activity.  
EMSA was performed using the recombinant CrNFκB, TRX6 protein and κB probe.  Purified 
recombinant TRX6 (200 ng) or GST (2 μg) were preincubated with CrNFκB at room temperature 
for 30 min and mixed with the labeled κB oligonucleotide (lanes 4 & 5). Complex formations 
were significantly enhanced by TRX6 (lanes 4), but not by recombinant GST (lane 5).  The 
negative control, TRX6 or recombinant GST alone, showed no binding to the κB probe (lanes 2 
& 3).  The complexes are indicated by an arrow.  Experiments were repeated three times with 






CHAPTER 4:   DISCUSSION 
 
4.1 The evolutionarily conserved NF-κB signaling pathway 
NF-κB family members are transcriptional factors that regulate the expression of 
a large number of target genes involved in physiological processes such as immune 
response, inflammation, apoptosis and progression of the cell cycle in different organisms 
(Bonizzi and Karin, 2004).  Since the discovery of NF-κB transcription factors in 1986 
(Sen and Baltimore, 1986), a wealth of information in understanding the mechanisms that 
operate in the NF-κB signaling pathway, and the functions of NF-κB in various diseases, 
has been generated for the mammalian systems (Hayden and Ghosh, 2004).  However, 
other than evidence of Toll homologues in several insect species, an IKKβ homologue in 
an oyster and NF-κB homologues in several dipteran insects (Hoffmann and Reichhart, 
2002), little is known about the NF-κB signaling pathway in other invertebrates.  
Therefore, we are in great need of information on the NF-κB signaling pathway in other 
invertebrates besides the insects.  In this study, we have isolated and characterized the 
NF-κB and IκB from the horseshoe crab (C. rotundicauda), and named these homologues 
CrNFκB and CrIκB, respectively.  To the best of our knowledge, except for Cactus in 
Drosophila, CrIκB is the only IκB characterized in invertebrates and CrNFκB is the only 
NF-κB identified in a non-insect species of arthropods. 
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4.1.1 The NF-κB/IκB signaling cascade of horseshoe crab is 
functionally comparable to that of the Drosophila and mammals 
Phylogenetic analysis showed that CrNFκB and CrIκB share high level of 
similarities with their mammalian homologues.  Despite the huge evolutionary distance 
between horseshoe crab and vertebrates, we showed that the CrNFκB and CrIκB display 
similar signature motifs as their respective vertebrate orthologues, notably, the Rel 
homology domain (RHD), the DNA binding motif and the nuclear localization signal 
(NLS) of CrNFκB; the 5 ankyrin repeats and the N-terminal potential phosphorylation 
sites of CrIκB (Figure 3.1 and 3.3).  In addition, from a fragment obtained during the 
cloning of CrIκB, we isolated the horseshoe crab p100 and p105 homologue, CrRelish.  
Like human p100, p105 and insect Relish proteins, the CrRelish is a mosaic protein 
which contains both RHD and inhibitory IκB domain (Figure 3.5).  It will be important to 
determine whether CrRelish is proteolytically processed during bacterial challenge.  The 
fact that human p100 and Drosophila Relish are cleaved to release its N-terminal 
activation domains suggests that the CrRelish probably undergoes similar process of 
activation upon bacterial infection.  Also, demonstrating the presence of a compound NF-
κB protein (CrRelish contains both RHD and inhibitory IκB domain) in horseshoe crab, 
insects, as well as mammals provides further support for the postulation that these 
proteins may serve important regulatory roles that cannot be accomplished by separating 
Rel/NF-κB and IκB proteins (Dushay et al, 1996).  Furthermore, the discoveries of 
CrNFκB, CrIκB and CrRelish in horseshoe crab strengthen the similarity of the 
mechanisms used by invertebrates and vertebrates to regulate their immune responses.   
 141
It has been shown that the RHD of the NF-κB transcription factor is the domain 
that binds the κB site.  Therefore, we examined the specific binding of the recombinant 
CrNFκB RHD with oligonucleotides harboring κB motif(s).  Results of EMSA strongly 
suggest that the horseshoe crab CrNFκB can bind to the κB site and its binding 
specificity was also confirmed.  Using EMSA, we demonstrated that the DNA 
recognition mechanism of CrNFκB is reminiscent of that of mammalian and Drosophila 
species.  We also observed that horseshoe crab CrNFκB proteins could physically 
interact with CrIκB proteins, providing evidence that horseshoe crab NF-κB molecules 
are functionally compatible with their mammalian counterparts.   
CrNFκB shows highest homology with NF-κB proteins in insects.  Thus, given 
the lack of horseshoe crab cell lines, it appeared appropriate to investigate the CrNFκB 
functions by performing transfection experiments in Drosophila cell line.  To test the 
transcription activation, the CrNFκB and κB reporter constructs were transfected into the 
Drosophila S2 cell.  Our results indicated that overexpression of CrNFκB can activate the 
C. rotundicauda Factor C (CrFC) κB reporter expression and the κB motif on the 
promoter of the reporter is necessary for the transactivation activity.  Furthermore, we 
demonstrated that CrIκB could specifically inhibit the binding of CrNFκB to the κB 
motif of the CrFC promoter and reduce its transcriptional activity.  Cell imaging also 
revealed that the NLS of CrNFκB is critical for its translocation into the nucleus.  The 
process can be inhibited by overexpression of CrIκB suggesting that the activity of 
CrNFκB is modulated by an autoregulatory feedback mechanism akin to that of the 
mammalian and Drosophila systems (Ghosh et al, 1998).   
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Gram-negative bacterial infection caused rapid degradation of CrIκB and nuclear 
translocation of CrNFκB, suggesting that the horseshoe crab NF-κB signaling pathway 
can be activated by pathogen infection.  Using RT-PCR, we confirmed that CrIκB is a 
target gene of CrNFκB.  This feedback regulation of NF-κB activity has also been 
observed in the vertebrates and Drosophila (Tran et al, 1997).  Lastly, we demonstrated 
that CriNOS, a homologue of mammalian iNOS, which is a classical target gene of NF-
κB pathway in mammals, is also transcriptionally regulated by CrNFκB in the horseshoe 
crab.  In summary, this study showed that the NF-κB activation pathway of the horseshoe 
crab is functionally comparable to that of the Drosophila and mammals, suggesting that 
the roles of NF-κB and its natural inhibitor, IκB, have co-evolved and remained 
conserved through evolution.  We anticipate that these findings would provide 
evolutionary perspectives into the signal transduction of immune response and provoke 
further interests in the scientific community to understand the origin of innate immunity 
and how it influences adaptive immunity. 
 
4.1.2 A proposed NF-κB signaling pathway in the horseshoe crab 
The phenomenal success of the immune defense of the horseshoe crab, one of the 
most ancient living arthropods, has contributed to its survival for ~550 million years 
(Størmer, 1952) and makes this species an excellent model to understand the origin of 
innate immunity.  Previously, the striking similarities between the extracellular 
Drosophila dorsoventral determination cascade and the horseshoe crab LPS-sensitive 
blood coagulation cascade have been observed (Ding et al, 2004).  In Drosophila, the 
dorsoventral cascade can activate the Toll-ligand, Spätzle, which then binds to the Toll 
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on the cell membrane and triggers the intracellular NF-κB signaling pathway.  In this 
work, we have revealed the presence of a primitive but functional CrNFκB/CrIκB 
signaling cascade and demonstrated its relevance to the immune defense of a horseshoe 
crab, C. rotundicauda.     
Our findings herein and the recent cloning of Toll-like receptor in the horseshoe 
crab (Inamori et al, 2004) have provided compelling evidence for a functional 
intracellular TLR/NF-κB signaling cascade.  Although, the direct ligand for horseshoe 
crab TLR activation is unclear, it has been proposed that the activation of LPS-sensitive 
blood coagulation cascade converts coagulogen (a homologue of Spätzle) to coagulin, 
which may serve as a ligand of horseshoe crab TLR (Bergner et al, 1996; Osaki and 
Kawabata, 2004; Wang et al, 2003).  Furthermore, we have isolated two cDNAs which 
are highly homologous to other components of the Rel/NF-κB pathway, including the 
TNF receptor-associated factor, CrTRAF and CrSlimb (Ding et al, 2005).  The CrSlimb 
is a homologue of human β-TrCP and Drosophila Slimb which are involved in the 
degradation of IκB proteins (Spencer et al, 1999).   Although the biological functions of 
these components remain to be elucidated further, their existence nonetheless provides 
additional evidence for a functional TLR/NF-κB cascade since several hundred million 
years ago, and the co-evolution of this signaling cascade.  Our findings provide further 
support to the view that a signaling mechanism mediated via NF-κB family of proteins, 
which controls the expression of immune defense genes probably originated from a 
common ancestry and was already present in the Urbilateria (Hoffmann and Reichhart, 
2002).  Figure 4.1 illustrates a scheme for this conservation and co-evolution of the NF-








4.2  The horseshoe crab Imd/Relish pathway 
In Drosophila, the Toll pathway mainly mediates immune defense against Gram-
positive bacteria and fungi.  The Imd pathway confers protection against Gram-negative 
bacterial infection.  In mosquito (Aedes aegypti), researches have shown that the Relish 
homologue is responsible for the regulation of the immune response to bacterial challenge; 
and REL1, a homologue of Drosophila Dorsal, regulates the antifungal immune pathway 
(Shin et al, 2005; Shin et al, 2003).   
In this project, we also isolated two NF-κB transcription factors, CrNFκB (a 
homologue of Drosophila Dorsal and mammalian p65) and CrRelish (a homologue of 
Drosophila Relish and mammalian p100).  The Gram-negative bacterial infection 
significantly enhanced the κB binding activity in the horseshoe crab hemocytes 
suggesting that Gram-negative bacterial infection could activate the horseshoe crab NF-
κB signaling pathway in vivo.  Addition of specific antibodies against CrNFκB only 
caused a partial supershift of the κB-binding complex.  The majority of the κB-binding 
complex could not be supershifted by the anti-CrNFκB antibody, which suggests the 
presence of κB motif-binding proteins other than CrNFκB in the horseshoe crab 
hemocyte.  Previous study has shown that amongst the three Drosophila NF-κB 
homologues  (Dorsal, Dif and Relish), Relish has relatively higher and broader binding 
activity to κB motifs (Han and Ip, 1999).  A similar mechanism is probably operational in 
the horseshoe crab as well and CrRelish may play a major role in forming the κB 
complex and in mediating the protection against Gram-negative bacterial infection.  
However, at this stage, whether the horseshoe crab CrNFκB and CrRelish play similar 
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roles as their corresponding homologues in the Drosophila and mosquito remains 
unknown.  The functional relevance of CrRelish and CrNFκB in mediating anti-bacterial 
activities against Gram-positive and against Gram-negative bacteria is the subject for 
further studies.  Nevertheless, the partial supershift with anti-CrNFκB antibody suggests 
that the DNA–protein complex formed with κB motif at least involves the presence of 
CrNFκB (Figure 3.17A).  Furthermore, although the exact identity of the unshifted 
complexes is unknown at this juncture, the data in Figure 3.16 nevertheless provide 
adequate evidence to show that the complexes are formed by κB motif binding proteins. 
 
4.3 The activation of NF-κB signaling pathway in horseshoe 
crab 
 
It has been observed that the activation of Toll in Drosophila and the activation of 
TLR in mammals are clearly different with regards to the detection of microorganisms 
(Hoffmann and Reichhart, 2002).  In the Drosophila, fungi and Gram-positive bacteria 
are recognized by circulating PRRs which then lead to the activation of a serine protease 
cascade and the proteolytically processed product of this cascade, Spätzle, is believed to 
be the ligand for Toll activation (Wang et al, 2003).  However, in mammals, the TLRs on 
the cell membrane interact directly with the PAMPs and activate the downstream NF-κB 
signaling pathway.  So far, only one Toll receptor in Drosophila is known to be strictly 
required for immune defense, although fruit flies express nine distinct Toll receptors 
(Tauszig et al, 2000).   This is distinct from the extensive roles played by the various 
mammalian TLRs which can recognize various PAMPs such as peptidoglycan, 
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lipoproteins, LPS, flagellin, DNA and RNA (Akira and Takeda, 2004).  It has been 
suggested that a significant number of circulating recognition proteins (such as the 
peptidoglycan recognition protein, PGRP) in the Drosophila may reflect the recognition 
of a broad spectrum of microbial patterns by the mammalian TLR family (Hoffmann and 
Reichhart, 2002).   
The exact mechanism of how horseshoe crab NF-κB is switched on upon 
pathogen infection is still uncertain.  However, like Drosophila, the horseshoe crab 
contains a plethora of proteins that have been shown to function as pathogen recognition 
proteins, such as Factor C, Factor G and C-reactive proteins (Iwanaga, 2002).   So far, 
only one type of TLR has been cloned from the horseshoe crab (Inamori et al, 2004).  
Therefore it is reasonable to postulate that similar to Drosophila, horseshoe crab probably 
utilizes a plethora of circulating pathogen recognition proteins in the blood, not a family 
of TLRs on the cell membrane, to detect the presence of intruding pathogens. 
Interestingly, it was recently reported that the Factor C of the Japanese horseshoe 
crab, like the mammalian TLR4 but not Drosophila Toll (Wasserman, 2000), could 
function as a pattern-recognition protein for LPS on the hemocyte surface. In this regard, 
the proteolytic activity of Factor C on the hemocytes was found to trigger a G protein-
mediated exocytosis for innate immune response (Ariki et al, 2004).  It will be interesting 
to investigate whether the membrane-localized Factor C could function as a receptor to 
activate the downstream signaling pathway that regulates the innate immune response.  
Indeed, previous studies also suggested that the exocytosis is mediated by a 
heterotrimeric GTP-binding protein that stimulates the inositol-1,4,5,-triphosphate (IP3)-
signaling pathway which leads to the increase of intracellular Mg2+ and Ca2+ (Solon et al, 
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1996).  It has also been reported that NF-κB signaling pathway can be activated by G-
protein coupled receptors via the IP3-Ca2+ signaling (Ye, 2001).  These observations 
corroborate the possibility that, like mammalian TLR (Hoffmann and Reichhart, 2002), 
Factor C may also function as a receptor on the membrane for the activation of NF-κB 
signaling pathway in the horseshoe crab (Wang et al, 2003).  
It is widely believed that LPS is a strong inducer of Toll/NF-κB signaling 
pathway in mammals (Akira and Takeda, 2004), however the function of LPS in 
activating NF-κB signaling in invertebrates is still unclear.  In 2003, Werner et al 
reported that both LPS and peptidoglycan could induce the expression of Drosophila 
antimicrobial peptides that is mediated by peptidoglycan recognition protein, PGRP-LC.  
They found that PGRP-LCx is the only isoform required to mediate signals from Gram-
positive bacterial peptidoglycan.  In contrast, the recognition of Gram-negative bacteria 
and bacterial LPS requires both PGRP-LCa and LCx (Werner et al, 2003).  They also 
postulated that the simultaneous requirement of two splice forms for the response to LPS 
suggests that the PGRPs may act as heterodimers or perhaps as higher multimers (Werner 
et al, 2003).  However, in the same year, Leulier et al. reported in Drosophila, that the 
Toll pathway is predominantly activated by Gram-positive lysine-type peptidoglycan, and 
that Gram-negative diaminopimelic acid-type peptidoglycan is the most potent inducer 
for the Imd pathway.  This observation suggests that the ability of Drosophila to 
discriminate between Gram-positive and Gram-negative bacteria relies on the recognition 
of specific forms of peptidoglycan but not LPS.  Indeed, they clarified that LPS is not the 
main determinant for Gram-negative bacterial recognition in Drosophila, which is in 
contrast to vertebrates (Leulier et al, 2003).  Because peptidoglycans from Gram-negative 
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bacteria are crosslinked with a peptide containing a diaminopimelic acid (DAP) residue, 
whereas a lysine is found in the same position of Gram-positive bacteria (Figure 4.2), 
they suggested that this variation probably results in distinct conformational difference, 
allowing discriminatory recognition (Leulier et al, 2003). 
In our studies, we observed that the Gram-negative bacteria could strongly induce 
the degradation of CrIκB and activate the NF-κB signaling pathway.  However, it is still 
unknown whether LPS or the Gram-negative peptidoglycan triggered the NF-κB 
signaling pathway.  Also, in horseshoe crabs, LPS has been shown to trigger the 
coagulation cascade that involves three serine protease zymogens: Factor C, Factor B and 
proclotting enzyme (Ding et al, 1993).  Factor C responds to picomolar of LPS and 
autocatalytically converts to its active form, which in turn transforms Factor B.  The 
activated Factor B converts the proclotting enzyme to clotting enzyme which converts 
coagulogen to an insoluble coagulin gel (Ding et al, 2004).   Therefore, it will be 
interesting to determine whether the ligands for the NF-κB signaling pathway are similar 
to that of the coagulation cascade, as well as to study the relationship between NF-κB 






















Figure 4.2: The structural comparison of Gram-negative and Gram-positive peptidoglycan. 
Peptidoglycan is a vast polymer consisting of interlocking chains of identical peptidoglycan 
monomers.  A peptidoglycan monomer consists of two joined amino sugars, N-acetylglucosamine 
(NG) and N-acetylmuramic acid (NM), with a pentapeptide.  The long sugar chains are joined to 
one another by means of peptide cross-links between the peptides.  The major difference between 
the Gram-negative and Gram-positive peptidoglycan is the third amino acid in the peptide chain.  
The third amino acid in the peptide chain of the Gram-negative bacterial peptidoglycan is 
diaminopimelic acid (DAP) (A).  However, the third amino acid in the peptide chain of the Gram-
positive bacterial peptidoglycan is lysine (B). Furthermore, the peptidoglycan of Gram-
negative bacteria is cross-linked by bond formation between the DAP molecule extending 
from one sugar backbone and the terminal Alanine of another (A). However, the Gram-
positive peptidoglycan is linked by a 5 amino acids interbridge between the Lysine of one 




4.4 The exocytosis and NF-κB signaling 
It is well known that the LPS-induced exocytosis of granular hemocytes is a key 
component of innate immunity in horseshoe crab.  In response to stimulation by LPS, the 
antimicrobial elicitors stored in the hemocyte granules are immediately secreted by 
A B
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exocytosis (Solon et al, 1996).  However, how these intra-granular molecules are 
replenished remains a mystery.  Our finding suggests that the expression of CrFC, which 
is an important defense molecule in the large granules, is under the control of NF-κB 
signaling pathway.  It is well known that the expression of a plethora of antimicrobial 
peptides in the Drosophila and mosquito is under the control of NF-κB signaling 
pathway (De Gregorio et al, 2002; Osta et al, 2004).   Hence, it is conceivable that the 
expression of horseshoe crab antimicrobial peptides is under similar transcriptional 
regulation. This phenomenon indicates that upon infection, the NF-κB signaling 
pathway-controlled transcription activation is a possible mechanism for replenishing the 
store of CrFC and antimicrobial peptides after exocytosis of the hemocyte granules.  This 
requires the sacrificial degranulation of the hemocyte (Iwanaga, 2002). 
In conclusion, although absent in C. elegans, the NF-κB/IκB signaling pathway 
has co-evolved and remained well-conserved from horseshoe crab to human, playing an 
archaic but crucial and fundamental role in innate immune response to regulate the 
expression of critical immune defense molecules.  We believe that the accumulation of 
data on NF-κB signal pathway from different invertebrates other than Drosophila should 









4.5 A novel form of TRX which regulates NF-κB activity 
TRX is generally a low-molecular weight 12 kDa cellular redox protein that is 
involved in numerous biological functions.  TRX is generally characterized by an amino 
acid sequence motif containing an active site, CGPC.  The two cysteine residues can be 
reversibly oxidized to form a disulfide bridge.  TRX has been reported to function as a 
reductive factor through its dithiol group and has multiple biological activities via the 
regulation of intracellular redox status (Hirota et al, 2002).  A majority of the TRX that 
have been reported to date from eukaryotic and prokaryotic organisms are initially 
translated as a 12 kDa protein (Powis and Montfort, 2001).  In this thesis, we describe the 
identification and characterization of a novel 16 kDa TRX which contains a WCPPC 
active motif in the horseshoe crab Carcinoscorpius rotundicauda (Cr-TRX1).  Despite 
notable differences in the mass and sequence of the catalytic site, the Cr-TRX1 appears to 
be functionally similar to the 12 kDa TRXs. 
 
4.5.1 The 16 kDa Cr-TRX1 is functionally similar to the 12 kDa TRX 
The Cr-TRX1 was cloned from a hemocyte subtractive library.  Sequence analysis 
revealed that the Cr-TRX1 is larger than the known classical 12 kDa counterpart and 
contains an atypical WCPPC catalytic motif.  Although Cr-TRX1 contains three Cys, 
only two in its active motif are exposed and redox sensitive.  The extra Cys residue at the 
N-terminus may be involved in homodimer formation.  To evaluate the TRX activity of 
Cr-TRX1, insulin reduction assay was performed according to the classical method 
described by Holmgren (1985).  The results suggest that the Cr-TRX1 is not only 
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functional, but it appears more efficacious than the E. coli counterpart.  To test the cross-
species (cross-phylum in this case) functionality of Cr-TRX1, we examined whether 
oxidized Cr-TRX1 can be reduced by rat TRXR in the presence of NADPH, by 
monitoring NADPH oxidation at 340 nm.  The results indicate that Cr-TRX1 could 
undergo cross-phylum reduction by mammalian thioredoxin reductase.  To confirm that 
Cr-TRX1 can function by itself as an antioxidant and protect DNA, we performed the 
DNA nicking assay.  The results indicate that Cr-TRX1 can protect DNA from reactive 
oxygen species-mediated nicking.   All of these results suggest that despite notable 
differences in its molecular mass and the active site sequence, the Cr-TRX1 is 
functionally similar to the 12 kDa TRX. 
 
4.5.2 The 16 kDa TRX is conserved from C. elegans to human 
The TRXs that have been characterized to date are nearly uniformly 12 kDa 
proteins with an active motif of WCGPC.  More recently, a 16 kDa class of TRX with an 
active motif of WCPPC (see Figure 3.23) was identified in the parasitic protozoa, 
trypanosomes (Ludemann et al, 1998).  All of these parasitic protozoa lack of the 
ubiquitous glutathione/glutathione reductase system and are very sensitive towards 
oxidative stress (Reckenfelderbaumer and Krauth-Siegel, 2002).  Since then, the 16 kDa 
TRX is believed to exist only in this protozoan and; therefore, it has been used as an 
attractive target for the development of new anti-parasitic drugs  (Krauth-Siegel and 
Coombs, 1999).   
Here, we report the identification of a 16 kDa TRX, with an active motif of 
WCPPC, in the horseshoe crab (an ancient arthropod) and demonstrate that the 16 kDa 
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TRXs are evolutionarily conserved from C. elegans to human.  Sequence alignment of 
these homologous proteins revealed that the catalytic WCPPC motif was largely 
conserved, indicating the potential importance of this motif in the 16 kDa TRX function.  
Although the active motifs of the 16 kDa TRXs in mammals have undergone marked 
changes, several other regions remained well conserved amongst the 16 kDa TRXs 
compared with the 12 kDa TRXs.  This observation suggests that the members of the 16 
kDa TRX has evolutionarily diverged from the 12 kDa TRXs at an early stage.  The 
predicted three-dimensional structure of 16 kDa revealed a folding very similar to that of 
parasitic protozoa 16 kDa TRX with five-stranded β-sheet surrounded by four α-helices 
(see Figure 1.6) (Alphey et al, 1999).  In particular, the active site motif CPPC is in a 
position homologous to that of the corresponding motif in parasitic protozoa 16 kDa TRX.  
Interestingly, although the 16 kDa TRX is present in many species, from C. elegans to 
human, it is absent in several insect species such as Drosophila and mosquito which, like 
horseshoe crab, also belong to arthropods.  It has been demonstrated that the antioxidant 
system in Drosophila, and probably in related insects, differs fundamentally from that in 
other organisms.  It lacks the glutathione reductase and the thioredoxin system supports 
GSSG reduction (Kanzok et al, 2001).  Our observation provides further support to the 
notion that antioxidant defense in insects is unusual compared to that in other organisms 
(Kanzok et al, 2001).   Our findings of the functional Cr-TRX1 (this work) and a full 
repertoire of GSTs (Ding et al, 2005) in the horseshoe crab suggest that although this 
species belongs to the arthropods, shared by insects, its oxidoreductase systems must 




4.6 The catalytic sequences of TRX families 
All organisms from bacteria to mammals contain multiple TRX isoforms.  
Although the amino acid sequences of TRX proteins from different species are not highly 
conserved, they all contain the conserved catalytic sequence, CXXC.  The sequence of 
the catalytic site from the 12 kDa class of TRX is highly conserved.  However, members 
of the TRX protein family that are larger than 12 kDa have variable residues associated 
with the active-site motif (Kunchithapautham et al, 2003).  For example, a human 32 kDa 
transmembrane protein, TMX, was found to contain the active site sequence WCPAC 
(Matsuo et al, 2001), a human 45 kDa TRX-related protein (PC-TRP) with the active site 
sequence of WCGHC (Wrammert et al, 2004), and a human 14 kDa TRX (TRP14) with 
the active site sequence WCPDC (Jeong et al, 2004b).  Similarly, the 16 kDa horseshoe 
crab TRX also contains an unusual WCPPC active-site motif.  Except for the diversity in 
the active site sequences, the enzymatic activity of various TRX isoforms is also different.  
For example, the 14 kDa human TRX (TRP14), with an active motif of WCPDC, exhibits 
markedly different substrate specificity compared to the 12 kDa TRXs.  Although TRP14 
could reduce small disulfide-containing peptides, it did not reduce the disulfides of 
known human TRX1 substrates, ribonucleotide reductase and peroxiredoxin (Jeong et al, 
2004b).  In contrast, despite notable differences in the amino acid sequence of the 
catalytic site, the 16 kDa Cr-TRX1 appeared to be functionally similar to the classical 12 
kDa TRXs.  This is consistent with the reports that the same variant active site (WCPPC) 
of TRXs in trypanosomes, Arabidopsis thaliana and human nucleoredoxin displayed 
comparable activity (Kurooka et al, 1997; Ludemann et al, 1998).  Therefore, it appears 
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that there is considerable flexibility in the two residues between the conserved Cys 
residues in the active site, and that the different catalytic sequences might confer diverse 
enzymatic activity and substrate specificity, indicating the functional diversity of the 
TRX system. 
Interestingly, like the other 16 kDa thioredoxin, the Cr-TRX1 also lacks the 
highly conserved Asp26, which is present in the E. coli TRX, and has been shown to play 
a crucial role for catalytic activity.  It is the only acidic residue not localized on the 
surface of the protein and mutation to an Ala increased the Km value for thioredoxin 
reductase by a factor for 10 (Katti et al, 1990).  In addition, the mutant E. coli thioredoxin 
protein had a drastically lowered ability to serve as a hydrogen donor for ribonucleotide 
reductase (Reckenfelderbaumer et al, 2000).  Our results clearly showed that the Cr-
TRX1 is an excellent substrate of mammalian thioredoxin reductase and is able to reduce 
insulin effectively.  These findings indicate that unlike the classical 12 kDa TRX, an 
acidic residue at this position is not essential for the catalytic activity of Cr-TRX1.  
 
4.7 The N-terminal extra cysteine residue of Cr-TRX1   
Based on the study on the human TRX1, it has been shown that the mammalian 
12 kDa TRXs have three conserved cysteine residues at positions 62, 69 and 73, besides 
the two conserved cysteines in the active motif.  Those Cys residues may impart unique 
biological properties to the mammalian 12 kDa TRXs (Holmgren, 1985).  The crystal 
structure also revealed that human TRX1 can form a dimer via Cys73, and the active site 
residues are buried in the dimer interface (Weichsel et al, 1996).  Surprisingly, although 
most of the 16 kDa TRXs, like the bacterial 12 kDa TRX, do not contain an extra Cys 
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residue besides the ones in the active site, the Cr-TRX1 possesses an extra Cys residue at 
the N-terminus (Figure 3.23).  Interestingly, while the Cr-TRX1 lacks the C-terminal 
extra Cys residue, it could form a dimer with a molecular mass of 32 kDa (Figure 3.31).  
It is possible the Cr-TRX1 can form a dimer via the N-terminal Cys15.  However, at this 
stage, it is still unclear if such dimer also exists under physiological conditions, and 
therefore, the role of the extra N-terminal Cys in the dimer formation needs further 
examination. Nevertheless, the mass spectrometric analysis of the Cr-TRX1 
demonstrated that only the two conserved Cys residues in the active site were redox 
active indicating that, similar to the human TRX1, the Cr-TRX1 dimer may represent a 
naturally occurring form of protein (Weichsel et al, 1996).  Further mutation and 
structure studies would be useful to define the function of the extra N-terminal Cys15 
residue in Cr-TRX1. 
 
4.8 The origin of the vertebrate 24 kDa TRXs   
In the vertebrates, there are two families of TRXs with high homology to the 16 
kDa TRX; one is 16 kDa and another one is 24 kDa (TRX6) (Figure 3.43).  However the 
invertebrates only possess the 16 kDa TRXs and the bacteria are devoid of these 
homologues.  This observation suggests that the 16 kDa TRXs have evolutionarily 
diverged from the 12 kDa TRXs at an early stage and the 16 kDa TRXs probably 
underwent gene duplication and divergence in the vertebrates and gave rise to the 24 kDa 
TRXs (Zhang, 2003) (Figure 3.43).  Interestingly, unlike the invariable WCPPC catalytic 
motif in the 16 kDa TRXs of invertebrates, the active sites of the 16 kDa and 24 kDa 
TRXs of vertebrates have undergone marked changes (Figure 3.44).  For human 16 kDa 
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TRX and zebrafish 24 kDa TRX, even the most conserved Cys residues has been 
replaced with Ser residues.  It is therefore reasonable to postulate that the duplication and 
further evolution of the gene encoding the 16 kDa TRX in the vertebrates have probably 
relaxed the selection pressures and accelerated the evolution of novel catalytic motifs and 
functions (Force et al, 1999; Zhang, 2003).  Therefore, it will be interesting to investigate 
if the 16 kDa and 24 kDa TRXs in mammals still conserve and exhibit the basic 
enzymatic functions of the invertebrate 16 kDa counterparts.  Simultaneously, it would be 
pertinent to explore the functional similarities /differences between the 16 kDa and 24 
kDa TRXs in the vertebrates.  This begs the following question: is it possible that each of 
these very similar TRX proteins will fulfill specific and important roles in the cell in 
addition to their ability to backup one another under some stress or inflammatory 
conditions?  The differing specificities may be due to their different amino acid 
sequences in the active motif that permit interactions with particular substrate proteins 
(Aslund and Beckwith, 1999).  Alternatively, there might be an adaptor molecule that 
connects the various TRXs and links TRXs to their respective substrates. 
 
4.9 Cr-TRX1 regulates NF-κB signaling pathway 
Human TRX1 has been shown to regulate the NF-κB activity distinctly in the 
cytoplasm and in the nucleus.  In the nucleus, TRX1 enhances NF-κB transactivation 
activity; however in the cytoplasm, TRX1 inhibits the degradation of IκB and prevents 
the activation of NF-κB (Hirota et al, 1999).  Studies by Matthews et al. (1992) and 
Meyer et al. (1993) showed the DNA-binding activity of NF-κB to be under redox 
regulation through the modulation of Cys residues, and that the NF-κB components, p50 
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and p65, contain well-conserved cysteine residues in their DNA-binding loops (Ghosh et 
al, 1995).  This implies that to activate NF-κB, an oxidative process that is antagonized 
by TRX must first facilitate IκB degradation, then translocated NF-κB in the nucleus  
must be reduced by TRX for effective DNA binding and transactivation (Flohe et al, 
1997).    
Our transient transfection studies showed that the 16 kDa Cr-TRX1 could 
positively regulate the TNFα-induced NF-κB activation and the enhancement of NF-κB-
dependent gene expression was not due to the expression level and subcellular 
localization of NF-κB proteins (Figure 3.39).  This regulation of NF-κB activity could be 
due to the redox regulation through the modulation of cysteine residues in Cr-TRX1, as 
observed from the complete loss of the augmentation of NF-κB activity when the HeLa 
cells were transfected with Cys-mutant Cr-TRX1 instead (Figure 3.38).  This suggests 
that, like human TRX1, the activity of the Cr-TRX1 could be attributable to the two 
strategically located cysteine residues at its active site, and that its activation of NF-κB 
activity is via the redox regulation. 
To determine whether the increase in NF-κB activity observed was indeed due to 
increase in its DNA-binding activity, gel shift assay utilizing biotin-labeled human NF-
κB consensus sequence was performed.  From Figure 3.40, it could be observed that 
under normal conditions, the DNA-binding activity of NF-κB was minimal.  However, 
with TNFα stress alone, there was a dramatic increase in the DNA-binding activity of 
NF-κB, as observed from the increased intensity of the protein-DNA complex.  With 
overexpression of Cr-TRX1 in the HeLa cells, the protein-DNA complex formation 
became more intense; but when mutant Cr-TRX1 was introduced instead, this complex 
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returned to the basal level (HeLa with TNFα stress only).  Hence, the TNFα-mediated 
increase in NF-κB activity in association with the overexpression of Cr-TRX1 is 
specifically attributable to the increase in DNA-binding activity of NF-κB.  Therefore, it 
is reasonable to postulate that similar to human TRX1 (Hirota et al, 1999; Matthews et al, 
1992), the Cr-TRX1 could reduce the Cys residue in the CrNFκB DNA-binding motif to 
enhance its binding to κB site. 
Interestingly, we found that the NF-κB-modulating activity is rather conserved in 
the human TRX6 as it could cross-enhance the horseshoe crab NF-κB DNA-binding 
activity as well (Figure 3.46), suggesting the functional conservation amongst the 16 kDa 
and 24 kDa TRXs.  Although the exact mechanism underlying the regulation of the NF-
κB activity by Cr-TRX1 and TRX6 is still unknown, our studies strongly suggest that the 
NF-κB regulatory activity might be a common characteristic of the 16 kDa TRXs.  The 
mechanism of TRX6-mediated regulation of the human NF-κB signaling pathway upon 
various stress conditions is being investigated in this lab to further define the functions of 
TRX6. 
Recently, Leveillard et al. (2004) demonstrated that a mouse homologue of the 24 
kDa human TRX6, named rod-derived cone viability factor (RdCVF), could slow down 
the degeneration of cone cell in animal models.  Thus, it offers a possible treatment for 
retinitis pigmentosa – an untreatable retinal disease.  The disease initiates with the loss of 
night vision due to rod photoreceptor degeneration, followed by irreversible, progressive 
loss of cone photoreceptors (Kajiwara et al, 1994).  As cones are essential for day and 
high-acuity vision, loss of the cones is responsible for the main visual handicap. 
Although the mechanism of how RdCVF protects the cone cells is still unknown, another 
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study by Krishnamoorthy (1999) found that preservation of NF-κB binding activity in the 
nucleus may be essential for mouse cone photoreceptor cells to survive photo-oxidative 
damage induced apoptosis.  
In this study, we have found that the human TRX6 could enhance the DNA 
binding ability of the horseshoe crab NF-κB in electrophoretic mobility shift assay, 
thereby indicating cross-species functionality and the conservation of an important 
biological function of the TRX6.  Therefore, we hypothesize that the human TRX6 might 



















CHAPTER 5:   CONCLUSIONS AND FUTURE PERSPECTIVES 
 
5.1 Conclusions 
5.1.1 NF-κB/IκB signaling cascade 
In this thesis, we have reported the elucidation of similar homologues of NF-κB 
and IκB in a species of horseshoe crab, the C. rotundicauda, and showed that their 
activation mechanism and transactivation properties were functionally comparable to that 
of the Drosophila and mammals.  We further demonstrated that the activated NF-κB can 
regulate the expression of immune-related genes in the hemocytes, including Factor C 
and iNOS.  Our findings clearly demonstrate that although absent in the C. elegans, the 
NF-κB/IκB signaling pathway has co-evolved and remained well-conserved from 
horseshoe crab to human, playing an archaic but crucial and fundamental role in innate 
immune response to regulate the expression of critical immune defense molecules (Wang 
et al, 2006b).  These observations reveal the earliest origin of a seminal signaling cascade 
and provide critical insights into the evolution of the NF-κB transcription factors.  Our 
findings provide further support to the view that NF-κB proteins originated from a 






5.1.2 The novel 16 kDa Cr-TRX1 and its role in NF-κB signaling 
pathway 
 
We also discovered a novel 16 kDa thioredoxin (Cr-TRX1) from the horseshoe 
crab which regulates the CrNFκB activity.  Previously, this 16 kDa TRX was thought to 
only exist in the parasitic protozoa of trypanosomes, an etiological cause of severe 
tropical diseases.  However we found that these 16 kDa TRXs also exist in higher 
eukaryotes and are evolutionary conserved from C. elegans to humans.  Although the Cr-
TRX1 is larger than the classical 12 kDa counterpart and contains an atypical catalytic 
motif, it possesses the classical thioredoxin activity.  Cr-TRX1 activates the NF-κB 
activity by enhancing its DNA-binding activity, suggesting possible roles of the Cr-TRX1 
in modulating NF-κB signaling pathway.  Importantly, we found that the 16 kDa TRX 
probably underwent gene duplication in the mammals to give rise to a novel 24 kDa TRX.  
We also demonstrated, surprisingly, that the human 24 kDa TRX could exert a cross-
phylum enhancement of the DNA-binding activity of the horseshoe crab NF-κB, 
suggesting the functional conservation amongst the 16 kDa and 24 kDa TRXs. 
 
5.2 Future perspectives 
Based on work done in this thesis, there are several interesting directions for 
future work in the areas of NF-κB signaling pathway and thioredoxin–mediated 
regulation of the NF-κB activity.  The following questions may be posed and innovative 
experiments may be designed to elucidate:  
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1)   What are the functional differences/ similarities between CrNFκB and CrRelish? 
We have isolated two NF-κB homologues, CrNFκB and CrRelish.  To better 
understand their roles in immune response, it will be necessary to examine the functional 
similarities/differences between the two NF-κB proteins.  Challenging the horseshoe 
crabs with different pathogens and inspecting the resulting activation of CrNFκB and 
CrRelish may serve to give an indication on how these NF-κB homologues mediate 
pathogen specific immune reactions.  Like its insect and mammalian homologues, the 
CrRelish is a mosaic protein which contains both RHD and inhibitory IκB domain.  It 
will be important to determine whether CrRelish is proteolytically processed during 
bacterial challenge and the consequential subcellular localization of the full-length and 
the cleavaged CrNFκB proteins.  Furthermore, the interactions between CrRelish and 
CrNFκB and the roles of different homo- and heterodimers on gene transcription may be 
investigated to better characterize their roles in innate immunity.    
 
2)  What are the receptors for horseshoe crab NF-κB pathway activation? 
Further study is also needed to demonstrate which receptor is responsible for the 
activation of horseshoe crab NF-κB signaling pathway (Inamori et al, 2004).   Recently, 
our lab has isolated a TLR homologue from the horseshoe crab (Loh et al. unpublished 
data).  It is therefore pertinent for us to examine if the horseshoe crab TLR could activate 
the NF-κB signaling pathway.  This can be achieved by overexpression of the horseshoe 
crab TLR and examining the activation of NF-κB pathway.  It will be interesting to 
demonstrate the membrane localization of the horseshoe crab TLR by 
immunocytochemistry.  Given that the horseshoe crab contains two NF-κB homologues, 
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further analysis may be required in order to understand the contribution of TLR to the 
activation of each of these NF-κB homologues upon pathogen infection.   
Recently, it has been demonstrated that the horseshoe crab Factor C also exist on 
the hemocytes membrane as a receptor for invading pathogens (Ariki et al, 2004).  It 
would be interesting to determine whether recognition of pathogen by the “Factor C 
receptor” would lead to the activation of NF-κB signaling pathway in horseshoe crab. 
 
3)   What are the functions of horseshoe crab iNOS in immune response and its    
      transcription regulation 
An iNOS homologue named CriNOS has been cloned from the horseshoe crab in 
our lab (unpublished data).  iNOS plays an important role in immune response in the 
Drosophila and mammals (Foley and O'Farrell, 2003).  Surprisingly, the C. elegans 
genome does not encode the NF-κB and iNOS gene.  It suggests that the CriNOS is 
probably the most ancient iNOS gene.  It also indicates that the NF-κB transcription 
factor and iNOS probably originated at the same time and have co-evolved.  Therefore, it 
will be interesting to investigate the function of CriNOS in the immune defense of 
horseshoe crab.  Several experiments can be carried out to characterize the functions of 
CriNOS:  i) analysis of the mRNA expression of iNOS and the level of NO in horseshoe 
crab hemocytes with or without bacterial challenge; ii) whether the recombinant iNOS 
can produce NO. 
Furthermore, our RT-PCR experiments already showed that bacterial infection 
can significantly induce the expression of iNOS and horseshoe crab NF-κB signaling 
pathway probably controls the up-regulation of CriNOS in the hemocytes (Figure 3.21).  
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The observation is very interesting because no such evidence has been forthcoming in 
any invertebrate.  In order to understand the mechanism of transcription regulation of 
CriNOS, the promoter of CriNOS could be isolated and characterized.  We expect the 
existence of potential κB site(s) on the promoter of CriNOS.  Then gel shift using iNOS 
promoter κB binding site(s) as probe may be performed to examine the binding 
characteristic of the CriNOS κB motif(s) with the NF-κB proteins.  Cotransfection of 
CrNFκB and iNOS promoter reporter can be performed as well to elucidate/delineate the 
promoter activity and active site(s) of CriNOS promoter. 
 
4)   What are the roles of the human 16 kDa TRX homologue (TRX6) in regulating     
      NF-κB signaling pathway? 
We have found that the 16 kDa Cr-TRX1 in the horseshoe crab could regulate the 
NF-κB signaling pathway.  Its human counterpart, TRX6, could enhance the horseshoe 
crab NF-κB DNA-binding activity as well.  It is thus imperative to seek translational 
insights from the horseshoe crab innate immune system to the human innate immune 
system.  To this end, it would be logical to test the ability of human TRX6 in regulating 
the human NF-κB signaling pathway. 
To achieve this, TRX6 will be overexpressed in different human cell lines and 
examined for its functions upon pathogen challenge and stress conditions.  We expect the 
TRX6 to synergistically up-regulate NF-κB activity upon challenge. To gain further 
insights into the mechanisms of action, real-time bioimaging may be exployed to 
examine whether TRX6 translocates into nucleus and colocalize with NF-κB using.  
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Furthermore, the role of TRX6 in regulating NF-κB signaling will be examined in NF-κB 
knockout mice. 
 
We envisage that research on the horseshoe crab innate immunity will establish 
fundamental understanding of the signaling pathway, which regulates the immune 
defense against the microbial infection.  Being devoid of adaptive immune response, our 
study on the horseshoe crab NF-κB signaling pathway and its regulation is unperturbed 
by potential interference of the adaptive immune response and serves as a prelude to the 
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